ESSENTIAL PATHWAYS AND GENE REGULATION FOR CELL WALL HOMEOSTASIS IN BACILLUS SUBTILIS by Zhao, Heng
  
 
 
ESSENTIAL PATHWAYS AND GENE REGULATION FOR CELL WALL HOMEOSTASIS 
IN BACILLUS SUBTILIS 
 
 
A dissertation 
Presented to the Faculty of the Graduate School  
of Cornell University 
in Partial Fulfillment of the Requirements for the Degree of  
Doctor of Philosophy 
 
By 
Heng Zhao 
August 2018 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2018 Heng Zhao 
ALL RIGHTS RESERVED  
  
 
ESSENTIAL PATHWAYS AND GENE REGULATION FOR CELL WALL 
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Heng Zhao, Ph.D. 
Cornell University 2018 
The cell wall is an essential component of most bacterial cells, and cell wall targeting 
antibiotics have greatly improved human health and life span. Despite intense research over the 
last 50 years, we still lack a complete understanding of how bacteria maintain cell wall homeostasis. 
Here we attempt to integrate new data from the last few years with some established ideas in the 
field, and we propose a new model of cell wall biogenesis in rod-shaped bacteria (Chapter 1). 
The lipid II cycle is central to peptidoglycan (PG) synthesis. A common C55 lipid carrier, 
undecaprenyl-pyrophosphate (UPP) is used for the synthesis of both peptidoglycan and wall 
teichoic acids to ferry precursors across the cytoplasmic membrane. Here we demonstrate that B. 
subtilis requires either one of two UPP phosphatases, UppP or BcrC, for the recycling of this 
essential molecule for continuous synthesis of cell wall (Chapter 2).  
Peptidoglycan synthesis relies on intermediates derived from central metabolism. We 
found that an aspB mutant is auxotrophic for aspartate and lyses when grown on Difco sporulation 
medium due to limitation of the peptidoglycan precursor meso-2,6-diaminopimelate (mDAP), a 
downstream metabolic intermediate of aspartate. Interestingly, we found that when bacteria 
experience a shortage of aspartate, the first breakpoint is not protein but peptidoglycan synthesis, 
which predisposes them to cell wall weakness and sensitizes them to antibiotics targeting late steps 
of PG synthesis. This work highlights the ability of perturbations of central metabolism to sensitize 
cells to peptidoglycan synthesis inhibitors (Chapter 3). 
  
 
Bacillus subtilis uses alternative sigma factors to regulate gene transcription upon stresses. 
Being a powerful double-edged sword, it is essential to keep this regulatory network under check. 
Here we show that the absence of its anti-sigma factor(s) leads to dysregulation of SigM, which 
drives a positive feedback loop for its own synthesis and SigM accumulates to a toxic level. High 
SigM activity overproduces membrane proteins and causes protein secretion stress, which lead to 
cell morphology and severe growth defects (Chapter 4). Collectively, the work in this dissertation 
provides additional insights of essential pathways and gene regulation for cell wall homeostasis in 
Bacillus subtilis. 
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Chapter 1. Don’t let sleeping dogmas lie: New views of 
peptidoglycan synthesis and its regulation 
1.1 Abstract 
Bacterial cell wall synthesis is the target for some of our most powerful antibiotics and has 
thus been the subject of intense research focus for more than 50 years. Surprisingly, we still lack 
a fundamental understanding of how bacteria build, maintain and expand their cell wall. Due to 
technical limitations, directly testing hypotheses about the coordination and biochemistry of cell 
wall synthesis enzymes or architecture has been challenging, and interpretation of data has 
therefore often relied on circumstantial evidence and implicit assumptions. A number of recent 
papers have exploited new technologies, like single molecule tracking and real-time, high 
resolution temporal mapping of cell wall synthesis processes, to address fundamental questions of 
bacterial cell wall biogenesis. The results have challenged established dogmas and it is therefore 
timely to integrate new data and old observations into a new model of cell wall biogenesis in rod-
shaped bacteria. 
1.2 Introduction 
Most bacteria surround themselves with a cell wall, a complex biopolymer with a crucial 
role in maintaining cellular integrity and cell shape. Due to its essentiality for bacterial growth and 
survival, the bacterial cell wall constitutes an ideal target for antibiotics, and there has been a 
longstanding scientific interest in the mechanisms of its synthesis and turnover. Pioneering work 
beginning over 50 years ago established the general composition of the cell wall (or sacculus) as 
a single large molecule made primarily of peptidoglycan (PG). The Gram-positive cell wall also 
contains a large amount of teichoic acid, including wall teichoic acids covalently linked to PG  
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(Brown et al., 2013, Reichmann & Grundling, 2011)). PG is a mesh-like macromolecule 
comprising roughly parallel glycan strands of polymerized disaccharide (N-acetylglucosamine-N-
acetylmuramic acid; or NAG-NAM), which are intermittently crosslinked with neighboring 
strands by peptide bonds between short oligopeptides (pentapeptides) attached to the NAM 
residues (Strominger et al., 1971, Strominger et al., 1959, Anderson et al., 1967, Anderson et al., 
1966).  
This basic PG structure is conserved amongst essentially all Bacteria, although there are 
variations in the details. These include differences in glycan strand chain length and a diversity of 
peptide crosslinks. The peptide crosslinks vary in amino acid composition and modifications (e.g. 
amidation), the addition in some species of interstrand bridging peptides, the precise site of 
interstrand linkage, and their overall density (Espaillat et al., 2016, Quintela et al., 1995). The PG 
sacculus can be further modified after synthesis by occasional additions to the glycan strands, for 
example of acetyl residues (O-acetylation, (Moynihan et al., 2014)). Despite these subtle variations, 
the overall PG structure is highly conserved when compared to other bacterial surface layers 
(including capsules, S-layers, and enterobacterial O-antigen) and therefore PG and its derivatives 
serve as effective pathogen-associated molecular patterns (PAMPs) for host recognition of 
bacterial infection (Mogensen, 2009).  
Despite being the focus of intense research, conspicuous gaps in our knowledge of PG 
biogenesis have persisted over decades, and some long-entrenched ideas have been found to be 
either incorrect or incomplete. Recent studies of the enzymology, genetics and cell biology of PG 
synthesis have challenged many long-standing assumptions. Here, we review recent insights into 
PG synthesis, largely from studies of the rod-shaped model organisms Escherichia coli and 
Bacillus subtilis. The focus will be the enzymology and cell biology of proteins involved in cell 
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elongation and division. We conclude by proposing a new model of cell wall biogenesis that 
incorporates these recent findings.  
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Figure 1.1. Unified (A) and Interdependent (B) models of peptidoglycan (PG) synthesis complexes.  
(A) In the unified model, RodAZ, MreB, aPBPs and bPBPs form one protein complex: guided by MreB, 
the aPBPs produce peptidoglycan strands via their TG domains while both aPBPs and bPBPs crosslink 
these strands into a tight PG mesh.  
(B) In the interdependent model, RodAZ, bPBP and MreB form one complex, while aPBP works in a 
different spatial and temporal frame. Glycan strands are produced by the transglycosylase RodA and are 
crosslinked by bPBP to existing PG. PG synthesis provides the force for pushing circumferential MreB 
movement. aPBPs exhibit a different movement pattern distinct from MreB, including two modes of 
movement: fast diffusion and slow movement (pause). These two systems are spatially distinct, but 
functionally interdependent for PG synthesis. 
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1.3 Enzymology of PG synthesis: variations, nuances, and the key points of 
controversy 
Assembly of the PG layer requires three major stages: precursor synthesis in the cytoplasm 
to generate the key intermediate lipid II, the lipid II cycle (translocation, transglycosylation, and 
recycling of the carrier lipid), and glycan strand crosslinking and maturation. As would be 
expected for such a central process in bacterial cell biology, the key enzymes for PG synthesis are 
generally well-established. However, the overall process displays more plasticity than originally 
envisioned, some key enzymes have remained elusive or controversial, and several puzzling 
genetic observations have only recently been resolved.  
PG synthesis starts in the cytoplasm, where the precursor molecule UDP-NAM-
pentapeptide is produced by enzymes encoded by the mur genes as well as the D-Ala-D-Ala ligase 
Ddl as the last soluble precursor (Lovering et al., 2012). Ligation of this precursor to an 
undecaprenyl (C55) carrier lipid by the membrane-associated enzyme MraY generates lipid I, the 
first membrane-associated intermediate. MurG ligates a NAG residue to lipid I to generate the 
final, lipidated disaccharide-pentapeptide precursor referred to as lipid II (Scheffers & Tol, 2015). 
Once synthesis is complete on the cytoplasmic face of the inner membrane, the lipid II precursor 
must be translocated (flipped) to the outer face of the membrane by a flippase, where the final 
steps of PG assembly occur. Following assembly, PG may be further modified and serves as a 
scaffold for the anchoring of wall teichoic acids (in Gram-positive bacteria), proteins, and other 
surface structures and appendages (Siegel et al., 2016, Brown et al., 2013, Guest & Raivio, 2016). 
Lipid II provides the subunits that are polymerized into glycan strands via a 
transglycosylation (TG) reaction. The lipid carrier is released as undecaprenyl-pyrophosphate and 
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recycled into the cytoplasm by a putative, as yet unidentified C55-pyrophosphate flippase, which 
may or may not be the same as the lipid II flippase. The TG reaction has historically been thought 
to be mediated solely by bifunctional (class A) penicillin binding proteins, here designated as 
aPBPs (Goffin & Ghuysen, 1998, Sauvage et al., 2008). The polysaccharide strands resulting from 
the TG reaction are subsequently covalently linked via D, D transpeptidation (TP) reactions to 
form peptide bond crosslinks between the glycan strands (Sauvage et al., 2008). The acceptor 
amino group derives from the side chain of the third amino acid (typically diaminopimelic acid, 
DAP3 or lysine, Lys3, depending on the species) with D-Ala4 as the donor (generating a 4-3 
crosslink); this results in the release of the terminal D-Ala5 from the donor strand (McDonough et 
al., 2002, Mainardi et al., 2008). The TP reaction can be mediated by either aPBPs (which possess 
both TG and TP activity) or by monofunctional D, D-transpeptidases (class B PBPs, designated 
here as bPBPs).  
This basic, textbook version of PG synthesis provides a framework for a more detailed 
consideration of how this process may differ between organisms or be modified in response to 
stress. Moreover, some of the central steps in PG synthesis have retained an aura of mystery, with 
a lack of consensus about the identity of key enzymes and some confounding genetic observations. 
Recent excitement centers on three major advances. First, the proteins that translocate the lipid II 
precursor from the cytosolic to the external face of the membrane are now becoming clear. Second, 
a long predicted but elusive PBP-independent TG activity has been defined. Third, variations in 
the nature of the PG intra-strand crosslinking reactions, and in particular the presence and impact 
of 3-3 in place of 4-3 crosslinks, is an emerging area of focus.   
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1.3.1 MurJ and functionally redundant lipid II flippases  
After its generation in the cytoplasm, the PG precursor lipid II must be translocated 
(“flipped”) across the cytoplasmic membrane to provide the substrate for cell wall synthesis 
enzymes. The identity of the lipid II flippase(s) has been the subject of a longstanding controversy. 
Using a reductionist bioinformatics approach, Ruiz first proposed the membrane-anchored protein 
MurJ as the lipid II flippase in E. coli and supported this notion by demonstrating that MurJ is 
essential and required for PG synthesis (both of which would be expected of a flippase) (Ruiz, 
2008). This was later challenged by Mohammadi et al., who used an in vitro assay to demonstrate 
flippase activity of purified FtsW protein, and thus speculated that SEDS (shape, elongation, 
division, and sporulation) family proteins (including RodA, FtsW and SpoVE in B. subtilis), rather 
than MurJ, were flippases (Mohammadi et al., 2011). Another key point of their argument was 
that while a flippase is expected to be universally essential, all MurJ homologues could be deleted 
in B. subtilis (Fay & Dworkin, 2009).  
Two recent studies have shed some more light on this controversy. Using an in vivo 
biochemical assay, Sham et al. demonstrated that MurJ does have lipid II flippase activity (Sham 
et al., 2014). Importantly, in the same study, depleting FtsW in a ∆rodA background (essentiality 
of rodA was suppressed by overexpression of the ftsQAZ operon (Kruse et al., 2005)) did not affect 
precursor translocation, suggesting that RodA and FtsW are entirely dispensable for this process. 
Another recent study addressed the important question of why MurJ proteins were (collectively) 
non-essential in B. subtilis. Using a synthetic lethal screen (via transposon insertion sequencing), 
Meeske et al. searched for genes that become essential in the absence of all MurJ homologs, 
arguing that an alternative flippase must exist and should be synthetic lethal with MurJ (Meeske 
et al., 2015). The screen was answered by a locus that was renamed amj (“alternate to MurJ”); 
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intriguingly, the predicted Amj protein bears no sequence or structural homology to MurJ. Using 
the in vivo biochemical assay mentioned above (Sham et al., 2014) it was demonstrated that both 
MurJ and Amj can mediate lipid II translocation across the inner membrane; in addition, Amj 
could functionally replace MurJ in E. coli. Interestingly, amj is induced in the absence of MurJ, 
and its expression depends on the cell wall stress responsive alternative sigma factor SigM 
(Helmann, 2016, Eiamphungporn & Helmann, 2008, Meeske et al., 2015).  Thus, B. subtilis can 
respond to inhibition of one of its flippases, perhaps by currently unknown antibiotics, with the 
expression of an alternative, structurally unrelated enzyme. In summary, there are now strong data 
supporting the role of MurJ and Amj as lipid II flippases. The role of FtsW remains controversial; 
however, recent revelations about the similar SEDS family protein RodA provide us with some 
room to speculate on FtsW function (see next section).  
Important open questions remain concerning the reverse side of the flippase reaction; after 
transglycosylation, the undecaprenyl pyrophosphate (UPP) portion of lipid II remains on the outer 
leaflet of the cytoplasmic membrane. UPP molecules in the cell membrane are limited and UPP 
must therefore be efficiently recycled. This is accomplished by known, membrane-associated 
enzymes (UPP phosphatases) that convert UPP to undecaprenyl phosphate (UP), which can be 
reintroduced into the lipid II cycle (El Ghachi et al., 2005, Zhao et al., 2016).  Due to the size and 
charge of the lipid carrier, it is generally expected to be translocated back into the cytoplasm by 
an enzyme facilitator rather than via spontaneous flipping, but the identity of this putative 
facilitator remains unknown.  
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1.3.2 The SEDS protein RodA has TG activity 
The transglycosylation (TG) reaction is a crucial step in periplasmic cell wall assembly. 
Until recently, two classes of enzymes were known or predicted to perform the TG reaction: 
monofunctional transglycosylases (MTGs) and the TG domains of aPBPs.  While MTGs have a 
demonstrated role in cell wall synthesis in some coccoid Gram-positive bacteria like 
Staphylococcus aureus (Reed et al., 2011), they are not widely conserved (absent for example in 
B. subtilis) and their physiological role in rod-shaped bacteria is unclear as there are no strong 
phenotypes associated with deletion or overexpression mutants (Denome et al., 1999, Di 
Berardino et al., 1996). Hence, the aPBPs were generally considered as the principal TGases 
during cell wall biosynthesis.  
This dogma was challenged over a decade ago, when David Popham’s group found that B. 
subtilis was able to grow (albeit poorly) in the absence of all aPBPs (McPherson & Popham, 2003). 
This striking finding strongly suggested that an unidentified TGase could compensate for the loss 
of aPBPs by collaborating with the TP function of a bPBP. Other groups have reported similar 
observations in Enterococcus spp. (Arbeloa et al., 2004, Rice et al., 2009). Intriguingly, a study 
from more than 30 years ago had already provided a candidate for Popham’s “missing” 
transglycosylase.  Ishino et al., while conducting studies on PG synthesis processes mediated by 
the bPBP2 (for clarity, we will add the a/b class prefix to specific PBPs throughout the text), found 
that crude membrane extracts of E. coli produced cell wall material when they were isolated from 
a strain in which bPBP2 as well as RodA were overproduced (the aPBPs were at the same time 
inactivated using antibiotics) (Ishino et al., 1986). Using bPBP2-specific antibiotics and 
thermosensitive variants of both bPBP2 and RodA, these authors dissected the contribution of each 
protein to the PG synthesis process and found that while bPBP2 was, as expected, required for the 
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crosslinking part of assembly, RodA was required for chain elongation. They then discussed the 
possibility that RodA itself possessed transglycosylase activity, but dismissed this as “unlikely” 
and rather concluded (in light of what was known about PBPs in 1986) that bPBP2 itself had TG 
activity that was somehow stimulated by RodA. These observations were thus not integrated into 
later models of cell wall synthesis. Later, the idea that RodA possessed TG activity was further 
obscured by the proposal (as noted above) that another SEDS protein, FtsW, functioned as a lipid 
II flippase based on an in vitro biochemical assay (Mohammadi et al., 2011), fueling the 
assumption that this was true for RodA as well. FtsW and RodA were thus tentatively assigned as 
flippases, as noted above.  
Several recent papers from the Bernhardt, Ruiz, Rudner and Errington labs have provided 
new insights into the roles of SEDS proteins. First, the identification of MurJ (and Amj in B. 
subtilis, see previous section) as a lipid II flippase (Meeske et al., 2015), re-established the 
possibility that RodA and FtsW have activities other than (or in addition to) precursor translocation. 
Then, using independent approaches (homology search (Meeske et al., 2016) or candidate genes 
elimination (Emami et al., 2017)), it was discovered that RodA has TGase activity in vitro (Meeske 
et al., 2016), and that overexpression of RodA rescued the strong growth defect of the B. subtilis 
strain lacking all aPBPs (Meeske et al., 2016, Emami et al., 2017). Possible natural molecule 
inhibitors of RodA were also identified (Emami et al., 2017).  
Interestingly, these data provided an explanation for another curious feature of B. subtilis: 
its resistance to moenomycin. Moenomycin is a potent aPBP transglycosylase inhibitor (Welzel, 
2007, Gampe et al., 2013, Rebets et al., 2014) whereas RodA TG activity was found to be 
unaffected by moenomycin in vitro (Meeske et al., 2016, McPherson & Popham, 2003). In B. 
subtilis, resistance to moenomycin depends on the SigM dependent cell envelope damage response, 
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and SigM induces expression of rodA (Eiamphungporn & Helmann, 2008, Meeske et al., 2016, 
Mascher et al., 2007). Thus, similar to Amj (see above), or PBP2a in Methicillin Resistant 
Staphylococcus aureus (Hao et al., 2012), B. subtilis enhances the expression of one cell wall 
synthesis enzyme (RodA) upon inhibition of another (aPBPs) (Meeske et al., 2015, Helmann, 
2016). 
RodA was also shown to contribute significant TG activity to cell wall synthesis mediated 
by the “elongasome” in E. coli (Cho et al., 2016). However, unlike its Gram-positive counterpart, 
this activity does not suffice to sustain growth in the absence of aPBPs. This might be a common 
feature in Gram-negative bacteria, as in these organisms depletion or inhibition of aPBPs typically 
leads to cessation of growth and/or lysis and death (Dorr et al., 2014, Yousif et al., 1985, Satta et 
al., 1995). 
Whether FtsW possesses TG activity has not been completely resolved. Recent 
biochemical evidence suggests that in E. coli, FtsW forms a complex with bPBP3 and aPBP1B at 
the division site (Leclercq et al., 2017). FtsW was also shown to bind lipid II and to negatively 
regulate aPBP1b activity using in vitro assays, and this inhibition was alleviated by the presence 
of bPBP3 (Leclercq et al., 2017). Importantly, FtsW did not exhibit TGase activity under these 
experimental conditions.  
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1.3.3 L,D-transpeptidases and diversification of PG architecture 
D-Ala4-D-DAP3 or D-Ala4-D-Lys3 (D,D) crosslinks (generally referred to as 4,3 
crosslinks), whose formation is mediated by D,D transpeptidases (the PBPs), have been established 
as the major type of PG crosslink. However, many bacteria also harbor L,D transpeptidases (LDT) 
(Magnet et al., 2008, Lavollay et al., 2008, Hernandez et al., 2015, Mainardi et al., 2000, Lam et 
al., 2009, Cava et al., 2011, Bramkamp, 2010, Magnet et al., 2007). These enzymes also catalyze 
TP reactions between two amino acids, e.g. between two DAP molecules in neighboring PG 
strands (using the energy stored in the DAP3-D-Ala4 bond), which at least in principle could lead 
to fully crosslinked PG.  Intriguingly, even mutants deleted in multiple or all L,D transpeptidases 
exhibit only minor phenotypes (Sanders & Pavelka, 2013) and the types of crosslinks these 
enzymes create (DAP-DAP or 3,3 crosslinks) are typically too rare to provide full structural 
integrity (Glauner et al., 1988, Desmarais et al., 2013). A notable exception is Agrobacterium 
tumefaciens, whose PG naturally consists of ~45% L,D crosslinks (Quintela et al., 1995). An 
increase in 3,3 crosslinks has been observed in multiple other species when cells enter stationary 
phase (where in Mycobacterium tuberculosis, up to 80% of PG can be crosslinked via DAP-DAP 
(Lavollay et al., 2008)), and under envelope stress conditions: activation of the Cpx response in E. 
coli for example led to a ~1.5-fold increase in DAP-DAP crosslinks (Lavollay et al., 2008, Bernal-
Cabas et al., 2015). It is therefore possible that L,D transpeptidation serves a supporting role for 
D,D crosslinks to further strengthen the PG meshwork under certain conditions.  
Early evidence that L,D transpeptidases could assume a more fundamental role in cell wall 
biogenesis came from the work of the Gutmann and Arthur labs. In a series of papers (Mainardi et 
al., 2000, Mainardi et al., 2002, Mainardi et al., 2005), these authors described the selection for a 
-lactam resistant mutant of Enterococcus faecalis, whose cell wall was found to be essentially 
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devoid of the classical D,D crosslinks mediated by PBPs. This mutant could grow in the presence 
of -lactam antibiotics by substituting the D,D crosslinks formed by the -lactam sensitive PBPs 
with those formed by a -lactam-insensitive  L,D transpeptidase named Ldtfm, which catalyzed 
transpeptidation between D-asparagine and L-lysine residues situated in neighboring PG strands, 
resulting in L,D (3,3) bonds (Mainardi et al., 2005). Interestingly, the activity or abundance of the 
Ldtfm or PBPs was unaltered in the resistant mutant. Instead, this strain showed an increase in the 
activity of a carboxypeptidase that removes the terminal D-Ala5; the resulting tetrapeptide 
sidestem is recognized by L,D transpeptidases, but not PBPs as a substrate. Thus, E. faecalis 
provides intrinsic substrate cues to reprogram the activity of PG crosslinking enzymes and thus 
the nature of its PG crosslinks. 
Another study recently reported that a similar mechanism of -lactam resistance can evolve 
in E. coli (Hugonnet et al., 2016). Upon multistep selection on -lactam antibiotics, a mutant 
emerged that had upregulated one of its L,D transpeptidases (YcbB) as well as the stringent 
response, a starvation response that leads to the accumulation of the alarmone ppGpp and 
subsequent reprogramming of transcription. While the connection between the stringent response 
and L,D-TP activity is unclear, this strain utilizes the TG activity of the aPBP1B in conjunction 
with TP activity of YcbB for cell wall synthesis and crosslinking. Like in E. faecium, the ability 
to form L,D crosslinks depended on the presence of a carboxypeptidase, in this case PBP5.  
Although these experiments involved mutants that were generated under severe and artificial 
selection conditions, these results clearly demonstrate that L,D-TPase activity can, at least in 
principle, be contribute significantly to the structural integrity of the cell wall. It remains to be 
seen whether the primary reliance on L,D transpeptidation for bacterial growth is an oddity 
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resulting from stringent conditions of mutant selection or can be an adaptive response (for example 
as a stress response mechanism in the presence of -lactam antibiotics) in nature as well. 
 
1.4 Cell biology of PG synthesis: New insights into the roles of the cytoskeletal 
proteins MreB and FtsZ  
The basic enzymology of PG synthesis was established in early studies following 
conventional approaches that integrated in vitro enzyme assays with chemical and structural 
characterization of reaction mechanisms and products. However, efforts to decipher the larger 
scale coordination of PG synthesis with cell growth and division did not make great strides until 
the advent of bacterial cell biology. The introduction of fluorescently labeled proteins, high 
resolution light microscopy methods, and, more recently, single-molecule tracking approaches has 
invigorated the field and enabled the development of new models of PG synthesis and its 
coordination. It is not enough to just be able to stitch together new PG; the newly synthesized 
glycan strands must be integrated into the existing sacculus in a manner that does not compromise 
the overall integrity and load-bearing properties of the wall, and old wall material must be 
simultaneously shed and recycled. How new areas of synthesis are defined in a manner appropriate 
for the maintenance of cell shape, as seen for example in rods, cocci, and helically shaped bacteria, 
has been a challenging problem. Here, we focus on the emerging view of the two primary 
biosynthetic, macromolecular complexes involved in synthesis of rod-shaped bacteria: the 
“elongasome” and the “divisome”.  
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1.4.1 MreB and the “elongasome”  
The transmembrane and periplasmic proteins associated with cell wall synthesis processes 
have been shown, or at least implicitly assumed, to be part of a single multiprotein complex called 
the “elongasome” (Laddomada et al., 2016, Egan et al., 2017, Errington, 2015) that contains 
structural components, as well as aPBPs, bPBPs, cell wall lytic enzymes (“autolysins”), and 
presumably a flippase. The “elongasome” was assumed to be spatio-temporally directed by the 
cytoskeletal protein MreB, a homologue of eukaryotic actin (van den Ent et al., 2001) that localizes 
to the lateral wall of the bacterial cell (Jones et al., 2001). One model suggests that MreB mediates 
the formation of regions with increased fluidity (RIFs), which affect distribution and diffusion of 
membrane proteins and may contribute to the organization of the “elongasome” (Strahl et al., 
2014). Until recently, a generally accepted model of cell wall synthesis proposed that MreB served 
to guide the aPBPs, which in turn produce peptidoglycan strands via their TG domains while the 
aPBPs and the bPBPs crosslink these strands into a tight PG mesh, fitting new material into cell 
wall gaps provided by the cleavage activity of autolysins (Figure 1.1A). However, the existence 
of an “elongasome” protein complex could never be demonstrated in vivo and recent single 
molecule tracking experiments revealed that MreB and aPBPs operate in distinct complexes (Cho 
et al., 2016). This, in addition to the recent revelation that RodA itself possesses TG activity, calls 
for a re-evaluation of MreB’s contribution to cell wall synthesis (Meeske et al., 2016, Emami et 
al., 2017). 
MreB is found in most rod-shaped bacteria and loss of MreB generally leads to the 
cessation of lateral cell wall synthesis and concomitant loss of rod-shape, establishing the 
cytoskeleton’s crucial role in directional PG insertion during cell elongation. MreB strongly 
interacts with RodA and RodZ in E. coli (Morgenstein et al., 2015) and the latter mediates the 
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indirect interaction between MreB and a bPBP. This established complex (MreB-RodAZ-bPBP) 
will be referred to hereafter as the “Rod complex”. 
Early localization studies using immunofluorescence and epifluorescence microscopy to 
visualize fluorescently tagged proteins in B. subtilis, E. coli and Caulobacter crescentus suggested 
that MreB localizes in helical filaments along the inner face of the cytoplasmic membrane spanning 
the lateral cell (Shih et al., 2003, Figge et al., 2004, Jones et al., 2001). However, using microscopy 
techniques that allowed for higher spatio-temporal resolution, it was later shown that instead of 
forming continuous filaments, MreB rotates around the cell in patches (arcs) whose motion 
depends on bPBP transpeptidation activity and the presence of RodA, but, at least in E. coli, not 
on the activity of aPBPs (Dominguez-Escobar et al., 2011, Garner et al., 2011, van Teeffelen et 
al., 2011). More recent data show that MreB locates to regions of negative curvature, and “corrects” 
this negative curvature by filling this region with newly synthesized PG, suggesting a self-
correcting feedback mechanism for cells to maintain rod shape (Ursell et al., 2014). Overall these 
data strongly support a model in which cell wall synthesis during cell elongation is mediated 
primarily by the Rod complex.  
Importantly, these single molecule studies have provided evidence for a spatial 
independence of the Rod complex and aPBPs (Figure 1.1B). In contrast,  the Rod complex and 
bPBPs appear to move along the same trajectories, suggesting that they may be coupled (Cho et 
al., 2016) (though it has to be noted that another study had previously found that MreB and bPBP2 
move at different velocities (Lee et al., 2014); this can be attributed to differences in imaging 
parameters and/or intrinsic differences between different fusion constructs, and may suggest that 
bPBP2’s circumferential motion is not essential for its function). In contrast, aPBPs showed a 
bimodal pattern of movement, with two distinct subpopulations: one exhibiting fast, diffusive 
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motion, and another moving at a speed an order of magnitude slower (Cho et al., 2016, Lee et al., 
2016). When considering the behavior of a single PBP molecule, these data can be interpreted as 
short periods of fast diffusion interspersed with temporary pauses. Although spatially independent, 
the partially redundant TG activities of the Rod complex and aPBPs are functionally coupled, as 
inactivation of one or the other leads to the same dramatic (~80%) decrease in incorporation of 
new cell wall material (Cho et al., 2016). This, together with the observation that in E. coli a bPBP 
interacts directly with aPBP1A (Banzhaf et al., 2012), suggests that the two seemingly independent 
activities of aPBPs and the Rod complex are somehow synergistic, and that they may at least 
transiently interface. A recent paper has exposed an additional layer of complexity about the 
relationship between the Rod complex and aPBPs. Using TIRF, Billaudeau et al. showed that in 
B. subtilis, MreB not only shows rotational movement, but has subpopulations that, similar to 
aPBPs, diffuse slowly or stop altogether (Billaudeau et al., 2017). This, coupled with indirect 
evidence of an interaction between MreB and aPBPs (Kawai et al., 2009) opens up the possibility 
that MreB and aPBPs associate. It is important to note that neither MreB patch rotational 
movement, nor aPBP activity, depend on each other (Cho et al., 2016, van Teeffelen et al., 2011); 
but whether diffusive MreB molecules functionally interact with aPBPs is not known. Further 
work is thus required to investigate the spatial and functional relationship between MreB (or at 
least a sub-population of it) and aPBPs. 
How does Rod-mediated cell wall synthesis apparently drive its own motion, while aPBPs, 
in principle mediating the exact same reactions, are more diffusive? One possibility is that RodA’s 
TG activity drives directional movement, and that its interaction with short, dynamic MreB arcs 
essentially reinforces this movement, while the aPBPs move along a similar trajectory for a short 
time, but produce shorter PG chains and diffuse away when the TG reaction is terminated (e.g. 
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through interaction with a putative chain termination factor, or due to an intrinsic capability to 
produce shorter PG chains). It is noteworthy that MreB was shown to interact with cytoplasmic 
cell wall precursor synthesis proteins and their localization changed during MreB depletion 
(Favini-Stabile et al., 2013, White et al., 2010, Rueff et al., 2014, Divakaruni et al., 2007), 
suggesting that MreB might coordinate the availability of precursors to generate a local pool of 
lipid II to support the activity of the Rod complex. This might be beneficial if RodA’s TG activity 
intrinsically generates longer PG strands than the aPBPs (generating shorter chains may enable the 
aPBPs to operate on a more limited local supply of lipid II).  
In the light of the existence of two independent cell wall synthesis complexes, an important 
open question is whether flippase activity is associated with one of the complexes, both, or is 
completely independent. Current data favor the latter hypothesis: heterologous expression of the 
Helicobacter pylori O-antigen flippase Wzk (Elhenawy et al., 2016) or B. subtilis Amj (Meeske 
et al., 2015) can functionally replace MurJ in E. coli. Amj has no homologs in E. coli and is thus 
unlikely to specifically interact with this organism’s cell wall synthesis machinery, suggesting that 
unguided lipid II flipping may be sufficient to sustain bacterial growth. Furthermore, cell wall 
incorporation after inhibition of either the Rod complex or aPBPs is not zero, implying residual 
flippase activity. Thus, it is likely that lipid II flippase activity is not strictly dependent on either 
complex. 
1.4.2 FtsZ and the divisome: FtsZ treadmilling drives PG synthesis at the septum 
FtsZ, a homolog of tubulin, is essential for cell division in many bacteria. Cytoplasmic 
FtsZ molecules polymerize at the inner face of the cytoplasmic membrane as a dynamic ring of 
FtsZ filaments of varying lengths (Michie & Lowe, 2006). This so-called “Z-ring” and various 
accessory factors anchor the assembly of a dynamic, spatio-temporally ordered multiprotein 
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complex called the divisome. The divisome contains what are generally assumed to be structural 
proteins, but also proteins involved in cell wall synthesis (PBPs) and turnover, like amidases and 
lytic transglycosylases (Egan & Vollmer, 2013). Ultimately, the FtsZ-guided divisome serves the 
function of facilitating cytokinesis, membrane constriction, synthesis of new cell wall material and 
finally daughter cell separation. Purified FtsZ is sufficient to initiate constriction of elongated 
liposomes (Osawa et al., 2009, Osawa et al., 2008), suggesting that FtsZ itself generates the forces 
for cell division, powered by GTP hydrolysis (RayChaudhuri & Park, 1992, de Boer et al., 1992). 
This was later challenged by results from experiments showing that constriction does not initiate 
in the absence of cell wall synthesis (Daley et al., 2016). Beyond these observations, the role of 
FtsZ outside of its anchor function remained largely mysterious.   
Several recent studies have addressed this issue with newly available super-resolution 
techniques. In two parallel studies, Bisson-Filho et al. and Yang et al. used single molecule 
tracking and super-resolution microscopy combined with targeted perturbations of division 
processes to assess the role of FtsZ filaments in the division process in B. subtilis and E. coli 
(Bisson-Filho et al., 2017, Yang et al., 2017b). Both groups found that short FtsZ filaments display 
a rotational, inward movement that coincides with the deposition of new cell wall material. 
Strikingly, and in contrast to MreB, FtsZ movement was independent of cell wall synthesis and 
driven by treadmilling, which depended on its GTPase activity. It thus appears that FtsZ generates 
its own motion, and induces cell wall synthesis during the constriction process. This observation 
could provide an explanation for previously inconsistent data: while FtsZ treadmilling by itself 
probably generates enough force to initiate membrane constriction, it is the reinforcement of these 
constrictions via guided traces of PG material that enables the completion of outer membrane 
constriction and cytokinesis. This more active, cytoskeleton-driven process of movement (as 
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opposed to MreB’s passive motion) might thus be necessary to apply the forces needed for cell 
division. 
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Figure 1.2. “Break before Make” model of peptidoglycan (PG) synthesis complexes. 
Rod/SEDS/MreB-associated endopeptidases locally cleave crosslinks in mature PG. RodA generates a PG 
template, which is attached to the sacculus via bPBPs (only one strand is shown here, note that in principle 
this could also be a raft structure of multiple parallel strands). The aPBPs then generate additional strands, 
which are crosslinked with nascent PG on one side and mature PG on the other, ensuring maintenance of 
structural integrity. Whether the Rod/SEDS/MreB complex interacts with aPBPs remains an open question. 
Crosslinked pentapeptide (asterisk) is formed when a nascent PG strand containing pentapeptide is 
crosslinked with another one. PBP-independent 3,3 crosslinks also exist albeit at low abundance under 
normal growth conditions. 
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1.5 An emerging model of PG synthesis for rod-shaped bacteria 
One of the most influential unified models of cell wall growth coordination was put forth 
in a seminal review paper by Höltje (Holtje, 1998). Asking how PG lytic and synthetic processes 
might be coordinated without compromising cell wall structural integrity, the author proposed that 
bacteria synthesize a precursor of three parallel, crosslinked PG strands, which would substitute 
for a single strand concomitantly removed by the coordinated activity of PG hydrolases; he termed 
this the “3-for-1” model. Höltje assumed that the parallel strands were generated before breaking 
any bonds in the PG meshwork (to ensure structural integrity), or a “make before break” mode of 
sacculus expansion.  This model has remained an important conceptual framework, but has not 
been re-evaluated in the light of subsequent new observations.  
We will attempt here to integrate new data on the mechanisms of PG biogenesis with 
previous observations into an updated model of cell wall biogenesis (Figure 1.2). Perhaps one of 
the most striking recent realizations is that the Rod complex and aPBPs are spatially distinct, yet 
their activities are interdependent. A possible model is that one cell wall synthesis complex creates 
a template structure for the other, consistent with what has been suggested by Wientjes et al. 
(Wientjes & Nanninga, 1991) and Cho et al. (Cho et al., 2016). We speculate that template 
generation is accomplished by the circumferentially moving population of the Rod complex, as 
steady, circumferential motion would be conducive to providing a regular template structure. In 
contrast, the aPBPs exhibit a diffusive motion interspersed with prolonged local persistence (Cho 
et al., 2016, Lee et al., 2016), which could suggest that their role is to diffuse freely until they 
recognize a PG trace or gap (e.g. one generated by the Rod complex) and then add new material 
to the template. Inhibition of a bPBP (PBP2) in E. coli results in the generation of PG fragments 
that are not incorporated into the PG meshwork but rather are rapidly degraded and recycled (Cho 
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et al., 2014, Uehara & Park, 2008), suggesting that in Rod-mediated PG synthesis, PBP2 provides 
the first point of attachment for nascent PG after (or while) it emerges from RodA-mediated 
transglycosylation. This first point of attachment would also be an important anchor providing a 
fulcrum for RodA-driven MreB movement; perhaps this is why inhibition of bPBPs stops MreB 
motion (van Teeffelen et al., 2011, Garner et al., 2011, Dominguez-Escobar et al., 2011) but allows 
futile synthesis of PG by RodA (Cho et al., 2016, Cho et al., 2014).  
Interestingly, at least in E. coli, a bPBP (PBP2) was shown to activate an aPBP (PBP1A) 
(Banzhaf et al., 2012). The fact that the Rod-associated bPBP stimulates the aPBP’s TG activity 
may suggest that rod-driven PG synthesis starts prior to aPBP-driven PG synthesis. We propose 
that the aPBPs likely use the Rod-mediated PG template to attach parallel (or possibly antiparallel) 
PG strands (Figure 1.2). In addition to providing lateral directionality of sacculus expansion, this 
is consistent with the observed existence of crosslinked PG strands containing pentapeptide: 
enzymatically, the only way to generate PG containing pentapeptides is when nascent PG is 
crosslinked with another strand of nascent PG (since the terminal D-Ala of the donor strand is lost 
in the crosslinking reaction). Moreover, pentapeptides are likely rapidly processed by 
carboxypeptidases associated with cell wall synthesis (Potluri et al., 2010, Santos et al., 2002, 
Atrih et al., 1999, Moll et al., 2015)), but  nascent-nascent crosslinks are indeed observed during 
pulse-chase PG labeling experiments (Burman & Park, 1984). Alternatively, these crosslinked PG 
strands containing pentapeptide may come from region with presumably less carboxypeptidase 
activity, for example the septum (Morales Angeles et al., 2017), or from PG generated by several 
Rod complexes working in parallel, as recently suggested for B. subtilis (Billaudeau et al., 2017). 
It is therefore possible that the Rod template actually consists of a PG “raft” structure of several 
strands that are then woven tightly into the cell wall by aPBPs. Why are the aPBPs partially 
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dispensable in B. subtilis (dependent on stress-response mediated upregulation of RodA) and not 
in E. coli? Perhaps the Rod complex template itself is enough to mediate sacculus expansion, as 
long as it is made in sufficient quantity (B. subtilis upregulates RodA upon aPBP deletion via the 
Sigma M cell wall stress sensing pathway) and as long as there is a sufficient stress-bearing 
“buffer”, i.e. a thick cell wall that can partially compensate for localized, inefficient crosslinking.  
Our model suggests that the Rod complex might coordinate its cell wall synthesis activity 
with PG cleavage by endopeptidases, which are required for the insertion of new PG material 
during cell elongation (Vollmer, 2012, Singh et al., 2012, Dorr et al., 2013) and should therefore 
immediately precede template attachment. Consistent with this hypothesis, MreB homologs in B. 
subtilis have been shown to direct the activities of elongation-specific endopeptidases LytE and 
(indirectly) CwlO (Dominguez-Cuevas et al., 2013, Meisner et al., 2013). Further, at least in 
Gram-negative bacteria, inhibition or depletion of aPBPs (leaving the putative RodA-autolysin 
complex active) typically leads to a catastrophic loss of the cell wall (Dorr et al., 2014, Yousif et 
al., 1985, Satta et al., 1995), while defects associated with the Rod complex (which might cause 
concurrent lack of major autolysin activation) are generally milder and simply result in an 
abrogation of cell elongation with loss of cellular integrity only after prolonged exposure (Tybring 
& Melchior, 1975, Iwai et al., 2002). Measurements of the incorporation of new cell wall material 
in the presence of antibiotics previously showed that inhibition of aPBPs resulted in a delayed 
inhibition of cell wall incorporation, and cessation of cell wall synthesis coincided with the onset 
of lysis (Wientjes & Nanninga, 1991). These observations are also consistent with Rod-associated 
cell wall cleavage and template generation, which would proceed even in the absence of aPBPs 
until a “tipping point” is reached where accumulated damage caused by the lack of subsequent 
aPBP-mediated crosslinking results in catastrophic failure of structural integrity. Recent results 
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demonstrate that E. coli endopeptidase activity increases aPBP-mediated cell wall attachment 
during inhibition of bPBP2 (Lai et al., 2017), suggesting that endopeptidases might, in addition to 
priming the Rod system, provide Rod-independent starting points (gaps) for PG synthesis by 
aPBPs.  
It remains to be seen what the roles of lytic transglycosylases (LTGs) are in the cell wall 
biosynthesis process. The typical PG breakdown products of these enzymes are detected during 
growth and at increased levels upon exposure to cell wall synthesis inhibitors; however, it is 
currently unclear whether removal of a strand (or strands) of mature PG is actually necessary for 
the insertion of new material. Alternatively, LTG breakdown products could be the result of the 
removal of the outer cell layer in Gram-positive bacteria, a proofreading capacity (removing 
erroneously crosslinked and thus potentially unstable cell wall material), as has been suggested 
previously (Cho et al., 2014), or simply the fact that nascent PG is produced in longer chains at 
first and then trimmed down to the length most appropriate for the current growth condition 
(Yunck et al., 2016, Vollmer & Holtje, 2004). 
In summary, we propose a “break before make” model. Endopeptidases locally cleave 
crosslinks in mature PG. RodA generates a PG template, which is attached to the sacculus via 
bPBPs. Since the Rod complex is not expected to perform an entire rotation around the cell (based 
on short PG chain lengths measured in various bacteria), these PG degradation events are initially 
localized and overall structural integrity is thus not immediately compromised. The aPBPs then 
generate additional strands, which are crosslinked with nascent PG on one side and mature PG on 
the other, ensuring that the local degradation events initiated by the Rod complex do not 
accumulate with harmful consequences.  Previous simulations and observations regarding bPBP2 
inactivation have indeed shown that the cell wall synthesis machinery, even in Gram-negative 
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bacteria, is surprisingly well-buffered and can sustain a fairly high amount of degradation before 
experiencing catastrophic failure (Lee et al., 2014, Huang et al., 2008). 
Important questions remain unanswered in the context of this model; most importantly, 
how the Rod complex defines start sites for PG synthesis, how aPBPs recognize the putative Rod 
template and what role the modulators of PBP activity play (such as the outer membrane localized 
activators in Gram-negative bacteria, (Typas et al., 2010, Paradis-Bleau et al., 2010)). After all, 
more than 50 years after its emergence, bacterial cell wall research still holds surprises, and is 
expected to continue doing so.  
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Chapter 2. Depletion of undecaprenyl pyrophosphate phosphatases 
(UPP-Pases) disrupts cell envelope biogenesis in Bacillus subtilis 
2.1 Abstract 
The integrity of the bacterial cell envelope is essential to sustain life by countering the high 
turgor pressure of the cell and providing a barrier against chemical insults. In Bacillus subtilis, 
synthesis of both peptidoglycan and wall teichoic acids requires a common C55 lipid carrier, 
undecaprenyl-pyrophosphate (UPP), to ferry precursors across the cytoplasmic membrane. The 
synthesis and recycling of UPP requires a phosphatase to generate the monophosphate form Und-
P, which is the substrate for peptidoglycan and wall teichoic acid synthases. Using an optimized 
CRISPR-dCas9 based transcriptional repression system (CRISPRi), we demonstrate that B. 
subtilis requires either of two UPP phosphatases, UppP or BcrC, for viability. We show that a third 
predicted lipid phosphatase (YodM), with homology to diacylglycerol pyrophosphatases, can also 
support growth when overexpressed. Depletion of UPP phosphatase activity leads to 
morphological defects consistent with a failure of cell envelope synthesis and strongly activates 
the M-dependent cell envelope stress response, including bcrC which encodes one of the two UPP 
phosphatases. These results highlight the utility of an optimized CRISPRi system for investigation 
of synthetic lethal gene pairs, clarify the nature of the B. subtilis UPP-Pase enzymes, and provide 
further evidence linking the M regulon to cell envelope homeostasis pathways.  
2.2 Introduction 
In bacterial peptidoglycan synthesis, a 55 carbon polyisoprenoid lipid carrier called 
undecaprenyl-pyrophosphate (UPP) is required to transport peptidoglycan precursor across the cell 
membrane (Jorgenson et al., 2015). UPP is synthesized by UppS and then dephosphorylated by a 
UPP phosphatase (UPP-Pase) to Und-P (Payne et al., 2007). The MraY enzyme uses Und-P as a 
 43 
 
substrate together with UDP-MurNAc-pentapeptide to synthesize lipid I, the first membrane-
bound precursor of peptidoglycan synthesis (Lovering et al., 2012). Addition of N-
acetylglucosamine (GlcNAc) by MurG completes the synthesis of the critical intermediate, lipid 
II. Lipid II is a single GlcNAc-MurNAc-pentapeptide unit linked to UPP as the lipid carrier and 
serves as a substrate for penicillin-binding proteins (PBPs) which incorporate the disaccharide unit 
into the growing glycan strands.  
Our understanding of this critical lipid II cycle is compromised by a lack of mechanistic 
understanding for key steps. The identity of the lipid II flippase required for the export of this 
essential precursor from the cytoplasmic to the external face of the membrane has been 
controversial. Recent results provide strong support for a role of MurJ as the lipid II flippase (Sham 
et al., 2014) and have further shown that this enzyme is redundant in function with a stress-
regulated alternate to MurJ (Amj) protein (Meeske et al., 2015). The recycling of the UPP carrier 
to Und-P also involves redundant enzymes, perhaps to allow the conversion to occur on either the 
inner or outer face of the membrane. UppS synthesizes UPP on the cytosolic face of the membrane. 
Subsequent dephosphorylation of UPP, also presumed to occur on the cytosolic face of the inner 
membrane, generates Und-P as substrate for MraY and TagO (Guillaume Manat, 2014). After 
transporting cell wall precursors to the outside of membrane, the lipid carrier is released as UPP, 
which must again be recycled back to Und-P by the action of a UPP-Pase (El Ghachi et al., 2005). 
This may occur by dephosphorylation on the outer face of the membrane, or by flipping of the 
UPP across the membrane to serve as a substrate for a UPP-Pase active on the inner face of the 
membrane. It is assumed that flipping of UPP (or Und-P) from the outer to the inner face of the 
membrane is facilitated by proteins, but the flippase has not been identified (Guillaume Manat, 
2014). It may be advantageous, in general, for cells to have UPP-Pase activity localized to both 
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faces of the membrane to facilitate de novo Und-P synthesis (on the inner face) and UPP recycling 
(on the outer face), and this may account in part for the redundancy commonly observed in UPP-
Pases (Bickford & Nick, 2013, Guillaume Manat, 2014, El Ghachi et al., 2005).  
In Gram-positive bacteria, the same UPP carrier is shared between the peptidoglycan and 
the wall teichoic acid (WTA) biosynthesis pathways. For WTA synthesis, Und-P serves as a 
substrate for TagO (Brown et al., 2013). As a result, mutations in later steps in WTA synthesis are 
lethal due to the sequestration of the limiting UPP carrier in dead-end products (D'Elia et al., 2006), 
and this observation has motivated the search for antibiotics active on late stages of WTA synthesis 
(Pasquina et al., 2013). A similar sequestration effect has been reported in Escherichia coli, when 
synthesis of the enterobacterial common antigen was impaired (Jorgenson et al., 2015), and in 
Streptococcus pneumoniae mutants defective in synthesis of serotype 2 capsule  (Xayarath & 
Yother, 2007). 
As expected for a critical lipid carrier, the synthesis and recycling of UPP is essential and 
is therefore an excellent target for antibacterials. Recent in silico, in vitro, and in vivo approaches 
have identified inhibitors of UppS (Durrant et al., 2011, Zhu et al., 2013, Farha et al., 2015), 
including a method that used CRISPR (clustered regularly interspersed short palindromic repeats) 
interference (CRISPRi) to identify drug targets (Peters et al., 2016a). We demonstrated previously 
that a ribosome-binding site mutation that decreased expression of UppS led to vancomycin 
resistance and activation of the M-dependent cell envelope stress response (Lee & Helmann, 
2013). Compounds that inhibit the recycling of UPP may also serve as effective antibiotics. The 
most widely used antibiotic of this class is bacitracin, which binds tightly to the pyrophosphate 
group on surface-exposed UPP to inhibit its dephosphorylation (Economou et al., 2013). 
Bacitracin also activates the M stress response and contributes to bacitracin resistance by 
 45 
 
increasing synthesis of BcrC (Cao & Helmann, 2002, Ohki et al., 2003, Kingston et al., 2014), a 
predicted UPP-Pase presumed to act on the outer face of the membrane to convert UPP (the target 
of bacitracin) into Und-P (Bernard et al., 2005). Finally, a variety of structurally diverse antibiotics, 
including glycopeptides and lantibiotics, bind to lipid II which serves to both inhibit cell wall 
synthesis and sequester the UPP carrier lipid (Schneider & Sahl, 2010).  
The identity of the UPP-Pases has been clearly established in E. coli where there are three 
UPP-pase enzymes (BacA, YbjG, and PgpB) and a fourth enzyme (YeiU, later renamed LpxT) 
exhibiting UPP-Pase activity in vitro (El Ghachi et al., 2005). The BacA family includes the 
eponymous BacA protein, while YbjG, PgpB and LpxT all belong to type 2 phosphatidic acid 
phosphatase (PAP2) superfamily. BacA provides 75% of the cell’s UPP-Pase activity, and 
overexpression of BacA makes cells bacitracin resistant (El Ghachi et al., 2005). PgpB was 
originally identified in mutant cells lacking phosphatidylglycerol phosphate phosphatase activity 
(Icho & Raetz, 1983), and is shown to have broad substrate specificity (Fan et al., 2014, Touze et 
al., 2008a). The BacA, YbjG, and PgpB enzymes are functionally redundant, and single mutants 
lacking any one of the three genes do not show significant growth defects. However, a triple mutant 
missing all three genes is not viable. Although LpxT displayed in vitro UPP-Pase activity, it could 
not support growth in the absence of at least one of the other three UPP-Pases (El Ghachi et al., 
2005). It was later found out that LpxT transfers phosphate from UPP to lipid A to produce lipid 
A 1-diphosphate, and in the process generates Und-P (Touze et al., 2008b).  In contrast, the number 
and identity of the UPP-Pases in B. subtilis has not been resolved.  
Genetic approaches to analyze the function of essential genes often rely on conditional 
mutants in which either gene expression or protein activity can be regulated. Optimization of 
conditional gene expression systems can be challenging (as reported also here), since leaky 
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expression may suffice to support viability even in the absence of induction, or the induced level 
may be insufficient to support viability. Recently, the CRISPR system, used by many bacterial and 
archaeal species to defend against foreign DNA, has been adapted as a powerful tool for 
conditionally regulating bacterial gene expression (Qi et al., 2013, Gilbert et al., 2014, Peters et 
al., 2015, Peters et al., 2016a).  
Here we report the use of an optimized CRISPR interference (CRISPRi) system to 
investigate the essentiality of candidate UPP-Pases in B. subtilis. Using CRISPRi, we have 
identified UppP and BcrC as two functionally redundant UPP-Pases. We have also identified a 
third lipid phosphatase (YodM) capable of supporting growth in the absence of these two enzymes, 
but only when artificially overexpressed. Depletion of essential UPP-Pases, predicted to interrupt 
synthesis of both peptidoglycan and WTA, results in cells that cannot maintain their rod shape and 
leads to induction of the M-dependent cell envelope stress response.  
2.3 Materials and Methods 
2.3.1 Strains, plasmids and growth condition 
All strains and plasmids used in this work are listed in Tables S2.4. Bacteria were grown 
in liquid lysogeny broth (LB) medium with shaking, or on LB plates (1.5% agar; Difco) at 37 ˚C 
unless otherwise stated. Plasmids were constructed using standard methods (Luo et al., 2010), and 
amplified in E. coli DH5α before transforming into B. subtilis. For selection of transformants, 100 
μg/ml ampicillin was used for E. coli.  Antibiotics used for selection of B. subtilis transformants 
include: kanamycin 15 μg/ml, spectinomycin 100 μg/ml, macrolide-lincosamide-streptogramin B 
(MLS, contains 1 μg/ml erythromycin and 25 μg/ml lincomycin), neomycin 10 μg/ml, 
chloramphenicol 10 μg/ml. 
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2.3.2 Genetic techniques 
Chromosomal and plasmid DNA transformation was performed as previously stated (Luo 
& Helmann, 2012). Markerless in-frame deletion mutants were constructed from BKE strains as 
described (Meeske et al., 2015). Briefly, BKE strains were acquired from the Bacillus Genetics 
Stock Center, chromosomal DNA was extracted, and the mutation containing an erm cassette was 
transformed into our WT 168 strain. The erm cassette was subsequently removed by introduction 
of plasmid pDR244, which was later cured by growing at the non-permissive temperature of 42 
˚C. Gene deletions were confirmed by PCR screening using flanking primers. Transduction was 
performed to move SPβ derivatives into the 168 strain as previously described (Harwood & 
Cutting, 1990). Unless otherwise described, all PCR products were generated using B. subtilis 168 
strain chromosomal DNA as template. DNA fragments used for gene over-expression were 
sequence verified. Null mutant construction was PCR screen verified to have the right size band. 
 
2.3.3 Construction of the CRISPRi-based transcriptional repression system  
The CRISPRi system was based on plasmid vectors that replicate in E. coli and integrate 
into the B. subtilis chromosome. Briefly, the gene encoding dCas9 is inserted into plasmid pAX01 
to form pJPM1. pJMP1 is then integrated into the B. subtilis ganA gene by double cross-over 
recombination. sgRNAs targeting bcrC or uppP were incorporated into integrative vectors by 
inverse PCR followed by cyclization by self-ligation. Expression of sgRNA is constitutive, and 
expression of dCas9 is induced by xylose. sgRNAs were selected based on their specificity for, 
and location within, target genes. We identified all PAM (Protospacer Adjacent Motif) sites (NGG 
for S. pyogenes dCas9) within target genes and designed all possible sgRNAs for those targets. 
We then assigned each sgRNA a specificity score by aligning progressive truncations of the 
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sgRNA sequences to the B. subtilis 168 genome using Bowtie (Langmead et al., 2009); sgRNAs 
that retained specificity after several truncations received better scores. We then selected the most 
specific sgRNAs that targeted the non-template strand and were near the 5´ end of the gene where 
CRISPR interference is thought to be most effective in bacteria (Qi et al., 2013, Peters et al., 2015). 
After choosing sgRNAs sequences, the constructs were made by inverse PCR using forward 
primer containing sequence specific to gene of interest (base paring region), and universal reverse 
primer which binds to the complementary strand of DNA adjacent to the base paring region. For 
example, bcrC-1 was made using pJMP3 as template, primer 6411 CRISPRi bcrC-1 F and 6415 
CRISPRi universal R. Inverse PCR product was self-ligated, and transformed into E. coli DH5α. 
Plasmids extracted from successful transformations were confirmed by sequencing before being 
used to transform B. subtilis. 
Construction of pSPβ-dCas9 was done by ligating a fragment containing Pxyl-dCas9 from 
pJMP1 into backbone of pJPM122, a plasmid that can integrate into SPβ prophage in strain 
ZB307A as described (Slack et al., 1993). To get the fragment containing Pxyl-dCas9, pJMP1 was 
first digested by SacII, treated with T4 DNA polymerase (NEB) to make a blunt-end, and then 
digested by SalI. DNA fragment containing Pxyl-dCas9 was gel purified. pJPM122 was digested 
with SalI and EcoRV, and backbone was recovered from agarose gel. The fragment containing 
Pxyl-dCas9 from pJMP1 was then ligated with pJPM122, forming plasmid pSPβ-dCas9. pSPβ-
dCas9 was then used to transform B. subtilis ZB307A. Transformants were PCR screened to 
confirm that a double cross-over recombination event occurred into the chromosome of ZB307A 
and named ZB307A-pSPβ-dCas9. Phage lysate from ZB307A-pSPβ-dCas9 was prepared using 
heat shock and was used to transduce B. subtilis 168 and its derivatives.  
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2.3.4 Disk diffusion assays 
Disk diffusion assays were performed as previously described (Kingston et al., 2014). 
Overnight cultures of test strains were re-inoculated into fresh LB liquid medium and grown to 
early log phase (OD600 ~0.4), and a 100 μl aliquot of the culture was mixed briefly with 4 ml LB 
soft agar (containing 0.75% agar, kept at 50 ˚C) before poured onto LB plates (containing 15 ml 
LB with 1.5% agar). Plates were then cooled and dried in a laminar airflow hood for 5 minutes. 
Filter paper disks were placed on the surface of the plate, and chemicals were added to the paper 
disks. Plates were then incubated at 37˚C for 16 h before the diameter of the zone of inhibition 
was measured. Numbers reported are diameter minus the 6.5 mm diameter of the filter paper disk. 
The chemicals added to the disks include: xylose 20 μl of 50% solution, bacitracin 400 μg, 
ampicillin 1 mg, penicillin 1 mg, cefuroxime 10 mg, vancomycin 100 μg, fosfomycin 1mg, D-
cycloserine 100 μg, lysozyme 100 μg, daptomycin 100 μg, nisin 1 mg, SDS 10 μl of 10% solution, 
Triton X-100 10 μl of 25% solution, EDTA 10 μl of 0.5 M (pH 8.0) solution, novobiocin 100 μg. 
 
2.3.5 Measurement of the fraction of suppressors 
Strains were grown in liquid LB medium supplemented with 1% glucose overnight, and 
then the overnight culture was re-inoculated into fresh LB liquid medium supplemented with 1% 
glucose and grown to early log phase (OD600 ~0.4). Serial dilutions were performed up to 10
-6. 
Cultures with 10-4, 10-5, and 10-6 dilutions were plated on LB plate supplemented with 1% glucose, 
and cultures with no dilution, 10-1, and 10-2 dilutions were plated on LB plate supplemented with 
2% xylose. Colonies were counted from plates having between 20-200 colonies, and colony 
forming units (CFU) were calculated. Fraction of suppressors is calculated by dividing CFU of 
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strains growing on xylose LB by CFU of the same strain growing on glucose LB. This experiment 
was done at least three times using biological replicates. 
 
2.3.6 Phase contrast time-lapse and fluorescence microscopy 
Strains were grown in CH medium (Sterlini & Mandelstam, 1969) in presence of 1% (w/v) 
glucose at 37 °C. Then the cells were harvested when the OD of the culture reaches ~0.4. Then 
cells were grown in CH in presence of 2%(w/v) xylose in a micro-fluidic chamber. The phase 
contrast time lapse images were acquired on a Nikon N-STORM microscope equipped with Plan 
Apo lambda 100x objective and a Hamamatsu ORCA CMOS camera. Images were taken every 
30 s. Images of FM5-95 (ThermoFisher) membrane staining were acquired on a GE DeltaVision 
Elite with DeltaVision connected to a PCO Edge sSCOS camera. A 561-nm laser and a 60X 1.45 
NA Plan Apo-objective were used. The excitation filter was YFP (with center wave length at 
513nm and 17nm bandwidth) and the emission filter was mCherry (with center wave length at 
632nm and 60nm bandwidth).  The cells were stained with 1X FM5-69 (2 μM) mounted on 1% 
agarose in CH medium pads and immediately imaged with an exposure time of 2 s. All images 
were analyzed using Morphometrics (Ursell et al., 2014) and home built MATLAB program.   
 
2.3.7 Whole genome sequencing and sequence analysis 
Chromosomal DNA of suppressor strains was extracted using Qiagen DNeasy Blood & 
Tissue Kit.  DNA was then sent for sequencing using Illumina HiSeq2500 High Output Mode with 
Single-end 100 bp reads. Sequencing results were analyzed using CLC workbench version 8.5.1. 
Single nucleotide variants (SNVs) were detected using default settings. 
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2.3.8 Microarray analysis 
The wild type and depletion strains were grown separately in liquid LB medium to OD600 
~0.4, and then each diluted 100-fold into two 250 ml flasks each containing fresh 50 ml LB 
medium. After 1.5 hours of initial growth, one of the two flasks of each strain was supplemented 
with 50% xylose to a final concentration of 2%, while the other flask was left untreated as control. 
After another 2.5 hours of growth, cells were collected and total RNA was extracted using phenol-
chloroform based method. Total RNA was quantified and quality of RNA was tested using Bio-
analyzer. RNA quality numbers for all four RNA samples are 10 out of 10. Total RNA were then 
treated with Turbo-DNAse (Thermo Fisher Scientific) to remove any possible DNA contamination, 
and then reverse transcribed using SuperScript™ Indirect cDNA Labeling System (Thermo Fisher 
Scientific) into cDNA. cDNA was aliquoted and labelled with either fluorescent dye 555 or dye 
647, and hybridized to microarray slides containing 60 nt oligonucleotides for each coding region 
according to laboratory protocol (Luo et al., 2010). Dye swap was performed to reduce systematic 
error caused by difference in labelling and hybridization efficiency for different dyes. For instance, 
in one hybridization cDNA of WT strain is labelled with dye 555 and cDNA of depletion strain is 
labelled with dye 647. In the dye swap experiment, cDNA from the WT will then be labelled with 
dye 647 and depletion strain dye 555. Transcriptome results have been deposited in the NCBI GEO 
database under accession number (to be added). 
Comparison of transcriptome among different strains and conditions were performed by 
comparing fluorescent signal from different pairs. Among the treated group, transcriptomes of the 
WT and depletion strains were compared to reveal change in gene transcription, and untreated WT 
and depletion strains were used as controls. Fold change for each gene is the average of two 
experiments containing a dye swap. Up- and down-regulated genes after UPP-Pase depletion were 
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defined as those with an average fold change of at least 3-fold, and at least 2-fold in each 
hybridization. It is also crucial that only signals well above background are considered trustworthy. 
Gene function and regulon information was acquired from SubtiWiki (http://subtiwiki.uni-
goettingen.de/;(Michna et al., 2014)) and prior publications. 
Cluster 3.0 (http://bonsai.hgc.jp/~mdehoon/software/cluster/software.htm) and Java 
Treeview (https://sourceforge.net/projects/jtreeview/) were used to generate heat maps. Briefly, 
we chose genes regulated by ECF sigma factors and two component systems involved in cell 
envelope homeostasis (e.g. WalR, BceR, LiaR, PsdR and YvrHb). Gene bcrC was not included in 
the list of genes (even though it is controlled by multiple ECF sigma factors), as it was artificially 
repressed using CRISPRi. Microarray fold change data were log10 transformed and used for 
hierarchical clustering (using uncentered correlation and complete linkage functions) showing 
genes that were up-regulated (red) or down-regulated (green).  
2.4 Results 
2.4.1 UppP and BcrC are functionally redundant UPP-Pases 
We identified B. subtilis UppP, BcrC and YodM as homologs of known UPP-Pases in E. 
coli using BLASTp with default parameters. UppP is a homolog of BacA whereas BcrC and YodM 
are homologs of YbjG, PgpB and LpxT, members of the PAP2 superfamily (Table S2.1). BcrC 
was previously shown to have UPP-Pase activity and to be regulated by M (Bernard et al., 2005, 
Cao & Helmann, 2002). UppP (YubB) was also speculated to function as a UPP-Pase based on 
homology, but played a less important role than BcrC in bacitracin resistance (Bernard et al., 2005). 
Mutations that affect UPP levels were later found to affect the sensitivity of B. subtilis to rare earth 
metals and, based on this phenotype, it was also suggested that BcrC was the major enzyme with 
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UppP having a minor role (Inaoka & Ochi, 2012). However, this assay may report specifically on 
the levels of extracellular UPP which is accessible for binding by rare earth metals.   
To investigate functional redundancy amongst these candidate UPP-Pases, we constructed 
single mutants with each UPP-Pase gene replaced by an antibiotic cassette, followed by 
transformation to make mutants missing two or all three UPP-Pases. While we could construct 
yodM bcrC and yodM uppP double mutants, we were unable to obtain the bcrC uppP double 
mutant in multiple attempts, despite previous suggestions that a double mutant had been obtained 
(Bernard et al., 2005, Inaoka & Ochi, 2012). For example, when chromosomal DNA from a 
bcrC::mls (macrolide-lincosamide-streptogramin B) strain was used to transform a uppP::spc 
(spectinomycin) strain, we recovered MLSR transformants, but only if the cells simultaneously 
acquired a functional copy of uppP (and therefore lost SpcR). This phenomenon, in which a cell 
acquires two unlinked markers by transformation, is referred to as congression. Overall, our 
findings indicate that bcrC and uppP are a synthetic lethal gene pair and likely encode the only 
functional UPP-Pases in B. subtilis, at least in our laboratory conditions.  
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Figure 2.1. Growth inhibition by depletion of BcrC and UppP.  
Photos of disk diffusion assay of WT and mutant strains. Cells were grown on LB plates with 
xylose on the filter paper disk to induce dCas9 and inhibit transcription of bcrC and/or uppP. (A) 
WT and mutants with either bcrC or uppP null mutations, or containing sgRNA targeting only one 
UPP-Pase are not sensitive to induction of dCas9 by xylose. (B) Mutants containing sgRNA for 
both bcrC and uppP (bcrC-1, uppP-1; bcrC-2, uppP-2), and mutants with a uppP null mutant and 
sgRNA for bcrC (ΔuppP, bcrC-1; ΔuppP, bcrC-2; ΔuppP, bcrC-1&2) are sensitive to xylose. (C) 
Mutant strain shows similar phenotypes in a ΔyodM background.  
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2.4.2 The YodM protein can provide UPP-Pase activity when overexpressed 
To characterize the physiological consequences of limiting UPP-Pase activity, we sought 
to generate conditional depletion strains. We introduced ectopic copies of bcrC, uppP, or yodM 
under the control of the IPTG inducible promoter Pspac(hy). Next, we attempted to sequentially 
delete bcrC and uppP under conditions where the ectopic gene was expressed. However, due to 
either leakiness or insufficient expression, we were unable to construct a depletion strain 
conditionally expressing bcrC or uppP, even after attempts to modify the ribosome binding site to 
change translational efficiency (Table S2.2)(Vellanoweth & Rabinowitz, 1992).  
One interesting result that emerged from this exercise is that YodM, if overexpressed, can 
support growth even in the absence of BcrC and UppP. In this strain, the native yodM RBS was 
replaced with a strong RBS (Vellanoweth & Rabinowitz, 1992) and the start codon was changed 
from TTG to ATG. The resulting Pspac(hy)-yodM construct allowed generation of a bcrC uppP 
double mutant strain that could grow in the presence, but not in the absence of IPTG (Figure S2.1). 
Note that this strain has two copies of yodM with one native copy and an ectopic copy controlled 
by Pspac(hy) and optimized for expression. Because of the homology between YodM and E. coli 
UPP-Pases and the fact that overexpression of YodM can rescue growth defect of bcrC uppP 
double mutant, we infer that YodM has some UPP-Pase activity, and this activity is sufficient to 
support growth in absence of the other two UPP-Pases when it is expressed at an artificially high 
level. However, YodM is not able to support growth of a bcrC uppP double mutant at its normal 
expression levels. Overall we conclude that BcrC and UppP are the two primary UPP-Pases, at 
least in our laboratory conditions. 
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Figure 2.2. Reduction of suppressor mutations in depletion strains.  
Fraction of suppressors in populations of various depletion strains. UPP-Pases depletion strains 
cannot grow on LB plates containing 2% xylose unless they have a suppressor mutation. Cells 
were plated on LB plates with or without 2% xylose, and the number of cells on each type of plate 
were counted and back calculated to CFU/ml. Fraction of suppressor in each population was 
calculated by dividing CFU of suppressors over CFU of total cells.  
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2.4.3 Demonstration of essentiality of UPP-Pases using CRISPRi 
We next explored the use of CRISPRi as a tool to monitor the effects of UPP-Pase depletion 
on cell physiology. The CRISPRi system uses a catalytically inactive form of the Cas9 
endonuclease (dCas9) and a single guide RNA (sgRNA) (Qi et al., 2013, Hawkins et al., 2015). 
The sgRNA contains a customizable 20-nt base pairing region to direct dCas9 to specific DNA 
sequences, and the dCas9:sgRNA complex binds DNA and serves as a road block to transcription. 
In the system used in this work, dCas9 gene is expressed from a xylose-inducible promoter and 
the sgRNAs were constitutively expressed (Peters et al., 2016a). Based on previous studies in E. 
coli (Qi et al., 2013) and mycobacteria (Choudhary et al., 2015), we anticipated that the strength 
of transcriptional repression would be increased by promoter proximal targeted complexes and by 
the use of two sgRNAs. We therefore designed bcrC-1 and uppP-1 sgRNAs to bind close to the 
transcription start site (predicted to have a strong repressive effect) and bcrC-2 and uppP-2 
sgRNAs to bind further downstream (predicted to have weaker repressive effects).    
The conditional depletion strains did not show any growth defect in the absence of the 
dCas9 inducer xylose, but were growth impaired in medium with xylose. In order to illustrate the 
functional redundancy of BcrC and UppP, we used disk diffusion assays as a measure of xylose 
sensitivity. B. subtilis is not sensitive to xylose per se, and can use it as a carbon source (Schmiedel 
& Hillen, 1996). As expected based on the phenotype of the null mutant strains, depletion of either 
uppP or bcrC using CRISPRi did not lead to xylose sensitivity (Figure 2.1A). However, strains in 
which both genes were targeted for transcriptional repression showed a notable sensitivity to 
xylose as shown by a clear zone of inhibition around the paper disk containing xylose (Figure 
2.1B). A similar effect was noted in strains where uppP was deleted and bcrC was targeted for 
transcriptional repression. Strains containing the weak sgRNAs bcrC-2 and uppP-2 showed a small 
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zone of inhibition, demonstrating that these cells are less xylose sensitive, and suggesting that 
bcrC-2 and uppP-2 provide less efficient in transcriptional repression (Figure 2.1B). This is 
consistent with the previous observation that sgRNAs farther from 5’ end of transcription start site 
caused weaker repression (Choudhary et al., 2015). In the uppP null mutant, depleting bcrC led to 
xylose-sensitivity. The use of the promoter proximal sgRNA bcrC-1 led to a high level of xylose 
sensitivity, and this was modestly increased with the inclusion of the second sgRNA, bcrC-2. We 
were not able to construct a strain with bcrC deleted and containing uppP-1, possibly due to leaky 
expression of dCas9 which has been shown to have moderate repressive activity even in the 
absence of xylose induction (Peters et al., 2016a).  
 
2.4.4 Optimization of CRISPRi to reduce suppressor formation in conditional depletion 
strains 
It is apparent that suppressors arise frequently in the zone of xylose-dependent growth 
inhibition (Figure 2.1B). Whole genome sequencing of ten independent suppressors revealed 
frameshift mutations in the dCas9 gene (nine strains), and a single base pair mutation in the bcrC 
gene which altered the PAM (Protospacer Adjacent Motif) sequence for sgRNA bcrC-1 and thus 
prevent binding of dCas9:sgRNA complex (one strain). To facilitate further physiological studies, 
we sought to first reduce the frequency of suppressors. Since our sequencing results indicate that 
inactivation of the gene encoding dCas9 is the single most frequent class of suppressor mutation, 
we constructed a merodiploid strain containing a second copy of dCas9 integrated into the SPβ 
prophage. We then monitored the frequency with which suppressors arise by plating the depletion 
strain on LB medium supplemented with 1% glucose or 2% xylose and comparing the colony 
forming units (CFU). As expected, strains with two copies of the gene encoding dCas9 displayed 
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a reduction (approximately 10-fold) in the frequency of suppressors (Figure 2.2). We also note that 
suppressor formation is somewhat higher in strains with dCas9 expressed only from the SPβ 
prophage locus rather than the ganA locus (Figure 2.2, Figure S2.2A). Since it is also possible to 
isolate suppressors that mutate either the sgRNA or its target, we reasoned that having two sgRNAs 
targeted to the same gene would further decrease the frequency of suppressors. In general, the 
frequency of suppressors was reduced in the uppP null strain carrying both bcrC-1 and bcrC-2 
sgRNAs relative to the strain with only bcrC-1, however these effects were rather modest. We 
hypothesized that another possible class of suppressors might result from up-regulation of yodM. 
Indeed, introduction of a yodM null mutation into the uppP bcrC-1 bcrC-2 strain greatly reduced 
the frequency of suppressors, but only if dCas9 was present in two copies (Figure 2.2, Figure S2.2B, 
C). These results indicate that inactivation of dCas9 is the most frequent cause of suppression (as 
inferred from the whole genome sequencing studies), and that the use of two sgRNAs and 
elimination of known or predicted pathways of suppression (such as upregulation of yodM) may 
be required for a significant further reduction in suppressor occurrence.  
We then isolated two independent suppressors from the optimized strain (HB17235) and 
performed whole genome sequencing. While we might have expected to discover mutations 
revealing novel UPP-Pase(s), each suppressor contained a frameshift mutation (base deletion) in a 
homopolymeric stretch within both dCas9 genes (one suppressor in TTCCTTTGAAAAAAA and 
the other in CAGTATCAAAAAAAA). The fact that both dCas9 genes in each suppressor strain 
have the same point mutation in each copy of the gene leads us to speculate that the first mutation 
may have resulted from a relatively frequent strand slippage event in the homopolymeric sequence 
followed by a gene conversion event to generate the double mutant.   
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One of our goals in generating depletion strains for UPP-Pases was to monitor the terminal 
phenotype, and this is complicated if suppressors arise at a high frequency. To determine if our 
optimized CRISPRi system had sufficiently reduced the appearance of suppressors to allow growth 
studies, we inoculated ~4x104 cells into 200 µl of xylose-containing medium using an automated 
BioScreen growth analyzer. For each strain, we monitored 30 replicate cultures (3 biological 
replicates containing 10 technical replicates each). In this assay, the majority of the cultures for 
each strain grew after a long lag phase (Table S2.3), suggesting that suppressors were arising that 
might therefore complicate analysis of the terminal phenotype. The single exception was our 
optimized strain (HB17235) which is a dCas9 merodiploid lacking both UppP and YodM and with 
two sgRNAs targeting bcrC. With this strain, there was outgrowth in less than 10% of the wells.  
 
2.4.5 Dynamics of UPP-Pase depletion  
To determine how long it takes for the existing BcrC protein to be depleted in the optimized 
(HB17235) strain and thereby limit growth, we monitored growth curves as a function of the initial 
inoculum in LB with either 1% glucose or 2% xylose. With a starting culture at initial OD600 0.14, 
the culture reached a final OD600 of 0.7 in the presence of 2% xylose, while it could reach OD600 
~1.2 with glucose (Figure 2.3). With each two-fold dilution of the initial inoculum, the final OD600 
reached under depletion conditions was also decreased by nearly 2-fold, consistent with a growth-
limiting depletion of pre-existing BcrC after 3 to 4 doublings.   
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Figure 2.3. Growth of depletion strain in depletion/non-depletion condition with different 
initial culture population size.  
Depletion strain (ganA::dCas9 SPβ::dCas9 ΔyodM uppP bcrC-1&2) growing at logarithm phase 
was diluted and re-inoculate into liquid LB medium supplemented with either 1% (w/v) glucose 
or 2% (w/v) xylose. Growth was carried at 37℃ with shaking. OD
600
 was measured every 15 
minutes.  Starting OD
600
 of ~0.1 was designated at “Dilution 1”, and further two-fold dilution was 
performed until the smallest inoculum contained 1/8 amount of the cells in “Dilution 1”. Different 
amount of initial inoculums affects final OD of cells growing in LB xylose medium, while had no 
significant on cells growing in LB glucose medium. 
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Figure 2.4. UPP-Pase depletion leads to curved and bulged cells.  
Microscopy images of depletion strains under depletion conditions. Cells were observed using 
phase contract and under 100X magnification (each pixel size is 65 nm). (A) Depletion strain 
(HB17325) growing in CH medium supplemented with 2% xylose at 37˚C. Cells showed normal 
morphology at the beginning of the experiment (0 min) and showed curved and bulged cells as 
UPP-Pases were depleted (200 min).  (B) Example showing how cell width was measured. Lines 
were draw across cell width, and cell width at each line was measured. The max width of each cell 
was used for quantification.  (C) Distribution of max cell width of depletion strain at the beginning 
of treatment (0 min). The majority of cells had max width of 0.95-1.05 μm, while approximately 
10% of cells have max width bigger than 1.2 μm.  (D) Change of fraction of cells having max cell 
width (Dmax, max diameter of cells) larger than 1.2 μm through time. The fraction increased 
significantly after 120 minutes and reached its peak after 180 minutes, indicating more and more 
cells began to form bulge as UPP-Pases were depleted. 
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2.4.6 Changes in cell morphology upon depletion of UPP-Pases 
Defects in cell wall synthesis often cause morphological changes as the integrity of the cell 
wall is compromised. For example, depletion of MreB and its homologs leads to a loss of rod shape 
and formation of bulged cells (Formstone & Errington, 2005), and cells missing all class A PBPs 
form longer and bent cells with abnormal protrusions into the cell plasma (McPherson & Popham, 
2003). Cells with UppS expression repressed by CRISPRi also show bulged cells without 
significant lysis (Peters et al., 2016a). We therefore anticipated a similar phenotype from the UPP-
Pase depletion strain. Cells were grown in a micro-fluidic chamber in CH medium supplemented 
with 2% xylose, and images were taken every 30 seconds. At the beginning of the experiment, 
cells did not show any obvious morphological defect relative to WT. After about 2 hours, cells 
grown with xylose began to form bulges (Figure 2.4, Movie S1). In comparison, WT cells did not 
exhibit any growth defect in presence of 2% xylose (Movie S2). Surprisingly, few cell lysis events 
were observed during the time lapse experiment. This is similar to what was observed in the UppS 
depletion strain (Schirner et al., 2015, Peters et al., 2016a), and in a strain depleted for lipid II 
flippases (Meeske et al., 2015). The lantibiotic NAI-107 (which targets UPP linked cell wall 
precursors such as lipid I, II and precursors of WTA) leads to a similar terminal phenotype (Munch 
et al., 2014).  
To quantify the fraction of cells forming bulges when UPP-Pases are depleted, we observed 
more than 200 cells at each time point and used Morphometrics and an in-house MATLAB script 
to measure cell width across the whole length of the cell, and determined the maximum cell width 
for each cell (Figure 2.4B). Before depletion of UPP-Pases, the majority of cells exhibited a 
maximum width of between 0.95 and 1.05 μm (Figure 2.4C) and only ~10% of cells had a 
width >1.2 μm (Figure 2.4C, D). As the cells grew under depletion conditions, the percentage of 
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cells with a maximal width above 1.2 μm increased significantly (Figure 2.4D). Septum formation 
was still present in the depletion strain as visualized with the membrane stain FM5-95, even when 
cells exhibited bulging (Figure S2.3). 
 
2.4.7 The UPP-Pase depletion strain is sensitive to cell envelope stress 
It has been reported that leaky expression of dCas9 in absence of xylose may lead to ~3-
fold repression of target genes (Peters et al., 2016a). We therefore hypothesized that our depletion 
strain may have reduced expression of UPP-Pases even in the absence of inducer. Indeed, the 
depletion strain exhibited more lysis than WT when stored on plates. To test this hypothesis, we 
used disk diffusion assays under non-inducing condition to monitor sensitivity to cell envelope 
stress conditions (Figure 2.5). In fact, the depletion strain is significantly (P<0.01) more sensitive 
to both bacitracin, which binds UPP and thereby inhibits UPP-Pase activity, and daptomycin. A 
more modest level of sensitivity (P<0.05) was noted for the peptidoglycan synthesis inhibitors 
vancomycin and fosfomycin. The depletion strain was not more sensitive to several other tested 
stress conditions including compounds that elicit membrane stress (Nisin, SDS, and Triton X-100). 
The reason for the increased sensitivity to some, but not other, peptidoglycan synthesis inhibitors 
is presently unclear, but interpreting such effects can be complex, as previously discussed  (Lee & 
Helmann, 2013).  
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Figure 2.5. Sensitivity of depletion strain against stresses under partial depletion condition. 
Cells were grown on LB plates with chemicals added onto the filter paper disk. Sensitivity of 
depletion strain was measured as the clear zone of inhibition around the paper disk. Chemicals 
used in this assay include bacitracin 400 μg, ampicillin 1 mg, penicillin 1 mg, cefuroxime 10 mg, 
vancomycin 100 μg, fosfomycin 1 mg, D-cycloserine 100 μg, lysozyme 100 μg, daptomycin 100 
μg, nisin 1 mg, SDS 10 μl of 10% solution, Triton X-100 10 μl of 25% solution, EDTA 10 μl of 
0.5 M (pH 8.0) solution, novobiocin 100 μg. The data are expressed as mean ± standard error (n=3). 
Statistical assay was performed using T test with two samples assuming unequal variances. * 
means two tail P value <0.05, ** means two tail P value <0.01. 
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2.4.8 Depletion of UPP-Pases triggers a cell envelope stress response 
To further characterize the effects of UPP-Pase depletion, we monitored changes in the 
transcriptome 2.5 h after addition of xylose to deplete BcrC, a time known to coincide with the 
onset of visible morphological changes and decreased growth (Figure 2.3, 2.4). In the depletion 
strain, >150 genes were >3-fold up-regulated and nearly 300 genes were >3-fold down-regulated 
(SI Excel Sheets). The set of up-regulated genes includes known cell envelope stress responses 
including, most notably, the M regulon. In contrast, down-regulated genes include many genes 
and regulons consistent with catabolite repression in the xylose-treated cultures, and with entry of 
the untreated cells into transition phase during the 2.5 h of incubation. The up-regulation of the 
flagellar and motility systems controlled by D in the control cells as they enter into transition 
phase likely explains the apparent down-regulation of these genes in the depletion strain.    
To gain further insights into the effects of UPP-Pase depletion on cell envelope stress 
responses we used hierarchical clustering to compare the expression of genes regulated by ECF 
sigma factors and the WalR, BceR, PsdR, LiaR and YvrHb two component system regulons 
(Figure 2.6). Microarray data generated in this study (UPP-Pase depletion), as well as for cells 
treated with targocil (Schirner et al., 2015), bacitracin (Mascher et al., 2003), D-cycloserine 
(Hutter et al., 2004), Triton X-100 (Hutter et al., 2004), and vancomycin (Eiamphungporn & 
Helmann, 2008) (SI Excel Sheets) were used for clustering and heat map generation as previously 
described (Eiamphungporn & Helmann, 2008). Based on the observations above, we anticipated 
that the effects of UPP-Pase depletion (occurring over 2.5 h) might not be directly comparable to 
those elicited by relatively short treatments with cell envelope antibiotics. Nevertheless, we noted 
several striking similarities. Specifically, the M regulon is selectively induced by UPP-Pase 
depletion, with comparatively weak effects noted for other ECF  factor stress responses. 
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Induction of the M regulon is consistent with the inclusion of the BcrC UPP-Pase as part of this 
regulon (Cao & Helmann, 2002), as well as the previously noted induction in cells treated with 
bacitracin (Mascher et al., 2003) or containing mutations that decrease UPP synthesis (Lee & 
Helmann, 2013). In contrast with M, the W regulon, most strongly activated by membrane stress 
conditions (Eiamphungporn & Helmann, 2008), was down-regulated in the depleted cells 
compared to the control.  
In addition to clustering based on genes, we also determined the clustering based on 
treatments. Among the antibiotics used for comparison, the treatment condition most similar to 
UPP-Pase depletion is targocil, which inhibits WTA export and therefore also causes a gradual 
depletion of the Und-P pool. D-cycloserine, an inhibitor of early steps in PG synthesis that 
converge with Und-P to allow lipid II synthesis, also leads to a similar set of stress responses. We 
might have expected bacitracin (which binds directly to UPP) to trigger a response similar to UPP-
Pase depletion. However, despite several similarities, bacitracin additionally elicits strong (albeit 
transient) induction of the BceR and LiaR regulons after 5 min of treatment (Radeck et al., 2016). 
This activation can happen at bacitracin concentrations well below the MIC and does not depend 
on cell wall damage (Fritz et al., 2015). The least similar stress conditions, compared to UPP-Pase 
depletion, were those elicited by Triton-X-100 and vancomycin, which both lead to induction of 
the large W regulon under the tested conditions.  
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Figure 2.6. UPP-Pase depletion induces the σ
M
 cell envelope stress response.  
Hierarchical clustering was used to generate a heat map of up-regulation (red) or down-regulation 
(green) of known cell envelope stress responsive genes (regulons indicated to the right). Cells were 
either depleted of UPP-Pase (compared to non-depletion control cells), or treated with targocil 
(TAR), D-cycloserine (CYC), bacitracin (BAC), Triton X-100 (TRI), or vancomycin (VAN). 
Numbers indicate the minutes of treatment with each antibiotic.  
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2.5 Discussion 
UPP is a crucial lipid carrier for synthesis of the cell envelope, including both 
peptidoglycan and WTA. In peptidoglycan synthesis, UPP serves as lipid carrier for the 
disaccharide-pentapeptide precursor in the central intermediate lipid II. Although initially 
synthesized as the pyrophosphate form (UPP), dephosphorylation is required to generate the 
substrate (Und-P) for MraY. Similarly, in B. subtilis strain 168, Und-P is required for WTA 
synthesis which is initiated by transfer of GlcNac-1-P from UDP-GlcNac to Und-P by TagO to 
generate the initial membrane-bound precursor. The peptidoglycan precursor, lipid II, is flipped 
across the membrane by either of two flippases, MurJ or Amj, where it serves as substrate for 
synthesis of the glycan polymer by PBPs. In contrast, synthesis of the WTA polymer occurs in the 
cytosol and the completed polymer (a glycerol-phosphate alternating copolymer in B. subtilis) is 
exported and then attached to PG. In both peptidoglycan and WTA synthesis, the UPP carrier is 
released on the extracytoplasmic face of the membrane (by PBPs or the TagTUV family of WTA-
attachases) and recycled (Brown et al., 2013).  
Disruption of cell envelope synthesis is one of the most effective strategies for inhibiting 
bacterial growth and numerous antibiotics target these processes. The lipid II cycle can be 
disrupted by compounds that inhibit UPP synthesis or that bind directly to lipid II (nisin, 
vancomycin, ramoplanin), and to UPP itself (bacitracin). Other PG synthesis inhibitors target the 
PBPs and thereby inhibit the transpeptidation (β-lactams) or transglycosylation (moenomycin) 
reactions. It is also possible to disrupt the lipid II cycle by blocking the synthesis of WTA at late 
steps, thereby leading to sequestration of this limiting lipid carrier (Pasquina et al., 2013).  
A common feature of many different compounds that inhibit the lipid II cycle is that they 
invoke cell envelope stress responses including activation of the M regulon (Helmann, 2016). A 
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major function of the M regulon is to increase the expression of key enzymes involved in cell 
envelope synthesis and to up-regulate alternative enzymes to replace those that might be inhibited. 
Notable examples of M-dependent compensation reactions include up-regulation of the lipid II 
flippase Amj (which substitutes for MurJ; (Meeske et al., 2015)), the lipoteichoic acid synthase 
LtaSa (YfnI, which substitutes for LtaS), and BcrC (which substitutes for UppP; (Cao & Helmann, 
2002, Eiamphungporn & Helmann, 2008)). Similarly, antibiotics that inhibit the lipid II cycle, 
including bacitracin (Mascher et al., 2003), vancomycin (Eiamphungporn & Helmann, 2008), 
moenomycin (Salzberg et al., 2011), and the WTA-targeting targocil (Schirner et al., 2015), all 
activate the M regulon (Helmann, 2016).  
Here, we set out to explore the role of three genes encoding candidate UPP-Pases in the 
lipid II cycle in B. subtilis. The CRISPRi system has been recently adapted as a tool to repress 
bacterial gene expression and facilitate the analysis of essential gene functions (Peters et al., 
2016a). Our inability to construct a uppP bcrC double mutant suggested that these two genes might 
be a synthetic lethal pair (in contrast with a previous report; (Bernard et al., 2005, Inaoka & Ochi, 
2012)), although they could both be deleted when a third candidate phosphatase, YodM, was 
overexpressed. The ability of YodM to rescue cell growth in a uppP bcrC double mutant and its 
homology to other UPP-Pases support a possible role for YodM as a UPP-Pase that is active under 
growth conditions not yet identified. Alternatively, this may be an adventitious reaction that only 
occurs when this enzyme is artifically overexpressed. This may be similar to the case in E.coli, 
where LpxT transfers phosphate from UPP to lipid A and as a product also generates Und-P (Touze 
et al., 2008b). The efficiency of recycling UPP by this reaction is not enough to support cell growth, 
but this enzyme indeed has UPP-Pase activity. To test the hypothesis that uppP and bcrC are a 
synthetic lethal pair, and to explore the physiological consequences of UPP-Pase depletion, we 
 71 
 
optimized a previously described CRISPRi repression system (Peters et al., 2016a) to minimize 
the appearance of suppressor mutations. We have here used two copies of dCas9 to reduce the 
occurrence of suppressor mutations. The frequency of suppressor mutations varies significantly 
between loci (unpublished results), and may be affected by the length of time required to deplete 
the cell of essential proteins. Whereas one sgRNA generally suffices for gene knockdown (Peters 
et al., 2016a), here we included two sgRNAs targeting the bcrC gene. The presence of two sgRNAs 
leads to a modest increase in repression efficiency as judged by xylose sensitivity (Figure 2.1B), 
and also slightly reduced the frequency of suppressors (Figure 2.2). In this system, the greatest 
reduction in suppressor frequency required deletion of yodM which eliminates the only other 
known protein with UPP-Pase activity (Figure 2.2). In general, optimization of CRISPRi for 
knockdown of essential genes (or sets of genes) may benefit from use of a dCas9 merodiploid 
since inactivation of dCas9 is one frequent cause of suppression. Further modifications worth 
exploring include the use of two sgRNAs per gene (although this effect may be minor) and 
elimination of known or predicted pathways of suppression. 
The two independent suppressor analyzed from our optimized strain each contained 
mutations in both copies of the dCas9 gene. The occurrence of frameshift mutations in runs of 
adenines suggests that these may be hot spots for mutagenesis, and the fact that each strain contains 
the same point mutation in both dCas9 genes suggests a gene conversion event after the first 
mutation. One way to further reduce the fraction of suppressors might be to use a dCas9 with a 
different coding sequence as the second copy. For example, swapping alternate but still preferred 
codons for B. subtilis (Moszer et al., 1999) could be used to reduce the number of homopolymeric 
sequences and also to reduce sequence-sequence similarity between two dCas9 genes. 
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Nevertheless, the fraction of suppressors in the optimized strain used in this study is sufficiently 
low to carry out the physiological assays performed here. 
Depletion of UPP-Pases leads to a cessation of growth after ~3-4 doublings. Even mild 
depletion (due to the leaky expression of dCas9 in the depletion strain) leads to an increase in 
sensitivity to bacitracin. As UPP is further depleted, the cells begin to display morphological 
abnormalities including a prominent bulging of the cells. This is consistent with the morphological 
changes induced by other genetic and chemical perturbations known to affect PG synthesis. 
Concomitant with the onset of morphological defects resulting from depletion of UPP, the cells 
strongly activate the M cell envelope stress response, consistent with the effects of other 
antibiotics targeting the lipid II cycle (Helmann, 2016).  
In conclusion, our results establish that B. subtilis requires either of two UPP-Pases for 
viability, UppP and BcrC. Because of the nature of Und-P synthesis and recycling, it is reasonable 
to speculate that one UPP-Pase has a cytosolic-facing active site and functions to convert UPP 
produced by UppS into Und-P for use in cell wall synthesis, while the other one recycles UPP 
produced as a product of the transglycosylase reaction catalyzed by class A PBPs. We speculate 
that the former activity is UppP, which might account for the minor role of this enzyme with 
respect to sensitivity to rare earth metals (Inaoka & Ochi, 2012). After each addition to the growing 
peptidoglycan (or WTA) polymer, UPP is released and must be dephosphorylated and flipped back 
to the cytoplasmic face of the membrane for reuse. This is the likely role for BcrC, which by 
reducing surface exposed UPP can prevent binding of bacitracin to its target. In contrast, all four 
of the E. coli UPP-Pases may have active sites on the outer face of the membrane. These include 
the PAP2 family UPP-Pases PgpB (Touze et al., 2008a), YbjG and YeiU (Tatar et al., 2007) and, 
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based on protein modeling, BacA (Chang et al., 2014). Manat and co-workers provided supporting 
evidence for this model using truncated BacA-β-lactamase reporters (Manat et al., 2015).  
Regardless of whether the two UPP-Pases in B. subtilis have their active sites on the same 
or opposite faces of the membrane, the fact that B. subtilis can survive with only one UPP-Pase 
suggests that UPP-Pase function needs only be localized to one face to support viability. This 
suggests that either de novo synthesized UPP is dephosphorylated inside the cell and the UPP 
product released by the transglycosylase reaction can be flipped from outside to inside, or that UPP 
synthesized in the cytoplasm is first flipped to the outside to be dephosphorylated, and then flipped 
back to the cytoplasmic face to support peptidoglycan (MraY) and WTA (TagO) synthesis. 
Flipping of Und-P or UPP is unlikely to be spontaneous, although the identity of any proteins that 
help catalyze this reaction is not yet clear. Ongoing efforts to define this and other poorly 
understood steps in the lipid II cycle will help to identify new candidates for the targeting of 
antibacterials and will refine our understanding of the complex mechanisms of acclimation to 
antibiotics in bacteria.  
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2.8 Supplemental Material 
2.8.1 Supplemental Figures 
 
 
 
 
Figure S2.1. Overexpression of YodM rescues growth defect of a uppP bcrC double mutant. 
Growth of yodM overexpression strain in absence and presence of 1 mM IPTG. An ectopic copy 
of yodM was overexpressed from the Pspac(hy) promoter with a strong RBS and ATG as start 
codon. 
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Figure S2.2 A dCas9 merodiploid reduces the frequency of spontaneous suppressor 
mutations.  
Photos of disk diffusion assay of WT and mutant strains. Cells were grown on LB plates with 
xylose added onto the filter paper disk. (A). Strains having single dCas9 in SPβ showed similar 
phenotype as having single dCas9 in ganA site, but had more of suppressors inside the clear zone. 
(B). Mutants containing two dCas9 is more sensitive to induction of dCas9 by addition of xylose. 
With chromosomal copy of yodM intact, there were still many suppressors inside the clear zone. 
(C).Mutants having two copies of dCas9 show similar phenotype in ΔyodM background. The 
number of suppressors is much smaller in ΔuppP bcrC-1&2 background lacking yodM. 
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Figure S2.3. Membrane stain of WT (A) and optimized depletion strain (B) after growing in 
presence of xylose. Cells were growing in CH medium containing 2% xylose and membrane was 
strained by FM5-95. Images were taken 4 hours after addition of xylose. Depletion strain (B) still 
formed septum (arrows) as WT strain (A) but exhibited bulging phenotype after depletion of UPP-
Pases. 
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2.8.2 Supplemental Tables 
 
Table S2.1. Homologs of E.coli UPP-Pases in B.subtilis 
E.coli 
UPP-Pase 
B.subtilis 
Homologue Query coverage
 E Value Identity 
BacA UppP 93% 5.00E-79 48% 
YbjG 
BcrC 78% 3.00E-18 30% 
YodM 33% 0.003 36% 
PgpB YodM 23% 0.01 34% 
YeiU (LpxT) BcrC 63% 0.005 23% 
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Table S2.2. IPTG-regulated expression of candidate UPP-Pases with altered  
RBS sequences in a bcrC uppP double mutant 
Ectopic copy of gene
a RBS* Growthb 
Pspac(hy)-bcrC   +IPTG -IPTG 
Native RBS aaatgtaaaagg tgattat ttg + + 
Native 6c aaatgtaaaagg gattat  ttg (-)   
Native 5 aaatgtaaaagg attat    ttg (-)   
Native 4 aaatgtaaaagg ttat      ttg (-)   
  
Pspac(hy)-uppP   
  
Native RBS aatggggagaa tcaaaatc atg (-) 
 
Strongc 7 taaggagg caaaatc atg + + 
Strong 6 taaggagg aaaatc   atg + + 
Strong 5 taaggagg aaatc     atg + + 
Strong 4 taaggagg aatc       atg + + 
        
Pspac(hy)-yodM       
Native RBS and Start Codon ttgaggtgg ttaaaa ttg (-)   
Strong 7 taaggagg tgattat atg + - 
*Predicted Ribosome Binding Site (RBS) is in bold, spacer region between RBS and start codon is in 
italic, and start codon is underlined. For purposes of clarity, one or more space was used between RBS, 
spacer region and start codon. 
a Transformation deleting bcrC and uppP in two consecutive steps was performed in strains with ectopic 
copy of indicated gene. In a successful transformation, resulting strain should miss both chromosomal 
copy of bcrC and uppP. 
b “+” indicates growth and “-” indicates no growth. (-) indicates that the strain could not be constructed 
due to failure to get transformants even under IPTG-inducing conditions. 
c Number after “strong” or “native” is the number of base pairs for the spacer region. 
 
 
 
 
 86 
 
Table S2.3. Percentage of suppressor outgrowth in selected strain backgrounds 
Strain Number Genotype 
Number of 
cultures with 
outgrowth a 
Percentage of 
cultures with 
outgrowth b 
HB17177 ganA::dCas9, bcrC-1, uppP-1 30 100% 
HB17190 
ganA::dCas9, yodM null markerless, uppP 
null markerless, bcrC-1, bcrC-2 
          30 100% 
HB17221 
ganA::dCas9, SPβ::dCas9, bcrC-1, 
uppP-1 
22 73.3% 
HB17235 
ganA::dCas9, SPβ::dCas9, yodM, uppP 
null markerless, bcrC-1, bcrC-2 
2 6.7% 
 
a. Suppressor outgrowth was monitored using an automated BioScreen growth analyzer. 
Approximately 4x104 logarithmic phase cells were inoculated into 200 µl of LB medium 
supplemented with final concentration of 2% (w/v) xylose. 30 replicate cultures (3 biological 
replicates containing 10 technical replicates each) were used for each strain. Outgrowth is defined 
as OD600>0.3 after 12 hours of incubation. 
b. Percentage of outgrowth cultures was calculated by dividing number of cultures with outgrowth 
by the total number (30) of cultures.  
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Table S2.4. Strains, plasmids and primers used in this study 
Strain 
Number Genotype 
168 Wild Type 
ZB307 trp+ phe+ SPβc2Δ2::Tn917::pSK10Δ6  
HB17042 bcrC::MLS 
HB17043 uppp::spec 
HB17044 yodM::tet 
HB17046 Pspac(hy)-uppP 
HB17045 Pspac(hy)-bcrC 
HB17047 Pspac(hy)-yodM 
HB17071 Pspac(hy)-uppP, bcrC::MLS 
HB17072 Pspac(hy)-uppP, uppP::spec 
HB17073 Pspac(hy)-yodM, bcrC::MLS 
HB17074 Pspac(hy)-yodM, uppP::spec 
HB17075 Pspac(hy)-bcrC*, bcrC::MLS, uppP::spec 
HB17076 Pspac(hy)-bcrC* RBS wk6 
HB17077 Pspac(hy)-bcrC* RBS wk5 
HB17078 Pspac(hy)-bcrC* RBS wk4 
HB17079 Pspac(hy)-uppP* RBS st7 
HB17080 Pspac(hy)-uppP* RBS st6 
HB17081 Pspac(hy)-uppP* RBS st5 
HB17082 Pspac(hy)-uppP* RBS st4 
HB17083 Pspac(hy)-bcrC* RBS wk6, bcrC::MLS 
HB17084 Pspac(hy)-bcrC* RBS wk5, bcrC::MLS 
HB17085 Pspac(hy)-bcrC* RBS wk4, bcrC::MLS 
HB17086 Pspac(hy)-uppP* RBS st7, bcrC::MLS 
HB17087 Pspac(hy)-uppP* RBS st6, bcrC::MLS 
HB17088 Pspac(hy)-uppP* RBS st5, bcrC::MLS 
HB17089 Pspac(hy)-uppP* RBS st4, bcrC::MLS 
HB17090 Pspac(hy)-bcrC* RBS wk6, uppP::spec 
HB17091 Pspac(hy)-bcrC* RBS wk5, uppP::spec 
HB17092 Pspac(hy)-bcrC* RBS wk4, uppP::spec 
HB17093 Pspac(hy)-uppP* RBS st7, uppP::spec 
HB17094 Pspac(hy)-uppP* RBS st6, uppP::spec 
HB17095 Pspac(hy)-uppP* RBS st5, uppP::spec 
HB17096 Pspac(hy)-uppP* RBS st4, uppP::spec 
HB17132 bcrC null makerless 
HB17160 uppP null markerless 
HB17162 yodM null markerless 
HB17164 bcrC, yodM null markerless 
HB17166 uppP, yodM null markerless 
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HB17167 ganA::dCas9 
HB17168 ganA::dCas9, bcrC null markerless 
HB17169 ganA::dCas9, uppP null markerless 
HB17170 ganA::dCas9, yodM null markerless 
HB17171 ganA::dCas9, bcrC, yodM null markerless 
HB17172 ganA::dCas9, uppP, yodM null markerless 
HB17173 ganA::dCas9, bcrC-1 
HB17174 ganA::dCas9, bcrC-2 
HB17175 ganA::dCas9, uppP-1 
HB17176 ganA::dCas9, uppP-2 
HB17177 ganA::dCas9, bcrC-1, uppP-1 
HB17178 ganA::dCas9, bcrC-2, uppP-2 
HB17179 ganA::dCas9, uppP null markerless, bcrC-1 
HB17180 ganA::dCas9, uppP null markerless, bcrC-2 
HB17181 ganA::dCas9, uppP null markerless, bcrC-1, bcrC-2 
HB17182 ganA::dCas9, yodM null markerless, bcrC-1 
HB17183 ganA::dCas9, yodM null markerless, bcrC-2 
HB17184 ganA::dCas9, yodM null markerless, uppP-1 
HB17185 ganA::dCas9, yodM null markerless, uppP-2 
HB17186 ganA::dCas9, yodM null markerless, bcrC-1, uppP-1 
HB17187 ganA::dCas9, yodM null markerless, bcrC-2, uppP-2 
HB17188 ganA::dCas9, yodM null markerless, uppP null markerless, bcrC-1 
HB17189 ganA::dCas9, yodM null markerless, uppP null markerless, bcrC-2 
HB17190 ganA::dCas9, yodM null markerless, uppP null markerless, bcrC-1, bcrC-2 
HB17191 SPβ::dCas9 
HB17192 SPβ::dCas9, bcrC null markerless 
HB17193 SPβ::dCas9, uppP null markerless 
HB17194 SPβ::dCas9, yodM null markerless 
HB17195 SPβ::dCas9, bcrC, yodM null markerless 
HB17196 SPβ::dCas9, uppP, yodM null markerless 
HB17197 SPβ::dCas9, bcrC-1 
HB17198 SPβ::dCas9, bcrC-2 
HB17199 SPβ::dCas9, uppP-1 
HB17200 SPβ::dCas9, uppP-2 
HB17201 SPβ::dCas9, bcrC-1, uppP-1 
HB17202 SPβ::dCas9, bcrC-2, uppP-2 
HB17203 SPβ::dCas9, uppP null markerless, bcrC-1 
HB17204 SPβ::dCas9, uppP null markerless, bcrC-2 
HB17205 SPβ::dCas9, uppP null markerless, bcrC-1, bcrC-2 
HB17206 SPβ::dCas9, yodM null markerless, bcrC-1 
HB17207 SPβ::dCas9, yodM null markerless, bcrC-2 
HB17208 SPβ::dCas9, yodM null markerless, uppP-1 
HB17209 SPβ::dCas9, yodM null markerless, uppP-2 
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HB17210 SPβ::dCas9, yodM null markerless, bcrC-1, uppP-1 
HB17211 SPβ::dCas9, yodM null markerless, bcrC-2, uppP-2 
HB17212 SPβ::dCas9, yodM null markerless, uppP null markerless, bcrC-1 
HB17213 SPβ::dCas9, yodM null markerless, uppP null markerless, bcrC-2 
HB17214 SPβ::dCas9, yodM null markerless, uppP null markerless, bcrC-1, bcrC-2 
HB17216 ganA::dCas9, SPβ::dCas9, bcrC-1 
HB17217 ganA::dCas9, SPβ::dCas9, bcrC-2 
HB17218 ganA::dCas9, SPβ::dCas9, uppP-1 
HB17219 ganA::dCas9, SPβ::dCas9, uppP-2 
HB17220 ganA::dCas9, SPβ::dCas9, uppP null markerless 
HB17221 ganA::dCas9, SPβ::dCas9, bcrC-1, uppP-1 
HB17222 ganA::dCas9, SPβ::dCas9, bcrC-2, uppP-2 
HB17223 ganA::dCas9, SPβ::dCas9, uppP null markerless, bcrC-1 
HB17224 ganA::dCas9, SPβ::dCas9, uppP null markerless, bcrC-2 
HB17225 ganA::dCas9, SPβ::dCas9, uppP null markerless, bcrC-1, bcrC-2 
HB17226 ganA::dCas9, SPβ::dCas9,  yodM null markerless, bcrC-1 
HB17227 ganA::dCas9, SPβ::dCas9,  yodM null markerless, bcrC-2 
HB17228 ganA::dCas9, SPβ::dCas9,  yodM null markerless, uppP-1 
HB17229 ganA::dCas9, SPβ::dCas9,  yodM null markerless, uppP-2 
HB17230 ganA::dCas9, SPβ::dCas9, yodM, uppP null markerless 
HB17231 ganA::dCas9, SPβ::dCas9,  yodM null markerless, bcrC-1, uppP-1 
HB17232 ganA::dCas9, SPβ::dCas9,  yodM null markerless, bcrC-2, uppP-2 
HB17233 ganA::dCas9, SPβ::dCas9, yodM, uppP null markerless, bcrC-1 
HB17234 ganA::dCas9, SPβ::dCas9, yodM, uppP null markerless, bcrC-2 
HB17235 ganA::dCas9, SPβ::dCas9, yodM, uppP null markerless, bcrC-1, bcrC-2 
HB17236 Pspac(hy)-yodM* RBS st7 
HB17237 Pspac(hy)-yodM* RBS st7, bcrC null markerless 
HB17239 Pspac(hy)-yodM* RBS st7, bcrC null markerless, uppP::spec 
Plasmid Description 
pPL82 Integration plasmid into amyE site 
pJMP1 Integration plasmid containing dCas9 into ganA site 
pJMP2 Integration plasmid for sgRNA into amyE site 
pJMP3 Integration plasmid for sgRNA into thrC site 
pJPM122 Integration plasmid into modified SPβ phage strain ZB307  
pSPβ::dCas9  Integration plasmid containing dCas9 into modified SPβ phage strain ZB307 
pJMP2-bcrC-2 pJMP2 with sgRNA bcrC-2 
pJMP3-bcrC-1 pJMP3 with sgRNA bcrC-1 
pJMP3-uppP-2 pJMP3 with sgRNA uppP-2 
pJMP2-uppP-1 pJMP2 with sgRNA uppP-1 
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Primer 
Number Name Sequence 
6048 bcrC-up-for ACTTAACGATGCACGGGGAA 
6049 bcrC-up-rev(mls) GAGGGTTGCCAGAGTTAAAGGATCCCATGGATTGCTTTAAAAATTTCGT 
6050 bcrC-down-for(mls) CGATTATGTCTTTTGCGCAGTCGGCCGTGAGGATCTACGAAGCCA 
6051 bcrC-down-rev AGTGAAGACAGCGGAAACCA 
6186 uppP up F ACGATCGTGAACAGCACCTT 
6189 uppP down R TCCAAGACATTTTTGGCGGC 
6221 bcrC depletion F XmaI  GATCCCCGGGTGTAAAAGGTGATTATTTGAACTAC 
6222 bcrC depletion R XbaI GATCTCTAGACTGTCTTGATTTCAGACGCC 
6223 uppP depletion F XmaI GATCCCCGGGTAATGGGGAGAATCAAAATC 
6224 uppP depletion R XbaI GATCTCTAGAAGGCTCGGAAAAGAGCCTTA 
6233 uppP up R sepc CGTTACGTTATTAGCGAGCCAGTCGGCGGCTACAAACAATTCCC 
6234 uppP down F spec CAATAAACCCTTGCCCTCGCTACGACTTGTCCCATTTGCAATCTATCG 
6235 yodM Up F GAGTGGCTTGAAACGGAGGA 
6236 yodM up R tet GAGAACAACCTGCACCATTGCAAGAAGAAACAAACTAACGGGCTTGT 
6237 yodM Down F tet GGGATCAACTTTGGGAGAGAGTTCCGAAAAGATTAAGCGGTTTCGAC 
6238 yodM Down R AAGGCGCAAAATCAACGCTT 
6239 yodM F XmaI GATCCCCGGGGCGGTCAGCTCCGGTTTTATT 
6240 yodM R XbaI GATCTCTAGAGCGTTTTTGCTGTGTTTTCCT 
6254 uppP depletion F HindIII (st7) GATCAAGCTTTAAGGAGGCAAAATCATGACTCTATGGGAATTG 
6255 uppP depletion F HindIII (st6) GATCAAGCTTTAAGGAGGAAAATCATGACTCTATGGGAATTGTTT 
6256 uppP depletion F HindIII (st5) GATCAAGCTTTAAGGAGGAAATCATGACTCTATGGGAATTGTTTG 
6257 uppP depletion F HindIII (st4) GATCAAGCTTTAAGGAGGAATCATGACTCTATGGGAATTGTTTG 
6258 bcrC depletion F HindIII (wk6) GATCAAGCTTTGTAAAAGGGATTATTTGAACTACGAAATTTTTAAAGC 
6259 bcrC depletion F HindIII (wk5) GATCAAGCTTTGTAAAAGGATTATTTGAACTACGAAATTTTTAAAGC 
6260 bcrC depletion F HindIII (wk4) GATCAAGCTTTGTAAAAGGTTATTTGAACTACGAAATTTTTAAAGC 
6411 CRISPRi bcrC-1 F AATTGTGATGAGATAGTCCAGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGC 
6412 CRISPRi bcrC-2 F TTCCGTGATGAAGACCATAAGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGC 
6413 CRISPRi uppP-1 F CACGATAGCTACTGCTAAAAGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGC 
6414 CRISPRi uppP-2 F AGCCCAGTAAATTTAAAATTGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGC 
6415 CRISPRi universal R ACATTTATTGTACAACACGAGCC 
6424 CRISPRi check F TGACAAAAATGGGCTCGTGT 
6425 CRISPRi check R ACTTCTGAGTTCGGCATGGG 
6426 yodM F HindIII (RBS st7) GATCAAGCTTTAAGGAGGTGATTATATGTACAAGCCCGTTAGTTTGTTTC 
6429 dCas9 check F CCGTCGTTGGAACTGCTTTG 
6430 dCas9 check R AGCATCCGTTTACGACCGTT 
6326 BKE MLS check R TTTTCTCGTTCATAGTAGTTCCTCC 
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Chapter 3. Aspartate deficiency limits peptidoglycan synthesis and 
sensitizes cells to antibiotics targeting cell wall synthesis in Bacillus 
subtilis 
3.1 Summary 
Peptidoglycan synthesis is an important target for antibiotics and relies on intermediates 
derived from central metabolism. As a result, alterations of metabolism may affect antibiotic 
sensitivity. An aspB mutant is auxotrophic for aspartate (Asp) and asparagine (Asn) and lyses 
when grown on Difco sporulation medium (DSM), but not on LB medium. Genetic and 
physiological studies, supported by amino acid analysis, reveal that cell lysis in DSM results from 
Asp limitation due to a relatively low Asp and high glutamate (Glu) concentrations, with Glu 
functioning as a competitive inhibitor of Asp uptake by the major Glu/Asp transporter GltT. Lysis 
can be specifically suppressed by supplementation with 2,6-diaminopimelate (DAP), which is 
imported by two different cystine uptake systems. These studies suggest that aspartate limitation 
depletes the peptidoglycan precursor meso-2,6-diaminopimelate (mDAP), inhibits peptidoglycan 
synthesis, upregulates the cell envelope stress response mediated by M and eventually leads to 
cell lysis. Aspartate limitation sensitizes cells to antibiotics targeting late steps of PG synthesis, 
but not steps prior to the addition of mDAP into the pentapeptide sidechain. This work highlights 
the ability of perturbations of central metabolism to sensitize cells to peptidoglycan synthesis 
inhibitors. 
3.2 Introduction 
Bacillus subtilis is a metabolically versatile soil bacterium and can synthesize all 20 amino 
acids. Amino acids are essential for synthesis of proteins and other macromolecules, and many can 
also be catabolized to yield intermediates of the tricarboxylic acid (TCA) cycle. Amino acid 
metabolism is governed by master regulators, such as CcpA, TnrA, and CodY, working in concert 
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with pathway-specific regulation by transcriptional, translational and post-translational 
mechanisms in a complex, interlinked network (Geiger & Wolz, 2014, Brantl & Licht, 2010, 
Sonenshein, 2007). 
 Glutamate (Glu) serves as a central link between nitrogen and carbon metabolism and, 
together with aspartate, functions as a key branch point amino acid linking amino acid biosynthesis 
with central carbon metabolism (Figure 3.1). Glutamate is synthesized by glutamate synthase (also 
known as glutamine oxoglutarate aminotransferase, GOGAT), encoded by gltAB in B. subtilis, 
which converts one molecule each of Gln and α-ketoglutarate into two molecules of Glu. 
Glutamate can be imported into the cell by GltT (Zaprasis et al., 2015), GltP (Tolner et al., 1995) 
and YveA (Lorca et al., 2003). 
 Glutamate homeostasis is tightly regulated in B. subtilis (Gunka & Commichau, 2012). 
Expression of gltAB is under control of GltC, which senses the ratio between Glu (the product) 
and α-ketoglutarate (the substrate) (Picossi et al., 2007). When growing on medium containing 
glucose and ammonium, cells are rich in TCA cycle intermediates and GltC is bound to α-
ketoglutarate and activates expression of gltAB (Commichau et al., 2007, Picossi et al., 2007). 
When intracellular Glu is high, Glu binds to GltC and represses gltAB (Picossi et al., 2007). In the 
presence of Arg or other amino acids that can be metabolized into Glu, the glutamate 
dehydrogenase RocG is induced and degrades Glu into α-ketoglutarate and ammonium (Belitsky 
& Sonenshein, 1998). GltC can also physically interact with RocG and it was suggested that this 
interaction affects GltC activity (Commichau et al., 2007, Picossi et al., 2007). B. subtilis 168 
contains two genes encoding glutamate dehydrogenases, a functional rocG gene and cryptic gudB 
gene (Belitsky & Sonenshein, 1998). When a rocG null mutant grows on complex sporulation 
medium, there is strong selection for mutations that regenerate functional gudB (Gunka et al., 
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2012), highlighting the importance of maintaining Glu homeostasis in the cell. In addition to 
serving as a major nitrogen donor and anion in the cell and a precursor for protein synthesis, Glu 
is also important for cell wall synthesis. D-glutamate, synthesized by glutamate racemase from L-
glutamate, is incorporated into the pentapeptide side-chain of the peptidoglycan (PG) precursor 
lipid II. Mutations that affect Glu homeostasis have been found to affect resistance to antibiotics 
targeting early (fosfomycin) and late (beta-lactams) stages of PG synthesis (Lee et al., 2012). 
 In contrast with Glu, synthesis of Asp is not known to be tightly regulated. The main 
pathway of Asp synthesis in B. subtilis is through aspartate transaminase AspB, which transfers 
an amino group from Glu to oxaloacetate to form Asp (Figure 3.1) (Ochi et al., 1981). AspB is 
constitutively and highly expressed, and is one of the most abundant proteins in vegetative cells 
(Eymann et al., 2004). Asp is imported by GltT, GltP and YveA (Zaprasis et al., 2015), which are 
also involved in Glu uptake. In B. subtilis, Asp can also be generated from Asn by L-asparaginases 
AnsA and AnsZ (Sun & Setlow, 1991). However, their regulation indicates that these 
asparaginases function in degradation of Asn (and then Asp) ultimately yielding fumarate (Daniel 
& Errington, 1993; Fisher & Wray, 2002).   
 Aspartate is the starting point for synthesis of the Asp family amino acids, which include 
Asn, Lys, Thr, Met and Ile. The pathway that generates Lys includes both meso-diaminopimelate 
(mDAP), which is used in PG synthesis in many bacteria, and a branch point to dipicolinate, 
important for heat resistance of endospores (Daniel & Errington, 1993, Chen et al., 1993) (Figure 
1). The regulation of Asp usage mostly results from feedback inhibition (Dumas et al., 2012). For 
example, three aspartokinases convert L-aspartate into L-aspartyl-4-phosphate, the first committed 
step for generating Asp family amino acids (except Asn). Aspartokinase I (DapG) is feedback 
inhibited by mDAP but not L,L-diaminopimelate (DAP) (Rosner & Paulus, 1971, Chen et al., 
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1993), aspartokinase II (LysC) by Lys (Zhang et al., 1990), and aspartokinase III (ThrD) by the 
simultaneous presence of Thr and Lys (Kobashi et al., 2001, Graves & Switzer, 1990). The branch 
point enzyme Hom initiates the synthesis of Met, Thr, and Ile, and can be feedback inhibited by 
these products (Gutierrez-Preciado et al., 2009).  
 In bacteria, the amino acid composition of the stem pentapeptide of PG is typically L-Ala1-
D-Glu2-mDAP3-D-Ala4-D-Ala5, with the third amino acid being L-lysine in some bacteria (Zhao 
et al., 2017). Whether mDAP3 or L-Lys3 is used is mainly dependent on the substrate specificity 
of the corresponding ligase (MurE), as well as the cytoplasmic concentration of L-lysine versus 
mDAP (Ruane et al., 2013). Because of its essential role in PG synthesis, the stem pentapeptide 
serves as an important target for antibiotics including D-cycloserine, vancomycin and teicoplanin. 
D-cycloserine is a mimic of D-Ala, and inhibits D-Ala-D-Ala synthesis by inhibiting both alanine 
racemase (Alr) and D-Ala-D-Ala ligase (Ddl) (Strominger et al., 1960). Vancomycin inhibits PG 
synthesis by binding to the D-Ala4-D-Ala5 termini of stem peptides thereby preventing 
transpeptidation (Arthur et al., 1996).  
  In this work, we characterized the growth properties of a B. subtilis aspB mutant in a 
variety of nutrient conditions, which revealed that Asp limitation under otherwise nutrient rich 
conditions leads to depletion of mDAP and cell lysis. Aspartate limitation is exacerbated by high 
concentrations of Glu, which competitively inhibits Asp import. Depletion of mDAP can be 
rescued by addition of its precursor DAP, which is imported through two cystine uptake systems, 
TcyABC and TcyP. Under these conditions, Asp deficiency sensitizes cells to antibiotics targeting 
late steps of PG synthesis, thereby highlighting the intimate connection between central 
metabolism, PG synthesis and antibiotic susceptibility. 
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Figure 3.1. Metabolic pathways relevant to this study. Cofactors such as NAD+/NADH are not shown 
in the reactions for simplicity. Solid lines indicate steps requiring a single enzyme, and dashed lines indicate multiple 
enzymatic reactions between two compounds. Other processes, such as uptake of cystine or DAP or incorporation of 
dipicolinic acid into endospore, are indicated with dotted lines. Fosfomycin inhibits the synthesis of UDP-N-
acetylmuramic acid (UDP-NAM) from UDP-N-acetylglucosamine (UDP-NAG) by inactivating MurAA. D-
cycloserine mimics D-Ala and inhibits both the alanine racemase (Alr) and D-Ala-D-Ala ligase (Ddl), which form D-
Ala-D-Ala to be added to complete the pentapeptide side chain. After synthesis at the cytoplasmic membrane, lipid II 
needs to be flipped to the outside of the membrane by lipid II flippase (the flipping step) and oligomerized into glycan 
strands (transglycosylation). The glycan strands are then crosslinked by the transpeptidase activity of penicillin 
binding proteins (PBP) into the mesh-like structure of peptidoglycan (transpeptidation). Vancomycin binds to the D-
Ala-D-Ala motif of lipid II and prevent transpeptidation. β-lactam antibiotics such as cefuroxime (CEF) bind to PBPs 
and prevent transpeptidation. Mg2+ can bind to and stabilize the cell envelope even under conditions of reduced 
peptidoglycan synthesis. 
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3.3 Results 
3.3.1 An aspartate transaminase mutant lyses on Difco sporulation medium (DSM) 
Moenomycin (MOE) is an antibiotic that inhibits the transglycosylase activity of class A 
PBPs for peptidoglycan synthesis (Figure 3.1). During a transposon library selection for MOE 
resistant (MOER) mutants, we identified multiple independent insertions in ypmB (Hachmann, 
2010), encoding a membrane protein of unknown function. A ypmB mutant has recently been 
shown to suppress the tetracycline sensitivity of an ezrA mutation (and the name tseB was therefore 
proposed) and has a reduced cell length (Gamba et al., 2015). However, the physiological function 
of YpmB remains unknown.  
 Interestingly, when grown on Difco sporulation medium (DSM) plates (a medium that 
induces sporulation), a ypmB::mls mutant exhibited pronounced cell lysis (Guariglia, 2013). Since 
ypmB is the second gene in a three-gene operon (ypmA-ypmB(tseB)-aspB) (Figure 3.2A), we tested 
if the MOER and DSM lysis phenotypes were due to a polar effect on the downstream aspB gene. 
The MOER phenotype of the ypmB::mls mutant can be suppressed by ectopic expression of ypmB 
(cells become MOE sensitive), but not aspB (Figure 3.2B). Indeed, ectopic expression of aspB 
increased MOER rather than restoring sensitivity (Figure 3.2B). In contrast, the DSM lysis 
phenotype was suppressed by aspB, but not ypmB (Figure 3.2C, D). We conclude that MOER 
results from lack of ypmB, but the DSM lysis phenotype results from reduced expression of aspB. 
The mechanism underlying the increased MOER of the ypmB mutant strain is not yet clear, but we 
note that YpmB is predicted to have PEPSY domains that are implicated in regulation of peptidase 
and perhaps other enzymatic activities of cell-membrane localized proteins (Yeats et al., 2004, 
Gamba et al., 2015). Here, we focus on the role of AspB in preventing cell lysis on DSM. 
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 Since the DSM lysis phenotype of the ypmB::mls mutant strain appeared to result from 
polarity, we next tested the growth properties of an aspB null mutant. When grown on a DSM plate 
at 37˚C overnight, an aspB null mutant lysed and this phenotype was complemented by ectopic 
expression of aspB (Figure 3.2C). When grown in liquid DSM, an aspB null mutant grew to OD600 
~0.25 and lysed back to OD600 ~0.1 (Figure 3.2D), suggestive of nutrient limitation. In comparison, 
an aspB mutant grew almost as well as the B. subtilis 168 parent strain (WT) in LB medium (Figure 
3.2B), which is richer in amino acids (Table 3.1).  
 The aspB gene encodes aspartate transaminase (interconverting L-glutamate and 
oxaloacetate to with L-aspartate and α-ketoglutarate; Figure 3.1), and an aspB null mutant is an 
Asp/Asn auxotroph (Figure S3.1A, B), as previously reported (Ochi et al., 1981). Supplementation 
of DSM with 10 mM Asp (final concentration) greatly increased cell yield and completely 
suppressed lysis (Figure 3.3A), suggesting that limitation for Asp may trigger lysis. Asn can be 
converted to Asp by two asparaginases, AnsA and AnsZ (Fisher & Wray, 2002). Consistently, 
addition of 10 mM Asn (final concentration) also suppressed the lysis phenotype in DSM (Figure 
3.3A). 
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Figure 3.2. Dissection of phenotypes caused by ypmB and aspB mutations.  
A. Genetic arrangement of the ypmAypmBaspB operon. B. Representative growth curves of strains 
in liquid LB with or without 1 μg ml-1 moenomycin. C. Colony morphology of strains on DSM 
plates after 20 hours of incubation at 37˚C. D. Representative growth curves of strains in liquid 
DSM. 1 mM final concentration of IPTG are used to induce Pspac(hy) promoter. All growth curves 
were measured at least 3 times with similar results. A representative measurement is shown. 
Strains used were ypmB::mls (HB12259), aspB (HB17401), ypmB::mls Pspac(hy)-ypmB 
(HB22913), ypmB::mls Pspac(hy)-aspB (HB17062), and aspB::kan Pspac(hy)-aspB (HB17060). Note 
that indistinguishable phenotypes were observed for the aspB and aspB::kan strains.  
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Figure 3.3. Lysis of the aspB mutant results from depletion of Asp and competition with Glu 
for GltT. Representative growth curves of aspB mutants in DSM:   
A. Effect of supplementation with 10 mM (final concentration) of the following amino acids: Asn, 
asparagine; Asp, aspartate; Glu, glutamate; Gln, glutamine. B. Effects of mutation of each of the 
known glutamate/aspartate importers. C. Effects of mutations affecting intracellular Glu synthesis 
and degradation. D. Effects of mutations in panel C combined with or without gltT. E. Residual 
concentration of Asp and Glu in DSM medium after growth of 24 hours of indicated bacterial 
strains, as well as acid hydrolyzed medium. The data is represented as the mean plus and minus 
one standard error of the mean. 
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Table 3.1. Amino Acid Composition of LB and DSM 
Amino Acidse (mM) LBa Hydrolyzed LBb DSMa Hydrolyzed DSMb 
Alanine 1.47 1.78 0.38 2.72 
Arginine 1.34 0.81 0.52 1.45 
Asparagine 0.49 0.11c 0.08 0.14c 
Aspartate 0.55 3.39 0.14 1.68 
Glutamine 4.50 5.51c 0.47 1.34c 
Glutamate 2.32 7.17 0.93 2.90 
Glycine 0.71 1.18 0.26 5.77 
Histidine 0.33 0.88 0.07 0.65 
Isoleucine 0.83 3.91 0.27 0.89 
Leucine 1.75 2.60 0.32 1.23 
Lysine 3.53 4.74 0.42 1.16 
Methionined 0.40 0.82 0.01 0.01 
Phenylalanine 0.99 2.96 0.37 0.75 
Proline 0.33 4.54 0.13 3.12 
Serined 0.88 3.36 0.30 1.50 
Threonined 2.38 5.55 0.27 1.14 
Tryptophand 0.45 0.07 0.06 0.07 
Tyrosined 0.31 0.94 0.21 0.08 
Valine 1.13 2.14 0.17 1.05 
a. The amino acid composition is measured in unhydrolyzed media. This method measures free amino 
acids in the medium, which includes amino acids sensitive to acid hydrolysis, but does not measure amino 
acids that are inside oligo- and polypeptides. One measurement was performed for each medium. The 
measurement was performed by Metabolomics Center, Roy J. Carver Biotechnology Center, University 
of Illinois at Urbana-Champaign using a GC/MS based method. 
b. The acid hydrolysis was performed by addition of concentrated HCl into media to a final concentration 
of 6 M in sealed glass tubes. The mixture was placed in a sand bath at 110 ˚C for 24 hours for hydrolysis. 
The mixture was then neutralized to pH 7 by addition of NaOH. Two samples were measured for each 
medium and the average is shown. The measurement was performed by Metabolomics Center, Roy J. 
Carver Biotechnology Center, University of Illinois at Urbana-Champaign using GC/MS based method. 
c. Asparagine and glutamine can be hydrolyzed to aspartate and glutamate, respectively. The presence of 
the amine form is likely due to incomplete hydrolysis.  
d. Methionine, serine, threonine, tryptophan and tyrosine are known to be unstable under acid hydrolysis 
condition and the data acquired can be lower than the true value to different degrees according to the 
stability of each amino acid.  
e. Cystine is not reported due to incomplete data acquired from the measurement. 
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3.3.2 Lysis of aspB results from depletion of Asp and competition with Glu for GltT 
Deletion of aspB blocks both the synthesis of Asp and the consumption of Glu, and under 
conditions of limiting Asp supply from the medium could lead to either depletion of Asp or 
accumulation of Glu in the cells. Because of the importance of Glu homeostasis in Bacillus subtilis, 
we first investigated whether the lysis of aspB on DSM is due to intracellular accumulation of Glu. 
Indeed, addition of 10 mM Glu (final concentration) to DSM medium reduced the peak OD600 of 
the aspB null mutant from ~0.25 to ~0.15 (Figure 3.3A). Furthermore, in minimal medium (MM) 
high Glu antagonized the ability of Asp to support aspB growth (Figure S3.1C). In B. subtilis, Gln 
is a preferred nitrogen source and can be readily converted into Glu (Detsch & Stulke, 2003). 
However, a high concentration of Gln (5 or 10 mM) did not have a similar inhibitory effect (Figure 
3.3A, S3.1C), although under this condition intracellular Glu levels should also be elevated. This 
led us to hypothesize that rather than being toxic itself, due to intracellular accumulation, Glu was 
acting as an antagonist of Asp import.  
  Glu and Asp can be imported by three Glu/Asp transporters, GltP, YveA and GltT (Tolner 
et al., 1995, Lorca et al., 2003), with GltT being the major importer for both amino acids (Zaprasis 
et al., 2015). To test whether growth inhibition of the aspB mutant by Glu might be caused by 
competitive inhibition of Asp import, we mutated each of the three Asp/Glu importers in an aspB 
null mutant to see if the deletion of an importer would mimic the addition of Glu. Although deletion 
of gltP or yveA in the aspB mutant did not cause a noticeable growth defect, inactivation of gltT 
greatly reduced the growth yield (peak OD600) of the aspB mutant (Figure 3.3B), similar to that 
seen for the aspB single mutant growing in DSM supplemented with Glu (Figure 3.3A). Thus, 
direct inactivation of Asp uptake by deleting gltT mimics the presence of high Glu, which may 
competitively inhibit uptake of Asp by GltT. 
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 To further demonstrate that lysis is affected by relative concentrations of Asp and Glu in 
the medium, we altered cells to increase consumption of Glu. Glutamate is degraded by glutamate 
dehydrogenases RocG and GudB (Commichau et al., 2008). We reasoned that degradation of 
intracellular Glu may allow cells to deplete Glu from the medium and facilitate Asp uptake. Indeed, 
when RocG was overexpressed from an IPTG inducible Pspac(hy) promoter it completely suppressed 
the lysis phenotype of the aspB null mutant, and the final OD600 increased from ~0.25 to about 
0.35 (Figure 3.3C), possibly due to the ability of cells to more efficiently access Asp from the 
medium. Similarly, deletion of glutamate synthase GltA, which prevents Glu synthesis, also 
rescued the aspB lysis phenotype (Figure 3.3C). If these effects of altering Glu metabolism are due 
to effects on Asp import, then these mutations should be epistatic with gltT. Indeed, in a gltT null 
background, overexpression of rocG or deletion of gltA could no longer rescue aspB lysis (Figure 
3.3D). This is consistent with the hypothesis that consumption of Glu facilitates Asp uptake. 
 This model makes several predictions about the levels of Glu and Asp in DSM medium (in 
which aspB cells lyse) and LB medium (in which they do not), and how these levels might be 
affected by mutations in central metabolism. Using amino acid analysis (Table 3.1), we found that 
DSM is relatively poor in Asp (0.14 mM free Asp without hydrolysis and 1.68 mM with 
hydrolysis, as hydrolysis releases free amino acids from oligopeptides) compared to LB (0.55 mM 
and 3.39 mM, respectively), consistent with published work (Sezonov et al., 2007). These 
differences in amino acid levels are reflected in the growth yield (final OD600) of the aspB mutant 
in the two media (Figure 3.2B, D), and are generally consistent with the dependence of growth 
yield on Asp supplementation as observed in MM (Figure S3.1A). In addition, DSM contains much 
more Glu (0.93 mM without and 2.90 mM with hydrolysis) than Asp. Since GltT has a similar 
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affinity for these two amino acids (Zaprasis et al., 2015), it is likely that Glu competitively inhibits 
Asp uptake under conditions of our experiments.  
 This model is further supported by analysis of residual free amino acids after 24 hours of 
growth of the WT, aspB, aspB gltA and aspB Pspac(hy)-rocG mutants in DSM. WT cells, which grew 
to high density (Figure 3.3C), deplete both free Asp (0.05 mM remaining) and Glu (0.1 mM 
remaining) (Figure 3.3E). In contrast, the aspB mutant failed to grow to high density (Figure 3.3C) 
and there was considerable Asp (0.16 mM) and high Glu (1.4 mM) in the spent medium (Figure 
3.3E). In aspB mutant cells overexpressing RocG, Glu in the medium was reduced to 0.21 mM 
and Asp to 0.04 mM, similar to WT (Figure 3.3E). Deletion of gltA also reduced residual Glu in a 
similar but less dramatic manner, and correspondingly increased the ability of cells to utilize Asp 
(Figure 3.3E). The additional Asp rendered accessible by lowering Glu is not large (estimated at 
~0.1 mM). This is consistent with the small increase of final OD600 when rocG is overexpressed 
(from OD600 0.25 to 0.4, Figure 3.3C), possibly because of limited Asp in DSM. Collectively, these 
results suggest that high exogeneous Glu competitively inhibits Asp uptake by GltT, thereby 
exacerbating Asp limitation of the aspB mutant in the relatively Asp-poor DSM medium.  
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Figure 3.4. Lysis of the aspB mutant can be suppressed by biochemical or genetic 
manipulations that favor production of mDAP.  
A. Representative growth curves of the aspB mutant in DSM supplemented with or without the 
following amino acids (final concentration of 10 mM each, except Trp is at 5 mM): DAP, L, L-
diaminopimelate; Met, methionine; Lys, lysine; Ile, isoleucine; Thr, threonine; Trp, tryptophan. B.  
Representative growth curves of mutants in liquid DSM. 1 mM final concentration of IPTG is 
added to induce Pspac(hy) promoter when present. 
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3.3.3 aspB lysis is caused by depletion of mDAP  
In addition to being used for protein synthesis, Asp is used for the synthesis of Lys, Thr, 
Met, and Ile, as well as mDAP for peptidoglycan synthesis and dipicolinic acid for endospores 
(Figure 3.1). We next tested whether supplementation with any of these metabolites could suppress 
lysis in DSM. Supplementation with DAP (also known as L, L-diaminopimelic acid or 2,6-DAP, 
a precursor of mDAP) completely suppressed lysis and allowed cells to achieve a final OD600 of 
~0.5 (Figure 3.4A), close to WT in this medium (maximal OD600 of 0.7-0.8; Figure 3.4C).  
We hypothesized that DAP supplementation was providing mDAP for PG synthesis 
(Figure 3.1), and thereby suppressing cell lysis. However, DAP is also a precursor for Lys. In 
contrast with DAP, cells grown in DSM supplemented with Lys still showed an initial lysis before 
a gradual recovery (Figure 3.4A). The slow recovery was not specific to Lys as we also observed 
some recovery when supplemented with Ile or Trp (Figure 3.4A). Although the WT B. subtilis 
strain 168 used in this work is a tryptophan auxotroph, Trp is unlikely to be limited for cell growth, 
as DSM contains ~0.06 mM Trp (Table 3.1), which is over ten times higher than the required 
amount (~0.005 mM) for WT to grow to an OD600 of ~0.6 in minimal medium (Figure S3.2A). In 
addition, supplementing DSM with up to 10 mM Trp did not significantly increase cell yield 
(Figure S3.2B). Thus, both Lys and Trp facilitate recovery of the aspB mutant in a dose dependent 
manner after lysis, but have no effect on lysis itself (Figure S3.3). We speculate that this effect 
may result from increased nutrition supply to the not yet lysed cells, which facilitates the 
cannibalization of Asp from lysed cells. Indeed, supplementation with TCA cycle intermediates 
also facilitates post-lysis recovery, but has no effect in preventing lysis (Figure S3.4). Overall, the 
much more dramatic restoration of growth and complete prevention of lysis with DAP compared 
with Lys suggest that growth limitation and lysis results from a lack of mDAP for PG synthesis.  
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We also noticed a modest effect in suppressing lysis by supplementation with Met (Figure 
3.4A). Met can be synthesized from Asp through a pathway starting with the branch point enzyme 
homoserine dehydrogenase (Hom) (Figure 3.1). Hom converts L-aspartate semi-aldehyde into 
homoserine, the precursor for synthesis of Met, Thr, and Ile, and can be feedback inhibited by Met 
(Gutierrez-Preciado et al., 2009). We hypothesized that the partial rescue effect from Met may 
result from inhibition of Hom, which would spare L-aspartate semi-aldehyde for the DapA 
pathway and synthesis of mDAP (Figure 3.1). Because DSM contains all the amino acids produced 
by the Hom pathway (Table 3.1), we can delete hom under these growth conditions (Figure 3.4B) 
and test whether this allows a redirection of L-aspartate semi-aldehyde into the DAP pathway. 
Indeed, deletion of hom completely abolished lysis in the aspB hom double mutant (Figure 3.4B). 
Overexpression of DapA using an IPTG-inducible promoter led to a similar phenotype (Figure 
3.4B), likely because it diverts more L-aspartate semi-aldehyde into the DAP pathway. In contrast, 
overexpression of Asd, the aspartate semi-aldehyde dehydrogenase that produces the common 
substrate for Hom and DapA, did not have much effect (Figure 3.4B). SpoVFAB synthesizes 
dipicolinic acid, an abundant component of endospores, and is a major pathway that consumes 
precursors for mDAP in sporulating cells (Daniel & Errington, 1993). Since this pathway is not 
active in vegetative cells, deletion of spoVFA had no effect on the aspB lysis phenotype (Figure 
3.4B).  
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Figure 3.5. Amino acid and mDAP limitation are physiologically distinct.  
A. Growth curve of the aspB mutant growing in DSM supplemented with 1 or 10 mM final 
concentration of DAP. B. Growth curve of WT and the aspB mutant in DSM supplemented with 
10 mM final concentration of DAP, and with or without TCA cycle intermediates (10 mM final 
concentration). C. Growth curve of mutants in DSM supplemented with 10 mM final concentration 
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of DAP, or 10 mM each of DAP and Glu. D. Growth curve of the aspB mutant in DSM, or MM 
supplemented with 0.5 mM Asp, 0.5% (w/v) casamino acids, or 0.5 mM Asp and a mixture of 17 
amino acids each at concentration of 0.1 mg ml-1. E. Growth rate of aspB mutant in different media. 
The growth rate is calculated as log2(OD600-T2/OD600-T1)/(T2-T1), in which T1 and T2 are two time 
points in the exponential phase of cell growth. When OD600<0.3, one doubling in cell cycle is 
approximated as a two-fold increase in OD600 value. The data is represented as the mean plus or 
minus one standard error of the mean, and statistically significant different samples (Student’s t 
test, two-tailed P<0.05) are labelled with different letters. All growth curves were measured at 
least 3 times and yielded similar results. A representative measurement is shown. 
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3.3.4 Amino acid and mDAP limitation are physiologically distinct 
An aspB mutant grown in DSM supplemented with 1 mM DAP temporarily ceases growth 
at roughly the same cell density as in the absence of DAP (OD600 ~0.3), but lysis (as defined by 
the loss of optical density) was inhibited and slow growth resumed to a final OD600 of ~0.45 after 
20 hours (Figure 3.5A).  With 10 mM DAP, cells grew to this same final OD600 after only 8 hours 
(Figure 3.5A). The similar final cell yield suggests that growth yield is ultimately determined by 
availability of Asp in the medium. Since the aspB mutant cannot grow to the same cell density as 
WT, even when supplemented with DAP (Figure 3.5B), we infer that the lowered growth rate and 
cell yield is due to insufficient Asp (or Asp family amino acids) for protein synthesis. We 
hypothesize that the growth rate stimulation with 10 mM compared to 1 mM DAP (Figure 3.5A) 
may be due to the known ability of mDAP to inhibit aspartokinase I (DapG) (Graves & Switzer, 
1990, Rosner & Paulus, 1971), which will reduce the amount of Asp used to synthesize other Asp 
family amino acids.  
 In addition to its role in Asp synthesis, AspB could in principle function as an anaplerotic 
enzyme by providing α-ketoglutarate to sustain TCA cycle function. To test whether this might be 
a cause for the reduced cell yield, we tested the effect of supplementation with both DAP and 10 
mM of various TCA cycle intermediates. None of the tested intermediates increased yield beyond 
that seen with DAP alone (Figure 3.5B), consistent with the idea that reduced growth of the aspB 
mutant under these conditions is due to an insufficiency of amino acids to support protein 
synthesis. Consistent results were observed in MM: an aspB mutant grown in MM supplemented 
with a limiting amount of Asp (1 mM) did not display an increase in cell yield when DAP was 
added (Figure S3.1D).  
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  When an aspB mutant is grown in the presence of 10 mM DAP, cells no longer lyse, and 
are likely growth limited by the requirement of Asp and Asp family amino acids for protein 
synthesis (Figure 3.1). This limitation can be exacerbated by removal of the major Asp uptake 
system, GltT. In the presence of DAP the aspB gltT double mutant grew slowly to OD600 ~0.5 
(Figure 3.5C). The similar final OD600 for the gltT+ and gltT strains suggests that the remaining 
Asp uptake system(s), presumably GltP and YveA (Tolner et al., 1995, Lorca et al., 2003), can 
still import Asp from the medium, albeit at a lower rate. However, these Asp uptake systems are 
still sensitive to Glu competition, as addition of 10 mM Glu completely abolished aspB gltT 
growth, even in the presence of DAP (Figure 3.5C). Overall, these data strongly suggest that when 
DAP is provided, growth and cell yield of the aspB mutant is determined by the availability of Asp 
for protein synthesis, whereas when mDAP is limited cell lysis results from a deficiency in PG 
synthesis.   
In contrast to the lysis observed in DSM, the aspB mutant did not lyse in MM when a low 
concentration of Asp was supplemented (0.5 mM or 1 mM, Figure S3.1D). One notable difference 
between these media is that in MM cells are synthesizing most amino acids and are only provided 
with Trp (0.24 mM) and a limiting amount of Asp, whereas DSM contains all 20 proteinaceous 
amino acids (Table 3.1). Indeed, when additional amino acids were supplemented into MM, either 
in the form of casamino acids (CAAs) or a mixture of 17 amino acids (17AAs; the 20 essential 
amino acids omitting Asp, Asn and Glu), the aspB mutant exhibited rapid lysis after reaching its 
peak OD600 (Figure 3.5D). We hypothesized that lysis might be correlated with growth rate, with 
fast-growing cells having more active autolysins and therefore being more vulnerable to a 
disruption in PG synthesis (Mah & O'Toole, 2001, Tuomanen et al., 1986). Indeed, under growth 
conditions that caused lysis of the aspB mutant (DSM, or in MM supplemented with 0.5% CAA 
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or 17AAs) the aspB mutant grew at a rate similar to, or even faster than, that of WT in DSM until 
Asp was depleted (Figure 3.5E). In comparison, when the aspB mutant was grown in MM with 
limiting Asp and ammonium as nitrogen source, cells grew slower and did not lyse after Asp 
depletion. Overall, our results suggest a correlation between growth rate and lysis, with rapid 
growth contributing to lysis upon mDAP depletion in the cell.   
 
3.3.5 DAP can be imported into B. subtilis by cystine uptake systems TcyABC and TcyP 
Previous studies suggest that in E. coli and Salmonella Typhimurium, DAP can be 
imported by cystine uptake systems, likely due to their structural similarity (Leive & Davis, 1965, 
Stephen & Nicholas, 1986) (Figure 3.6A). There are two cystine uptake systems in E. coli (Berger 
& Heppel, 1972), with TcyJLN able to uptake DAP and TcyP more specific for cystine (Chonoles 
Imlay et al., 2015). Uptake of DAP in Bacillus megaterium was resistant to the presence of cystine, 
suggesting the uptake is not through cystine import pathways (Gally et al., 1991). However, in the 
same study Bacillus subtilis 168 exhibited no detectable DAP uptake with or without cystine 
(Gally et al., 1991), in contrast to our observation that DAP can suppress the lysis of the aspB 
mutant.  
To investigate if DAP is imported into the cells using cystine uptake systems in B. subtilis, 
we used the lysis phenotype of the aspB mutant as a readout and tested whether cystine can abolish 
the rescue of lysis by DAP. With supplementation with 600 μM cystine, 1 mM DAP could no 
longer prevent the aspB lysis (Figure 3.6B), suggesting that B. subtilis can indeed import DAP and 
this uptake is likely through cystine uptake pathways. However, the import is likely to be slow and 
unable to replace endogenous DAP synthesis, as supplementation with 10 mM DAP cannot bypass 
the essentiality of genes (such as dapB and dapL) upstream of DAP synthesis in the mDAP/lysine 
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pathway, as tested using CRISPRi based gene knockdown strains (Peters et al., 2016b), either in 
LB and DSM (data not shown), or in minimal medium (no cystine to compete with DAP import)  
supplemented with 3.4 mM Lys(Figure S3.5).  
In B. subtilis, there are three cystine uptake systems: TcyABC, TcyJKLMN and TcyP 
(Burguiere et al., 2004). TcyABC and TcyJKLMN are ATP binding cassette (ABC) transporters 
and TcyP is a proton-cystine symporter. To determine which of these three cystine uptake systems 
are involved in DAP import, we tested mutant strains lacking one, two, or all three systems for the 
ability of DAP to prevent lysis of the aspB mutant (Figure 3.6C). The results suggest that TcyABC 
and TcyP are the two major DAP uptake systems, with TcyJKLMN playing little if any role. The 
limited role for TcyJKLMN was surprising since import of L-[14C]-cystine by this system is known 
to be partially inhibited by mDAP (Burguiere et al., 2004). Regardless, our results suggest that 
TcyJKLMN does not import sufficient DAP to suppress lysis and support growth under these 
conditions.   
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Figure 3.6. DAP can be imported through cystine uptake systems TcyABC and TcyP.  
A. Chemical structure of 2,6-DAP and cystine. B. Growth curve of the aspB mutant growing in 
DSM with or without supplementation with DAP (1 mM final concentration), Cys (600 μM 
cystine), and DAP + Cys (1 mM DAP and 600 μM cystine). C. Growth curves of different strains 
in DSM supplemented with 10 mM DAP. All growth curves were measured at least 3 times and 
yielded similar results. A representative measurement is shown. 
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3.3.6 Depletion of mDAP causes cell wall stress and cell morphology defects  
Since mDAP is an essential substrate for PG synthesis, mDAP limitation is predicted to 
impair PG synthesis ultimately leading to cell lysis. Indeed, microscopic images revealed many 
bulged cells and cell debris when the aspB mutant was grown in liquid DSM, while such deformed 
cells were rare in the 168 WT (Figure 3.7A, red arrows). When supplemented with DAP, the lysis 
phenotype was suppressed (Figure 3.7B), and bulged cells were much less frequent (Figure 3.7E). 
Divalent cations such as Mg2+ are known to suppress PG defects, in part through altering the 
acetylation level of mDAP in peptidoglycan (Dajkovic et al., 2017) and possibly by other 
mechanisms including stabilization of negatively charged cell wall through cation-anion 
interactions. Consistent with the idea that lysis of an aspB null mutant is due to lack of mDAP and 
weakened PG, addition of 10 mM MgSO4 suppressed the lysis phenotype of aspB (Figure 3.7B, 
E).  
The alternative sigma factor M is known to be upregulated when PG synthesis is inhibited 
(Helmann, 2016). Using a PM-lux luciferase reporter containing the M dependent autoregulatory 
promoter of the sigM gene, we found that M activity was strongly induced after 3 hours of growth 
in DSM medium, around the same time that growth of the aspB mutant ceased (Figure 3.7C, dotted 
line). However, within the first hour after growth ceased and cells began to lyse, the M activity 
increased another 2- to 3-fold, as measured by luciferase activity (Figure 3.7C, dashed line). It is 
worth noting that because the luciferase enzyme we used in this work has an estimated half-life of 
only 4.2 minutes (Radeck et al., 2013) it seems that there is still ongoing protein synthesis even 
when the Asp pool is very limited and cells fail to generate enough mDAP for PG synthesis. 
Although addition of either DAP or Mg2+ can suppress the lysis of the aspB mutant, their 
mechanisms are quite different: addition of DAP rescues PG synthesis by providing the limiting 
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mDAP precursor, whereas Mg2+ stabilizes the cell wall without solving the underlying problem. 
Consistently, addition of DAP almost completely suppressed induction of M while 
supplementation with Mg2+ did not (Figure 3.7D). We also compared these two mechanisms of 
suppressing lysis by monitoring cell morphology after 24 hours of growth in supplemented DSM. 
In WT cultures, phase-bright endospores were readily visible after 24 hours of growth in DSM, 
while almost no endospores were present in the aspB mutant. Addition of DAP enabled a smaller 
population to form phase-bright endospores while addition of Mg2+ apparently did not. Using Oufti 
software (Paintdakhi et al., 2016), we scored more than 600 cells (exclusive of spores) for each 
strain and growth condition, and measured cell length and width and calculated the width to length 
ratio (Figure 3.7E, F). Insufficient peptidoglycan synthesis in the aspB mutant significantly 
changed cell shape: the aspB mutant was about 11% shorter and 13% wider than WT cells, causing 
a 27% increase in the width to length ratio (Figure 3.7F). Addition of DAP or Mg2+ did not strongly 
affect the width/length ratio of WT cells. However, supplementation with DAP partially reversed 
the shape effects in the aspB mutant and reduced the change in aspect ratio from a 27% to a 9% 
increase relative to WT. In contrast, addition of Mg2+ did not restore cells to a more WT shape 
(Figure 3.7F). In fact, the aspB mutant supplemented with Mg2+ displayed a further increase of the 
width to length ratio relative to WT (Figure 3.7F). These data suggest that although addition of 
either DAP and Mg2+ suppress cell lysis, the intrinsic differences between the two mechanisms 
result in different cell morphologies.   
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Figure 3.7. Limitation of mDAP causes cell wall stress and cell morphology defects.  
A. Representative phase contrast microscopic images of WT and the aspB mutant after 12 hours 
of growth in DSM. Red arrows point to deformed or lysed cells.  B. Growth curve of the aspB 
mutant in DSM with or without supplementation with 10 mM MgSO4 or 10 mM DAP. C. M 
activity (relative light unit (RLU)/OD600, left axis, closed symbols) and OD600 (right axis, open 
symbols) of WT and the aspB mutant in DSM. The dotted line indicates the time when the aspB 
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mutant starts to lyse, and the dashed line indicates when the luciferase synthesis begins to decrease. 
Because the luciferase has a short half-life (~4 minutes), OD600 and luminescence were measured 
every 12 minutes to generate near real time gene expression data. D. M activity (relative light unit 
(RLU)/OD600) of the aspB mutant in DSM with or without supplement of 10 mM DAP or 10 mM 
MgSO4. All growth curves were measured at least 3 times and yielded similar results. A 
representative measurement is shown. E. Representative phase contrast microscopic images of WT 
and the aspB mutant after 24 hours of growth in DSM, with or without supplementing 10 mM 
DAP or MgSO4. Red arrows point to deformed or lysed cells. F. Comparison of cell length, width 
and aspect between WT and the aspB mutant under different growth conditions. n is the number 
of cells measured per strain per condition. Percentage change of the mean compared to WT is 
shown above each data plot. The bottom and top of the box are the first and third quartiles, the 
band inside the box is the second quartile (the median), and the X inside the box is the mean. 
Whiskers are one standard deviation above or below the mean. Outliers are shown as single dots.  
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3.3.7 Limitation of mDAP sensitizes cells to cell wall antibiotics  
Since the aspB mutant is limited for mDAP availability, we tested the effect on sensitivity 
against several antibiotics targeting PG synthesis. For this analysis, we used Mueller-Hinton (MH) 
medium in which aspB mutant has less of a growth defect than in DSM: single colonies grow with 
normal morphology on MH plates, with comparatively mild lysis apparent in the colony centers 
and the inoculation loading zone (Figure S3.6). Using MH medium, we found that an aspB mutant 
was no more sensitive than WT to fosfomycin or D-cycloserine (Figure 3.8A), two antibiotics 
targeting early steps of PG synthesis (Figure 3.1). However, the aspB mutant was significantly 
more sensitive to antibiotics targeting PG synthesis steps downstream of lipid II, including 
vancomycin and the beta-lactam antibiotic cefuroxime (Figure 3.8A). Addition of 10 mM Asp 
completely rescued the sensitivity to vancomycin and partially to cefuroxime (Figure 3.8B, C), 
consistent with the sensitivity being caused by a restricted availability of mDAP. Addition of DAP 
did not rescue sensitivity to vancomycin or cefuroxime (data not shown), possibly due to slow 
import through the cystine uptake systems. Interestingly, while addition of α-ketoglutarate together 
with Asp did not have any effect on cefuroxime resistance, it reduced sensitivity to vancomycin in 
both WT and the aspB mutant background. The mechanism of this altered sensitivity is not yet 
clear.  
Even when grown in the Asp-rich LB medium, the aspB mutant exhibited increased MOES 
(Figure 3.2B) and, consistently, our original ypmB::mls mutant (polar on the downstream aspB) 
can become further resistant to MOE when aspB is overexpressed ectopically from an IPTG 
inducible promoter. As a mimic for the substrate of class A PBPs (aPBPs), MOE is most potent 
when its aPBP targets are not bound to their true substrate lipid II. The reduced expression of aspB 
in the ypmB::mls mutant likely leads to partial mDAP depletion and reduced lipid II production. 
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Experiments using a non-polar ypmB mutant revealed strong MOE resistance, similar to a 
ypmB::mls complemented with an ectopic copy of aspB (data not shown). Overall, the sensitivity 
of aspB towards vancomycin, cefuroxime and MOE demonstrates that limitation of Asp (and 
consequently mDAP) sensitizes cells to antibiotics targeting PG synthesis, likely due to a reduced 
pool of lipid II.   
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Figure 3.8. Limitation of mDAP sensitizes cells to antibiotics targeting late steps in PG 
synthesis.  
A. Sensitivity of WT and the aspB mutant against cefuroxime, vancomycin, D-cycloserine and 
fosfomycin. Pairwise comparison was made to test if difference between samples are statistically 
significant (Student’s t test, two-tailed. ***, P<0.01; NS, not significant.) B. Sensitivity of WT and 
the aspB mutant against cefuroxime when grown in MH, MH+Asp, or MH+Asp+αKG (α-
ketoglutarate). C. Sensitivity of WT and the aspB mutant against vancomycin when grown in MH, 
MH+Asp, or MH+Asp+αKG. Pairwise comparison was made (Student’s t test, two-tailed P<0.05), 
and samples with statistically significant differences are labelled with different letters. The data is 
represented as the mean plus or minus one standard error of the mean, with sample number n 
greater-than or equal to 3. 
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3.4 Discussion   
 It is increasingly appreciated that sensitivity to antibiotics is dependent on the metabolic 
state of the cell. Changes in carbon source, or from aerobic to anaerobic metabolism, can have 
dramatic effects on antibiotic susceptibility (Yang et al., 2017a, Su et al., 2018). It may be possible 
to exploit such effects by combining antibiotics that inhibit essential cellular processes with 
compounds that alter metabolism to increase susceptibility. Development of new antibiotics also 
relies on understanding cell metabolism: for example, inhibitors of pathways presumed to be 
essential, such as fatty acid synthesis, may in fact be ineffective if the targeted organism does not 
require this pathway in the host (Brinster et al., 2009, Balemans et al., 2010). To complicate 
matters further, cell populations are heterogeneous and variations in levels of metabolites or 
specific proteins may determine survival after antibiotic challenge, and can partially explain the 
phenomenon of highly resistant persister cells (Fisher et al., 2017, Shan et al., 2017, Lee & Collins, 
2011). 
In this work, we show that an aspB null mutation growing in rich medium with limited Asp 
ceases growth and lyses due to depletion of mDAP, an essential intermediate for PG synthesis. 
Lysis can be prevented by chemical complementation (DAP supplementation), and this property 
enabled us to assign two cystine uptake systems (TcyABC and TcyP) as the major DAP importers 
(Figure 3.6, Figure S3.5). Lysis could also be suppressed by addition of Asp or optimized 
utilization of available Asp or a variety of genetic manipulations that increased the flux of limited 
Asp into the DAP pathway. For example, increased consumption of Glu can alleviate competitive 
inhibition of Asp import (largely through GltT) (Figure 3.3), and provision of Met can spare the 
branch point intermediate L-aspartate semialdehyde for entry into the DAP pathway (Figure 3.4A, 
B). Interestingly, a recent study in Salmonella Typhimurium shows that a Met auxotroph (ΔmetB) 
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also affects PG synthesis, and leads to a disproportionate increase relative to WT of UDP-NAM-
L-Ala-D-Glu (1000-fold) compared to UDP-NAM-L-Ala-D-Glu-mDAP (5-fold) (Husna et al., 
2018). One possibility is that the metB mutation increases the amount of L-aspartate semi-aldehyde 
shunted into the Hom pathway for Met synthesis, thereby contributing to a depletion of mDAP 
and accumulation of the co-substrate for UDP-NAM-L-Ala-D-Glu-mDAP synthesis.  
 Because an aspB null mutant is unable to de novo synthesize Asp, cells rely on import from 
the medium to support protein and peptidoglycan synthesis. By measuring amino acid content in 
DSM and LB medium, we propose that the growth defect of the aspB null mutant is due to Asp 
limitation exacerbated by competition with Glu for Asp uptake. Our results suggest that GltT is 
the major Glu/Asp importer, and are in agreement with prior work (Zaprasis et al., 2015), even 
though our conditions are drastically different (our experiments are done in DSM, a complex 
medium containing all essential amino acids, whereas Zaprasis et al. used a glucose ammonium 
based minimal medium supplemented with 20 μM of Glu or Asp). Growth of the aspB mutant can 
be strongly inhibited by Glu, even in the presence of DAP, suggesting that all major Asp importers 
are sensitive to Glu-inhibition. Interestingly, Asp uptake is crucial for host colonization of 
Mycobacterium tuberculosis (Gouzy et al., 2013a, Gouzy et al., 2013b), highlighting the 
importance of understanding Asp uptake systems and their role in bacterial physiology. 
A major finding of this work is that the growth defect of the aspB mutant on DSM can be 
separated into two parts. In the presence of added DAP, growth limitation results primarily from 
amino acid limitation for protein synthesis. In contrast, when no DAP is added the initial response 
to Asp limitation is cell wall stress, resulting from the lack of mDAP, inducing the M regulon and 
predisposing cells to lysis. A reduced capacity for mDAP synthesis in the aspB null mutant 
contributes to an aberrant cell morphology (Figure 3.7) and sensitivity to antibiotics targeting late 
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steps in PG synthesis (Figure 3.8), likely caused by a limited pool of lipid II. These results are 
analogous to the cross-talk recently noted in Caulobacter crescentus in which mutations that lead 
to -ketoglutarate accumulation can inhibit mDAP synthesis, leading to antibiotic sensitivity 
(Irnov et al., 2017). 
In conclusion, in the absence of exogenous DAP, PG synthesis is the first critical process 
that fails as Asp is depleted (Figure 3.7C).  The resultant cell lysis may be dependent on growth 
rate: when growing slowly in MM, the aspB mutant does not lyse after depletion of Asp and 
mDAP, while addition of free amino acids increases growth rate and lysis. Interestingly, a similar 
observation was made over 35 years ago when it was noted that the depletion of mDAP in an 
auxotrophic strain of E. coli leads to more rapid lysis in fast-growing than slow-growing cells 
(Leduc et al., 1982). One possible explanation is that both PG synthesizing and degrading enzymes 
are more active in fast growing cells than slow-growing cells, and thus the imbalance is more 
severe in fast-growing cells when PG synthesis is limited by mDAP depletion. Overall, this work 
highlights the important connection between central metabolism and cell wall synthesis and 
reveals how alterations in central metabolism that limit peptidoglycan sidechain biosynthesis may 
increase sensitivity to peptidoglycan synthesis inhibitors. 
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Table 3.2. Strains used in this study 
Number Genotype Reference/Construction a 
168 Wild type B. subtilis strain (trpC2) Lab stock 
HB12259 ypmB::mls LFH PCR → 168 (Guariglia, 2013) b 
HB17053 aspB::kan LFH PCR → 168 b 
HB17058 P
spac(hy)
-aspB pPL82-aspB → 168  
HB17060 aspB::kan, P
spac(hy)
-aspB HB17053 → HB17058 
HB17062 ypmB::mls, P
spac(hy)
-aspB HB12259 → HB17058 
HB17325 PM-lux pBS3Clux-PM → 168 
HB17401 ΔaspB BKE22370 → 168, then the erm cassette removed using pDR244 
HB20720 Pspac(hy)-rocG pPL82-rocG → 168 
HB20749 P
spac(hy)
-rocG aspB-erm BKE22370 → HB20720 
HB20873 ΔgltA BKE18450 → 168, then the erm cassette removed using pDR244 
HB22836 yveA::erm BKE34470 → 168 
HB20874 ΔgltA aspB::erm BKE22370 → HB20873 
HB22838 gltP::erm BKE02340 → 168 
HB22841 gltT::erm aspB::kan HB17053 → HB22851 
HB22842 gltP::erm aspB::kan HB17053 → HB22838 
HB22843 yveA::erm aspB::kan HB17053 → HB22836 
HB22851 gltT::erm BKE10220 → 168 
HB22869 ΔtcyC BKE03590 → 168, then the erm cassette removed using pDR244 
HB22870 ΔtcyP BKE09130 → 168, then the erm cassette removed using pDR244 
HB22871 ΔtcyJKLMN See Experiment Procedure 
HB22878 ΔtcyC tcyP BKE03590 → HB22870, then the erm cassette removed using pDR244 
HB22879 ΔtcyC tcyJKLMN BKE03590 → HB22871, then the erm cassette removed using pDR244 
HB22880 ΔtcyP tcyJKLMN BKE09130 → HB22871, then the erm cassette removed using pDR244 
HB22881 ΔtcyC tcyP tcyJKLMN BKE03590 → HB22880, then the erm cassette removed using pDR244 
HB22885 ΔspoVFA BKE16730 → 168, then the erm cassette removed using pDR244 
HB22887 Δhom BKE32260 → 168, then the erm cassette removed using pDR244 
HB22890 ΔspoVFA aspB::kan HB17053 → HB22885 
HB22892 ΔtcyC aspB::kan HB17053 → HB22869 
HB22893 ΔtcyP aspB::kan HB17053 → HB22870 
HB22894 ΔtcyJKLMN aspB::kan HB17053 → HB22871 
HB22895 ΔtcyC tcyP aspB::kan HB17053 → HB22878 
HB22896 ΔtcyC tcyJKLMN aspB::kan HB17053 → HB22879 
HB22897 ΔtcyP tcyJKLMN aspB::kan HB17053 → HB22880 
HB22898 ΔtcyC tcyP tcyJKLMN aspB::kan HB17053 → HB22881 
HB22900 Δhom aspB::kan HB17053 → HB22887 
HB22910 P
spac(hy)
-ypmB pPL82-ypmB → 168 
HB22913 ypmB::mls P
spac(hy)
-ypmB HB12259 → HB22910 
HB22917 P
spac(hy)
-asd pPL82-asd → 168 
HB22919 P
spac(hy)
-dapA pPL82-dapA → 168 
HB22921 P
spac(hy)
-asd aspB::kan HB17053 → HB22917 
HB22923 P
spac(hy)
-dapA aspB::kan HB17053 → HB22919 
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HB22932 ΔgltA P
spac(hy)
-rocG HB20720 → HB20873 
HB22933 ΔgltA gltT-erm BKE10220 → HB20873 
HB22934 P
spac(hy)
-rocG gltT-erm HB20720 → HB22851 
HB22935 ΔgltA P
spac(hy)
-rocG aspB::kan HB17053 → HB22932 
HB22937 ΔgltA gltT-erm aspB::kan HB17053 → HB22933 
HB22939 P
spac(hy)
-rocG gltT-erm aspB::kan HB17053 → HB22934 
HB22951 P
M
-lux aspB::kan HB17053 → HB17325 
a. “→” indicates transformation using DNA from the former (donor) into the latter (recipient). 
b. Most of the open reading frame is replaced by an antibiotic cassette. 
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3.5 Experimental Procedures 
3.5.1 Strains, primers, media and growth condition 
All strains used in this work are listed in Table 2, and all DNA primers are listed in Table 
S1. Bacteria were routinely grown in liquid lysogeny broth (LB), Difco Sporulation Medium 
(DSM) or minimal medium (MM) with vigorous shaking, or on plates (1.5% agar; Difco) at 37 ˚C 
unless otherwise stated. LB medium contains 10 g tryptone, 5 g yeast extract, and 5 g NaCl per 
liter. DSM (per 500 ml) includes 5 ml 10% KCl, 5 ml 1.2% MgSO4*7H2O, 4 g Bacto nutrient 
broth powder, 0.25 ml 1 M NaOH, and water to bring the volume to 500 ml. The medium is 
autoclaved at 121 ˚C for 20 minutes. After autoclaving, the following filter sterilized ingredients 
were added: 0.5 ml 1 M Ca(NO3)2, 0.05 ml 0.1 M MnCl2, and 10 mM FeSO4. The minimal medium 
contains 2% glucose, 2 g l-1 (NH4)2SO4, 40 mM MOPS (pH 7.4), 1.2 mM K2HPO4, 0.8 mM 
KH2PO4, 1 g l
-1 sodium citrate.2H2O, 245 μM L-tryptophan, 80 nM MnCl2, 1 μM FeSO4 and 0.5 
mM MgSO4. The mixture of 17 amino acids includes alanine, arginine, cysteine, glutamine, 
glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, 
threonine, tryptophan, tyrosine and valine. Final concentrations for each amino acid used in the 
growth measurement is 0.1 mg ml-1. For growth curve measurements, 1 μl log phase culture (OD600 
~0.4) was inoculated into 200 µl of liquid medium per well in a Bioscreen 100-well plate, the plate 
was shaken vigorously and OD600 was measured every 15 minutes using an automated BioScreen 
growth analyzer. Plasmids were constructed using standard methods (Luo et al., 2010), and 
amplified in E. coli DH5α before transforming into B. subtilis. For selection of transformants, 100 
μg ml-1 ampicillin was used for E. coli.  Antibiotics used for selection of B. subtilis transformants 
include: kanamycin 15 μg ml-1, spectinomycin 100 μg ml-1, macrolide-lincosamide-streptogramin 
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B (MLS, contains 1 μg ml-1 erythromycin and 25 μg ml-1 lincomycin), and chloramphenicol 10 μg 
ml-1. 
3.5.2 Genetic techniques 
LFH PCR, chromosomal and plasmid DNA transformation was performed as previously 
stated (Zhao et al., 2016). The kanamycin resistance and MLS resistance cassettes were PCR 
amplified from plasmids pDG780 and pDG646, respectively (Guerout-Fleury et al., 1995). The 
pPL82 plasmid-based Pspac(hy) overexpression constructs were linearized and integrated into the 
amyE locus (Quisel et al., 2001). Markerless in-frame deletion mutants (indicated by ∆ in Table 
2) were constructed from BKE strains as described (Koo et al., 2017). Briefly, BKE strains were 
acquired from the Bacillus Genetics Stock Center, chromosomal DNA was extracted, and the 
mutation containing an ermR cassette was transformed into our WT 168 strain. The ermR cassette 
was subsequently removed by introduction of the Cre recombinase carried on plasmid pDR244, 
which was later cured by growing at the non-permissive temperature of 42 ˚ C. Gene deletions were 
confirmed by PCR screening using flanking primers. Unless otherwise described, all PCR products 
were generated using B. subtilis 168 strain chromosomal DNA as template. DNA fragments used 
for gene over-expression were sequence verified. Null mutant constructions were verified by PCR. 
The mutant missing the entire tcyJKLMN operon was constructed in three steps. Briefly, a 
fragment containing the region upstream of tcyJ and adjacent erm cassette was amplified from 
BKE29380 (tcyJ::erm), and another fragment containing the erm cassette and downstream region 
of tcyN was amplified from BKE29340 (tcyN::erm). These two fragments were joined by overlap 
PCR using the shared erm cassette and yielded a fragment containing the upstream of tcyJ and the 
downstream of tcyN, with the entire tcyJKLMN operon replaced by an erm cassette. The fragment 
was used to transform WT strain and the erm cassette was later removed by the Cre recombinase 
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encoded on plasmid pDR244. Unless otherwise stated, the aspB strain was used as a 
representative null mutant, and the aspB::kan or aspB::erm allele was used for construction of 
strains with multiple mutations (Table 2). The aspB, aspB::kan and aspB::erm strains were 
compared in most growth experiments and were phenotypically indistinguishable. 
3.5.3 Disk Diffusion Assay 
Disk diffusion assays was performed as previously described (Kingston et al., 2014). 
Briefly, overnight cultures in LB medium were inoculated into fresh LB medium and grown to 
exponential phase with OD600 of 0.4. A 100 µl aliquot of each culture was mixed with 4 ml of 
0.75% MH soft agar (kept at 50°C) and directly poured onto a prewarmed 37°C MH plate 
(containing 15 ml of 1.5% MH agar). After the soft agar solidified, a filter paper disk with diameter 
of 6.5 mm was placed on top of the soft agar, and an antibiotic to be tested was added to the paper 
disk. The plate was kept at room temperature for 5 minutes to let the antibiotic to be absorbed into 
the medium, and then moved to 37°C incubator for 20 hours. The overall diameter of the inhibition 
zone was measured along two pairs of orthogonal lines, and zones of inhibition are reported as the 
average diameter of the four measurements for each biological replicate. At least four biological 
replicates were used for each antibiotic and strain combination. The quantity of antibiotics used 
per disk is cefuroxime 10 μg, vancomycin 50 μg, D-cycloserine 500 μg, or fosfomycin 500 μg. 
3.5.4 Amino Acid Analysis 
Amino acid analysis (AAA) was performed by Metabolomics Center, Roy J. Carver 
Biotechnology Center, University of Illinois at Urbana-Champaign using GC/MS based method. 
For AAA of used medium, cells were grown in the medium for 24 hours, and then removed from 
the medium by centrifugation at 5000 g for 10 minutes, followed by filtration of the supernatant 
through 0.22 μm filter. Concentrations of free amino acids were then measured using quantitative 
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GC/MS based method.  To measure total amino acids in media which contain oligo- and 
polypeptides, the medium was hydrolyzed (Davidson, 2003). Briefly, HCl was added to 6 M and 
samples kept at 110 ˚C in a sand bath for 24 hours. Hydrolyzed medium was then centrifuged at 
5000 g for 10 minutes, followed by filtration through 0.22 μm filter to remove particles formed 
during the hydrolysis. Hydrolyzed medium containing 6 M HCl was neutralized by NaOH to pH 
7.0 before AAA. 
3.5.5 Luciferase reporter construction and measurement 
The PM-lux luciferase reporter was constructed by inserting the M-controlled promoter of 
sigM (PM) amplified using primers 6808 and 6809 into the multicloning sites of pBS3Clux (Radeck 
et al., 2013). The insert was confirmed by sequencing, the plasmid was linearized and integrated 
into the B. subtilis sacA locus. For luciferase measurements, 1 μl of exponentially growing cells 
were inoculated into 99 μl of fresh medium in a 96 well plate, incubated at 37 ˚C with shaking 
using a SpectraMax i3x plate reader. Because the luciferase has a short half-life (~4 minutes), 
OD600 and luminescence were measured every 12 min. The data was analyzed using SoftMax Pro 
7.0 software. PM promoter activity was normalized by dividing the relative light units (RLU) by 
OD600. 
3.5.6 Phase contrast microscopy 
Cells were grown in liquid medium for the time indicated and loaded on saline (0.90% 
NaCl, w/v) agarose pads (0.8% final concentration) on a glass slide. Phase contrast images were 
taken using a Leica DMi8 microscope equipped with a 100x immersion objective and Leica 
Application Suite X software. Cell length and width were measured using Oufti per the software’s 
instruction (Paintdakhi et al., 2016). 
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3.7 Supplemental Material 
3.7.1 Supplemental Figures 
 
 
Figure S3.1. Growth curves of wild type and the aspB mutant in minimal medium.  
A. Growth curves of WT and the aspB mutant in MM with or without supplementation with Asp 
(mM). B. Growth curves of WT and the aspB mutant in MM with or without supplementation with 
Asn (mM). C. Growth curves of the aspB mutant in MM supplemented with 1 mM Asp and 
different amount of Glu. D. Growth curves of the aspB mutant in minimal medium supplemented 
with 1 mM Asp and different amount of DAP, unit for concentration is mM. All growth curves 
were measured at least 3 times and a representative measurement is shown. 
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Figure S3.2. Tryptophan is not limited for growth in DSM.  
A. Growth curves of WT strain 168 in minimal medium supplemented with 
different amount of tryptophan. Unit for Trp concentration is mM. WT reaches 
maximum OD
600
 when 0.005 mM or higher concentration of Trp is provided.  
B. Growth curves of the WT in DSM supplemented with different amount of Trp 
(unit for Trp concentration is mM). Maximum OD
600
 does not increase as up to 10 
mM is supplemented. All growth curves were measured at least 3 times and a 
representative measurement is shown. 
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Figure S3.3. Effect of Lys and Trp on the recovery of the aspB mutant after lysis. Unit for 
Lys and Trp concentration is mM.  
A. Growth curves of the aspB mutant in DSM supplemented with different amount of Lys.  
B. Growth curves of the aspB mutant in DSM supplemented with different amount of Trp. All 
growth curves were measured at least 3 times and a representative measurement is shown. 
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Figure S3.4. Effect of TCA cycle intermediates on the recovery of the aspB mutant after lysis 
in DSM. All supplements are supplemented to a final concentration of 10 mM.  
A. Growth curves of the WT and B. the aspB mutant in DSM supplemented with different amount 
of TCA cycle intermediates. All growth curves were measured at least 3 times and a representative 
measurement is shown. 
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Figure S3.5 Supplement of DAP cannot rescue growth when transcription of essential genes 
upstream of DAP in the mDAP synthesis pathway are blocked by dCas9. Growth curves of 
dapB and dapL CRISPRi strains were preformed in minimal medium supplemented with 3.4 mM 
of lysine (final concentration). The medium is either additionally supplemented with a final 
concentration of 2% xylose (to induce dCas9), 10 mM DAP, or 2%xylose + 10 mM DAP. 
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Figure S3.6. Colony morphology of the aspB mutant growing on LB (left) and MH (right) 
after incubation at 37 ˚C for 24 hours. 
 
 
 
 
 
 
 
 
 
 
 144 
 
3.7.2 Supplemental Tables 
Table S3.1. Primers used in this study 
Primer Number Primer Name Sequence 
6225 aspB up F TGCAAAATGTGAGCTTGCCC 
6226 aspB up R kan CCTATCACCTCAAATGGTTCGCTGTGCCAGTGTGGTTGATGGTG 
6227 aspB down F kan CGAGCGCCTACGAGGAATTTGTATCGAGCCATTGAAAGAATCAAGCGT 
6228 aspB down R ATTCTTGGGAACGGGGCTTT 
6243 aspB F GATCCCCGGGAGACGAATTAGGGGGAGTTCAA 
6244 aspB R GATCTCTAGACCCGCTCTTAACTAACCGGG 
6326 BKE MLS check R TTTTCTCGTTCATAGTAGTTCCTCC 
6327 BKE MLS check F CCTTAAAACATGCAGGAATTGACG 
6554 BKE-Scar-F GCAGGCGAGAAAGGAGAGA 
6555 BKE-Scar-R CGAGGCTCCTGTCACTGCT 
6808 PsigM-F-EcoRI  AGCTGAATTCGCCGTTTGCATGTAATGTG   
6809 PsigM-R-PstI AGCTCTGCAGCAGTAAGTCTTCAGCAAGATGC   
7182 gltA-check-F CTGCTGATTGCTGATTGGGC 
7183 gltA-check-R  AACGGTGTACCGCAATCCAT 
8152 gltP-check-F   GGGGACTTTTTCGCCAACAT 
8153 gltP-check-R   GTAAACGCAAGACTGGCAGC 
8154 yveA-check-F   TTTGTTGGCGACGGGAAAAC 
8155 yveA-check-R   GTGCCGGCCTTTTTGACAAT 
8156 gltT-check-F   AGGTTAGGTCAAAGCTCACCTG 
8157 gltT-check-R   GGGCGGAACTGATCAAAAGC 
8183 tcyA-F   AACGATTTATTGCGCGGCTC 
8184 tcyA-R   CCCCTGAAAGTATCGGCCAG 
8185 tcyC-F   ATGTCATCGAACGGCGTCTT 
8186 tcyC-R   GCCAAGGCGGCTTTGTTTTA 
8187 tcyJ-F   GGGGAATATCAGACTGGCGG 
8188 tcyJ-R   GTTCCAGTTCCGACCGTGAT 
8189 tcyN-F   CCAGAGATTACAGGGACGGC 
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8190 tcyN-R   ATGGCGCACCCCATATTTCA 
8191 tcyP-F   AATTCGCACTTGACCCATCG 
8192 tcyP-R   TAGGCAAACTGAGACAGCCG 
8237 hom-check-F   TCAAAACAGGAGCGGGCTTA 
8238 hom-check-R   TGTAAAGTTAGCGCCGGTGT 
8240 ypmB-HindIII-F  ATCGAAGCTTAGGAGGTGAGAAGATGAGAAAAAAAGCA 
8241 ypmB-XbaI-R  ATCGTCTAGACTAATTCGTCTTAAGGCGTGATATTT 
8258 asd-XmaI-F   ATCGCCCGGGAAGCTGATTGGCGGAAGGAG 
8259 asd-XbaI-R   ATCGTCTAGACAGGCTGATAGCGCCTTACT 
8262 dapA-XmaI-F   ATCGCCCGGGACGCTTTGCATGAAGTGTTTGA 
8263 dapA-XbaI-R   ATCGTCTAGATGACCGCGTTTGTTTCACTG 
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Chapter 4. Dysregulation of a cell envelope stress response sigma factor 
causes lethal membrane secretion stress 
4.1 Abstract 
The Gram-positive model organism Bacillus subtilis has 19 known sigma factors. 
Replacement of the primary sigma factor (SigA) with alternative sigma factors allows modification 
of transcriptional specificity of RNA polymerase (RNAP) and cell differentiation. Sigma M is an 
extracytoplasmic function (ECF) sigma factor, and responds to cell wall stress by upregulating key 
genes and alternative pathways in cell wall synthesis. Two membrane bound anti-SigM factors, 
YhdL and YhdK, sequester and inactivate SigM in the absence of cell wall stress. Null mutations 
in yhdK cause high level SigM activity, slow growth and abnormal cell morphology, while the 
absence of yhdL causes cell death. This stress can be alleviated at either the transcriptional level 
by reducing SigM activity, or by mutation in the membrane insertase YidC. This work suggests a 
scenario in which bacterial cells experience a primary stress (cell wall stress) and upregulate an 
alternative sigma (SigM) in response, thereby potentially imposing on themselves a secondary 
stress. 
4.2 Introduction 
In order to survive and thrive in different environment niches and under ever changing 
growth conditions, bacteria have evolved complex mechanisms to regulate their gene expression 
in response to environmental cues, and an important way of changing gene expression is the use 
of alternative sigma factors (Feklistov et al., 2014). Unlike the housekeeping sigma factor 
(designated SigA in many bacteria) which transcribes essential genes for growth (DNA replication, 
protein synthesis, etc.), alternative sigma factors are used under conditions in which a subset of 
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genes are required or beneficial for growth. Under these conditions, one or more alternative sigma 
factors become active, bind to RNA polymerase (RNAP) core and transcribe a subset of genes 
specific for the alternative sigma factor (Mascher, 2013).  
 Bacillus subtilis strain 168 contains eighteen known alternative sigma factors, among 
which are seven extracytoplasmic function (ECF) sigma factors responding to cell envelope 
stresses (Souza et al., 2014, Mascher, 2013). While each sigma factor has a specific set of genes 
under its transcriptional control, there is considerable amount of overlap between sigma factors 
(Mascher et al., 2007). Among the seven ECF sigma factors, SigM, SigV, SigW and SigX are best 
studied, and respond to stresses caused by agents inhibiting peptidoglycan (PG) synthesis, 
lysozyme, detergents and membrane-disrupting agents, and cationic antimicrobials, respectively 
(Helmann, 2016, Wiegert et al., 2001). The overlap in the SigMWX regulon is highlighted by 
biochemistry and genetic studies showing that deletion of one sigma factor can only achieve partial 
loss of resistance against some antibiotics (Huang et al., 1998) (Mascher et al., 2007). Interestingly, 
a mutant missing all seven ECF sigma factors is more sensitive to many cell envelope targeting 
compounds, but is overall similar in phenotype to a mutant missing only SigMWX (Asai et al., 
2008, Luo et al., 2010). SigV is induced by lysozyme and confers lysozyme resistance by O-
acetylation of the PG and D-alanylation of teichoic acids (Ho et al., 2011, Guariglia-Oropeza & 
Helmann, 2011). The function of the other three ECF sigma factors, SigY, SigZ and YlaC is not 
clear. 
 SigM is one of the most well studied ECF sigma factors in B. subtilis. SigM transcribes a 
set of ~60 genes in response to stresses in peptidoglycan (PG) synthesis, with many of them being 
central to PG synthesis (Eiamphungporn & Helmann, 2008, Jervis et al., 2007). Upon PG synthesis 
stresses, it can upregulate transcription of key enzymes (PonA, a class A PBP, for example) 
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(Eiamphungporn & Helmann, 2008), or turn on alternative pathways (such as Amj, alternative to 
the lipid II flippase MurJ) (Meeske et al., 2015) (reviewed in (Helmann, 2016)). A sigM mutant 
has growth defects in the presence of high salt or 5% ethanol, and is highly sensitive to cell wall 
targeting antibiotics including β-lactams, bacitracin and moenomycin (Luo & Helmann, 2012, 
Thackray & Moir, 2003).  
Sigma M is co-transcribed in an operon with its two anti-sigma factors, YhdL and YhdK. 
The operon is transcribed from two promoters, a constitutive SigA-controlled promoter PA and an 
autoregulatory SigM-controlled promoter PM (Figure 4.1A) (Thackray & Moir, 2003). In the 
absence of cell envelope stresses, the sigM operon is mostly transcribed from PA (Horsburgh & 
Moir, 1999). Upon co-translation with its two anti-sigma factors, SigM is sequestered on the 
membrane by YhdL and YhdK, with direct interaction between YhdL and SigM (Yoshimura et 
al., 2004, Asai, 2018). In response to cell envelope stresses, SigM is released from YhdL and 
YhdK through an unknown mechanism, binds to RNA polymerase (RNAP) in the cytoplasm and 
activates transcription of the genes in its regulon (Mascher, 2013). The autoregulatory PM allows 
SigM to transcribe its own sigMyhdLyhdK operon and form a positive feedback loop as newly 
synthesized SigM is not bound to its anti-sigma factors in presence of cell wall stress (Thackray 
& Moir, 2003). It is yet to be understood how the cytoplasmic SigM is inactivated after the stress 
condition is resolved.  
Among the two anti-sigma factors, YhdL is reported to be essential due to high SigM 
activity in its absence (Thackray & Moir, 2003, Kobayashi et al., 2003). The function of the other 
anti-sigma factor YhdK is not clear. In this work we show that absence of either anti-sigma factor 
drastically increases SigM activity and leads to a cell growth defect (ΔyhdK) or cell death (ΔyhdL). 
High SigM activity leads to membrane secretion stress, likely caused by overproduction of SigM 
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transcribed membrane proteins. This stress can be alleviated at either the transcriptional level by 
reducing SigM activity, or by mutation in the membrane insertase YidC. This work suggests a 
scenario in which bacterial cells experience a primary stress (cell wall stress) and upregulate an 
alternative sigma (SigM) in response, thereby potentially imposing on themselves a secondary 
stress. 
4.3 Results 
4.3.1 Excess SigM activity is toxic in the absence of anti-sigma factors 
Because SigM controls its own transcription from the autoregulatory PM promoter, we use 
the activity of this promoter as a proxy for SigM activity and constructed a PM-lux luciferase 
reporter to monitor SigM activity during growth (measurement of luminescence every 12 minutes). 
We found that in a wild type 168 (WT168) strain, SigM is transiently induced by about 10-fold in 
mid-exponential growth phase and quickly returns to background level when grown in LB medium 
(Figure 4.1B), similar to a previous report (Horsburgh & Moir, 1999). The transient induction is 
likely caused by rapid cell growth and the need to upregulate wall synthesis in the exponential 
growth phase. A sigM null mutant does not exhibit this transient induction, suggesting the 
induction is specific to SigM activity (Figure 4.1B). A yhdK null mutant shows much higher SigM 
activity than WT throughout the growth, with an ~100-fold increase compared to WT at their 
respective peaks (Figure 4.1C). The yhdK mutant also exhibits other growth defects, including 
long filamentous cell morphology (Figure 4.1D), slow growth in liquid culture (Figure 4.1E), and 
small colony size (Figure 4.1F).  
YhdL is reported to be an essential gene (Kobayashi et al., 2003), and indeed we could not 
obtain a yhdL null mutant in the B. subtilis 168 strain background. Transformation of a yhdL::kan 
allele into a strain with PM-lacZ generates tiny blue colonies and big white colonies that contain 
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mutations in the sigM gene (Figure 4.6C and Sanger sequencing results, data not shown), and the 
tiny blue colonies do not grow after re-streaking on fresh medium (data not shown). The growth 
defect of yhdK/L mutants is due to high SigM activity, as a strain missing the whole sigMyhdLyhdK 
operon has normal cell morphology and a growth rate similar to WT (Figure 4.1D, E). Overall 
these results confirm that high SigM activity is toxic to cells, consistent with previous reports. 
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Figure 4.1. Excess SigM activity is toxic in the absence of anti-sigma factors.  
(A). Operon structure of sigMyhdLK. (B). SigM activity monitored using a PM-lux reporter during 
growth of WT168 and sigM mutant. (C). Peak SigM activity in different strain backgrounds. (D). 
Cell morphology of different strains under phase contrast microscope. (E). Growth curve of 
different strains. The OD600 was measured using Bioscreen every 15 minutes, and every fourth 
number is plotted. (F). Colony size of different strains on LB plate after 24 hours of incubation at 
37°C. (G). Colony size of different strains on LB plate supplemented with 2% xylose (final 
concentration) after 24 hours of incubation at 37°C. 
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4.3.2 Alleviation of SigM toxicity by overexpressing SigA or removing the positive feedback 
of SigM. 
We next sought to address the reason for the toxicity from high SigM activity. Because of 
the limited number of RNAP core enzyme in the cell, different sigma factors need to compete for 
the core enzyme to transcribe their regulons (Park et al., 2018, Ganguly & Chatterji, 2012, 
Grigorova et al., 2006). It is possible that high SigM over compete SigA for the latter’s essential 
functions. Alternatively, high SigM activity can cause overexpression of its regulon, of which one 
or more genes may become toxic when overexpressed. To test if one or both hypotheses are correct, 
we constructed a PxylA-sigA strain in which SigA can be overexpressed from a xylose inducible 
promoter. Overexpression of SigA can outcompete SigM and reduce SigM toxicity in both the 
yhdK and yhdL backgrounds. When SigA is overexpressed, the colony size of the yhdK mutant is 
greatly increased (Figure 4.1G), and a yhdL mutant is now viable and the viability is xylose-
dependent (data not shown). Using a PM-lux luciferase reporter, we found that overexpression of 
sigA significantly reduces SigM activity in both yhdK and yhdL mutant (data not shown).  
The high SigM activity is mostly from PM and the positive feedback loop. In a strain with 
an ectopic sigM only under its PA but not PM promoter, the native sigMyhdLK operon can be 
deleted. The mutant has a PA-sigM in the cell without any anti-sigma M factor, and shows an 
intermediate increase in SigM activity (Figure 4.1C), slightly longer cell morphology (Figure 4. 
1E), some retardation in grow rate (Figure 4.1E), and a colony size smaller than WT but bigger 
than the yhdK null mutant (Figure 4.1F). Overexpression of SigA may reduce SigM activity partly 
by compromising the positive feedback loop, as lowered SigM activity caused by overexpression 
of SigA will reduce the amount of sigM autoregulation. Overall, our results suggest that excess 
SigM activity is toxic for cells in absence of its anti-sigma factors, mainly from the positive 
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feedback of the autoregulatory PM promoter of the sigMyhdLyhdK operon, and overexpression of 
SigA can suppress the toxicity resulting from high SigM. 
 
 
 
Figure 4.2. Suppressor mutations in core RNA polymerase rescues lethality of yhdL null 
mutation.  
(A). Experiment scheme for isolation of suppressors in yhdL null mutant background. (B). 
WebLogo of amino acid substitutions in RpoB (β subunit) and RpoC (β’ subunit). (C). 
Localization of substitutions in RpoB and RpoC to E. coli RNA polymerase holoenzyme with σ70.  
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4.3.3 Single amino acid substitutions in RNA polymerase suppress SigM toxicity 
Even though overexpression of SigA or breaking the positive feedback loop can rescue 
cells from lethality of high SigM activity, this observation does not distinguish which hypothesis 
above (competition with SigA vs. overexpression of toxic protein(s)) is correct, as both genetic 
modifications would result in less overexpression of potentially toxic protein(s). To identify the 
potential toxic protein(s), we turned to forward genetics to look for suppressors that can survive 
high SigM activity, hoping to find suppressors with mutations affecting the expression or activity 
of potentially toxic proteins. To this end, we constructed a yhdL depletion strain with an ectopic 
xylose-inducible yhdL and a deletion of the native yhdL. We also introduced a second copy of 
sigM and xylR to reduce the chance of getting trivial suppressors that have mutations in sigM or 
xylR. A PM-lacZ reporter was used to visualize high SigM activity with blue color on plates 
containing X-Gal (5-bromo-4-chloro-3-indolyl β-D-galactopyranoside) (Figure 4.2A). The 
depletion strain was grown in the presence of xylose to high density, washed twice to remove 
xylose, and then plated without xylose to select suppressors that can grow in the absence of YhdL 
(Figure 4.2A). This selection yielded some big white colonies that have mutations in both copies 
of sigM (Sanger sequencing results, data not shown), tiny blue colonies that readily generate white 
suppressors when re-streaked onto fresh plates, and medium sized light blue colonies that have 
elevated SigM activity in the absence of YhdL yet are still relatively healthy and do not generate 
white suppressors when re-streaked (data not shown). Several suppressors of this type were 
analyzed by whole genome re-sequencing, and four independent suppressor mutations were 
identified with each containing a single point mutation. These four mutations affect subunits of 
core RNA polymerase (RNAP), with one mutation affecting RpoB (β) (D1101N), and the other 
three affecting RpoC (β’): N330K, R335H, and R335C (Figure 4. 2B). These four mutations are 
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in three conserved amino acids among RpoB/C proteins, suggesting these amino acid residues are 
important for the conserved structure and function of RNAP (Figure 4.2B). 
Because there is no structure available for B. subtilis RNAP bound to an ECF sigma factor, 
we mapped all four mutations to E. coli RNAP bound to σ70 for insights of how these mutations 
may affect RNAP-sigma factor interaction. All three affected amino acids (RpoBD1101, RpoCN330 
and RpoCR335) map close to the region 3 of E. coli σ70, suggesting these amino acids may be 
important for RNAP-sigma factor interaction. While ECF sigma factors such as SigM do not have 
a region 3 between region 2 and 4, there is a linker region between region 2 and 4, which may be 
close to RNAP and important for RNAP-sigma factor interaction. We thus speculate that these 
mutations in RNAP may affect RNAP-sigma factor interaction, lead to reduced SigM activity, and 
thus alleviate the toxicity of SigM in the absence of anti-sigma factor YhdL. 
To test if these mutations reduce SigM activity, we attempted to reconstruct these 
mutations at the native locus using CRISPR. We were able to construct RpoBD1101N and RpoCR335H 
at their native loci, and both the RpoBD1101N and RpoCR335H mutants show slightly slower growth 
than WT in LB medium (Figure 4.3A). The RpoCR335H mutant exhibits mildly filamentous cell 
morphology (Figure 4.3B). Attempts to combine both RpoBD1101N and RpoCR335H mutations in one 
strain were not successful. Using the same PM-lux reporter described above, we found that the 
yhdK null mutants with RpoBD1101N or RpoCR335H show 1,000-fold or 200-fold reduction of peak 
SigM activity, respectively, compared to the yhdK null mutant with WT RNAP (Figure 4.3C). The 
filamentous cell morphology of the yhdK null is also greatly suppressed by mutations in RNAP 
(Figure 4.3D), consistent with the idea that the morphology defect of the yhdK mutant is from high 
SigM activity. In addition, yhdL can be deleted in the RpoBD1101N and RpoCR335H mutant strains. 
With the RpoB/C mutations, the yhdL null mutants exhibit higher SigM activity than their yhdK 
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null counterparts (Figure 4.3C) and show more severe cell morphology defect (Figure 4.3D). 
However, even in the absence of yhdL, the SigM activity is still 5- to 8-fold lower in these RpoB/C 
mutants than the yhdK null mutant with WT RNAP. Overall these data show that single amino 
acid substitutions in RpoB or RpoC can suppress the lethality of a yhdL deletion, and the growth 
defect of both yhdL and yhdK mutations. The SigM activity is reduced with the RpoB/C mutations, 
possibly due to reduced interaction between the mutant RNAP and Sigma M. 
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Figure 4.3. Single amino acid substitutions in RNA polymerase suppress SigM toxicity.  
(A). Growth curve of WT and rpoB/C mutants. (B). Cell morphology using phase contrast 
microscopy of WT and rpoB/C mutants. (C). Peak SigM activity of different strains. Fold change 
between different strains are indicated with arrows and numbers. (D). Cell morphology using phase 
contrast microscopy of different strains. A yhdL null mutant with WT RNA polymerase is lethal, 
and shown as a tombstone. 
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4.3.4 Pleiotropic effect of the RpoBD1101N and RpoCR335H substitution on alternative sigma 
factors 
Because mutations in core RNAP may affect its interaction with many sigma factors and 
thereby alter the transcription efficiency of many genes, we next used sporulation as a 
representative assay to assess the activity of other sigma factors. Sporulation is a complex 
developmental process in B. subtilis and requires the sequential activation of multiple sigma 
factors (Piggot & Hilbert, 2004, Stragier & Losick, 1996). To test whether RpoBD1101N and 
RpoCR335H mutations affect interactions between RNAP and sporulation sigma factors, we 
measured sporulation efficiency of these mutants after 48 hours of growth in Difco Sporulation 
Medium (DSM). We found that the RpoBD1101N strain was impaired in the formation of heat 
resistant spores (0.6% in RpoBD1101N comparing to 66.8% in WT), whereas the RpoC
R335H strain 
had a milder sporulation defect (13.6% in RpoCR335H) (Figure 4.4A). This result suggests that the 
RpoBD1101N mutant may have sporulation blocked in a certain stage. To find out at which stage 
sporulation is blocked, we used dual labelling of cells with membrane dyes FM 4-64 and 
mitotracker green. FM 4-64 can label both the mother cell and forespore membranes before the 
forespore is engulfed, but cannot penetrate the membrane to label the forespore membrane after 
the engulfment is complete and two membranes are separated by the cytoplasm of the mother cell. 
In comparison, mitotracker green can label both membranes before and after the engulfment step 
(Figure 4.4B). Using these two dyes, we scored cells of WT and RNAP mutants after 4, 7, 14 and 
28 hours (over 300 cells per strain per time point) after inoculation in DSM, and found that both 
RpoBD1101N and RpoCR335H mutants showed reduced rate of asymmetric division, an early 
morphological landmark of sporulation. More importantly, the RpoBD1101N strain is defective in 
finishing the engulfment step. In comparison, the RpoCR335H strain can go through the engulfment 
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step, albeit with a smaller portion of cells than WT at the end of the observed 28 hours. To identify 
which sporulation factor failed to be activated, we constructed PspoVG42-lux, PspoIIM-lux and PspoVFA-
lux to directly measure activity of SigH, SigE and SigK, respectively. Our results show that 
compared to WT cells, SigH activity is increased in the RpoCR335H mutant and decreased in the 
RpoBD1101N mutant (Figure 4.4C). The construct measuring SigE and SigK activity, however, 
yielded no signal even in WT background (data not shown). This is likely because of an intrinsic 
limitation of luciferase reporters, as the generation of signal luminescence uses a lot of ATP, which 
may be insufficient in sporulating cells. Overall these results suggest that RpoBD1101N and 
RpoCR335H strains have pleotropic and sometimes different effects in phenotypes that rely on 
alternative sigma factors, possibly due to altered interaction of mutant RNAP with one or more 
sigma factors. 
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Figure 4.4. Pleiotropic effect of the RpoBD1101N and RpoCR335H substitution on alternative 
sigma factors.  
(A). Efficiency of generating heat resistant endospores of different strains after 48 hours of 
inoculation in Difco Sporulation Medium (DSM) at 37°C. (B). Quantification of different strains 
going through stages in sporulation after different amount of time after inoculation in DSM at 
37°C. Representative images of cells in different sporulation stages are shown on the left. (C). 
SigH activity measured using a PspoVG42-lux reporter in different strain backgrounds. 
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4.3.5 RpoCR335H substitution causes increased SigW activity 
We next tested sensitivity of RpoBD1101N and RpoCR335H mutant strains against several 
compounds targeting the cell envelope, and found these two mutants are similar to or slightly more 
sensitive than WT to lysozyme, vancomycin, ampicillin and EDTA (Figure 4.5A). The RpoBD1101N 
mutant strain is also more sensitive to fosfomycin than WT cells (Figure 4.5B). Surprisingly, we 
found the RpoCR335H strain is much more resistant to fosfomycin than WT (Figure 4.5B). 
Fosfomycin resistance is provided by fosB, a SigW-dependent gene that encodes a bacillithiol-S-
transferase that inactivates fosfomycin (Cao et al., 2001, Lamers et al., 2012, Roberts et al., 2013). 
To test if the fosfomycin resistance of RpoCR335H mutant is SigW-dependent, we deleted sigW 
gene in RpoCR335H mutant, and found the rpoCR335H sigW double mutant is as sensitive to 
fosfomycin as a sigW single mutant with WT RNAP, suggesting the resistance is SigW-dependent, 
and RpoCR335H mutant likely has increased SigW activity. We next constructed a PfosB-lux reporter 
strain to directly measure SigW activity in WT and RpoCR335H mutant. We found that even when 
growing in LB medium without fosfomycin, SigW activity is about 10-fold higher in the 
RpoCR335H mutant than WT (Figure 4.5C). Overall, our results suggest that the RpoCR335H mutant 
has increased SigW activity. This increased activity could be due to increased affinity between the 
mutant RNAP and SigW, although this has not been measured directly. 
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Figure 4.5. RpoCR335H substitution causes increased SigW activity.  
(A). Sensitivity of WT and rpoB/C mutants to vancomycin, ampicillin, EDTA and lysozyme, 
measured using zone of inhibition assay. (B). Zone of inhibition assay showing sensitivity of 
different strains to fosfomycin. (C). SigW activity measured using a PfosB-lux reporter of WT and 
RpoCR335H strain. 
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Figure 4.6. SpoIIIJQ140K substitution is necessary and sufficient for tolerance of high SigM 
activity.  
(A). yhdL is not essential in Bacillus subtilis strain PY79 background. (B). Transformation plate 
using chromosomal DNA of the viable PY79 yhdL::kan to transform 168 strain with a PM-lacZ 
reporter. The arrows show intermediate sized blue colonies, suggesting relatively healthy cells 
with high SigM activity. (C). Mapping of co-transformed DNA fragments from 16 transformants 
onto chromosome of strain 168. Gene yhdL and co-transformed DNA are labelled. 
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Figure 4.6. SpoIIIJQ140K substitution is necessary and sufficient for tolerance of high SigM 
activity (continued).  
(D). Alignment of YidC homologs from different firmicute strains and E. coli. The red box shows  
the highly conserved Q140 of SpoIIIJ in B. subtilis strain 168. (E). Transformation plates of yhdL 
deletion from strains with different spoIIIJ alleles. All strains have PM-lacZ reporter to show blue 
color on plates containing X-Gal if SigM activity is high. (F) Cell morphology of yhdL mutants 
under phase contrast microscope. 
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Figure 4.6. SpoIIIJQ140K substitution is necessary and sufficient for tolerance of high SigM 
activity (continued).  
(G). Colony morphology, size and cell morphology of yhdK mutants in strain 168 background 
with different spoIIIJ alleles. (H). Colony morphology, size and cell morphology of yhdK mutants 
in strain PY79 background with different spoIIIJ alleles. 
 
 
 
 
 
 167 
 
4.3.6 The gene yhdL is not essential in B. subtilis strain PY79  
Our work above shows that high SigM activity can be alleviated by changes in the 
transcription level, either by overexpression of SigA, breaking the positive feedback loop, or 
mutations in RNAP that differentially affect the activity of sigma factors, and likely have reduced 
affinity for SigM. However, because all these manipulations also reduce the amount of expressed 
SigM proteins, we cannot draw a conclusion of whether the toxicity of excess SigM is due to its 
competition against SigA, or a downstream consequence caused by overproduction of certain 
protein(s). Fortunately, during the pursuit of another project we found that yhdL is not essential in 
PY79, another commonly used laboratory strain of Bacillus subtilis (Youngman et al., 1984). In a 
PY79 background strain containing a PM-lacZ reporter, deletion of yhdL generate transformants 
with reduced colony size than WT and exhibits high SigM activity as indicated by the blue color 
on LB plate containing X-Gal (Figure 4.6A, C). This mutant is relatively stable, with occasional 
appearance of suppressors that have a large white colony morphology (likely containing mutations 
in sigM). To identify the genetic differences that confer tolerance to high SigM in PY79, we 
compared the genome between B. subtilis strain 168 and PY79. There are over a hundred single 
nucleotide polymorphisms (SNPs) between 168 and PY79, as well as four large deletion from the 
genome of PY79 (including the SPβ prophage), causing a reduction of 180 kb from the PY79 
genome comparing to 168 (Zeigler et al., 2008, Schroeder & Simmons, 2013).  
To look for differences that may account for the different tolerance of high SigM, we first 
compared all the genes in the SigM regulon and the Spx regulon (Spx is a transcription regulator 
that belongs to the SigM regulon) and found no difference between the coding sequence of these 
genes. Since we know from the study above that mutations that alter sigM transcription can affect 
SigM activity, we next compared the sequence of sigA, rpoB/C and the surrounding sequence of 
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sigM, and only identified one region downstream of sigA that is different between the two strains. 
In 168, three transcriptional upshifts are labelled in the region of difference, producing a putative 
antisense RNA reverse complement to the mRNA of sigA (Nicolas et al., 2012). In PY79, 12 bp 
are missing and this leads to one less predicted promoter for the antisense RNA, potentially causing 
higher SigA level in PY79 than 168. To test if this difference accounts for the non-essentiality of 
yhdL in PY79, we mutated 168 to delete the promoter that is absent in PY79 using CRISPR. 
However, yhdL is still essential in the 168 antisigA* strain, suggesting that this difference does not 
play a major, if any, role in the essentiality of yhdL. 
 
4.3.7 A single point mutation in SpoIIIJ is necessary and sufficient for tolerance of high SigM 
activity 
We then tried a nonbiased forward genetics-based selection to identify the difference 
between PY79 and 168 that enables PY79 to tolerate high SigM. Because each competent cell of 
B. subtilis contains about 50 binding sites for DNA uptake, a competent cell can take multiple 
pieces of DNA during a transformation experiment, a phenomenon known as congression (Dubnau 
& Cirigliano, 1972). We transformed a 168 strain containing PM-lacZ with a high concentration of 
chromosomal DNA from the viable PY79 yhdL::kan strain, and selected for kanamycin resistant 
transformants on a LB plate supplemented with X-Gal. The majority of transformants were tiny 
blue colonies that cannot be re-streaked onto fresh plates (consistent with the essentiality of the 
YhdL antisigma factor in the 168 background), with a few big white colonies (likely sigM mutants) 
and intermediate sized blue colonies (Figure 4.6B). The intermediate blue colonies grew to a 
similar size as a yhdL null mutant in PY79, and have a low frequency of generating big white 
suppressors after re-streaking to a fresh plate, suggesting that in these suppressors the difference 
 169 
 
between 168 and PY79 was co-transformed into 168 besides the yhdL::kan allele. Whole genome 
sequencing was performed on these transformants and the reads were mapped to the reference 
genome of 168 to identify loss or mutation of genes in strain 168. Unmapped reads were de novo 
assembled and BLAST against PY79 reference genome to identify transfer of gene(s) that are 
unique to PY79.  By mapping the transfer of SNPs unique to PY79 into the 168 chromosome we 
were able to define segments of the genome that had co-transformed with, but were unlinked to, 
the yhdL::kan mutation (Figure 4.6C). Out of 16 sequenced transformants, 14 of them contain a 
single SNP encoding a missense mutation in the spoIIIJ gene (SpoIIIJQ140K).   
SpoIIIJ belongs to the YidC membrane insertase family and is responsible for inserting 
membrane proteins into the lipid membrane, independently or in association with the Sec secretion 
system (Kumazaki et al., 2014, Tsirigotaki et al., 2017, Hennon et al., 2015). E. coli encodes one 
homolog of YidC, while some bacteria such as B. subtilis encodes two homologs, YidC1 (SpoIIIJ) 
and YidC2 (Hennon et al., 2015, Saller et al., 2009).YidC1 was originally named SpoIIIJ because 
of its essential role in sporulation (Saller et al., 2009, Errington et al., 1992), although it is also 
expressed in vegetative cells. The expression of the other YidC homolog YidC2 is regulated by an 
upstream gene MifM, which monitors the total membrane insertase activity and only allow 
expression of YidC2 when there is insufficient amount of SpoIIIJ (Chiba & Ito, 2015). Both 
SpoIIIJ and YidC2 can fulfill the essential function of YidC insertase individually, with SpoIIIJ 
essential for sporulation (Corte et al., 2014) and YidC2 partly play a role in the development of 
competence (Saller et al., 2011). Interestingly, an alignment of SpoIIIJ homologs revealed that the 
Gln 140 is highly conserved among bacteria and only B. subtilis PY79 contains Lys at this position 
(Figure 4.6D).  
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To test if this Gln to Lys (Q140K) substitution is necessary and sufficient for tolerance of 
high SigM, we next constructed the SpoIIIJQ140K mutant in strain 168 using CRISPR and found 
that yhdL is no longer essential in presence of the SpoIIIJQ140K point mutation (Figure 4.6E). 
Conversely, changing the Lys 140 into Gln in PY79 abolished the ability of PY79 to tolerate loss 
of yhdL (Figure 4. 6E), suggesting that the SpoIIIJQ140K point mutation is necessary and sufficient 
for tolerance of the yhdL deletion mutation. The PY79 SpoIIIJK140 is dominant over the 168 
SpoIIIJQ140 in the ability to tolerate the yhdL deletion, since merodiploid strains (expression of the 
PY79 SpoIIIJK140 from a xylose-inducible promoter in the presence of 168 SpoIIIJQ140, or 
expression of SpoIIIJQ140 in the presence of PY79’s native SpoIIIJK140) expressing both alleles of 
SpoIIIJ still tolerate loss of yhdL (Figure 4.6E). This suggests that SpoIIIJQ140K results from a gain 
of function mutation. Phase contrast microscopy reveals that a 168 SpoIIIJQ140K yhdL mutant has 
a similar but slightly more elongated cell morphology comparing a PY79 yhdL mutant (Figure 
4.6F), confirming the significant role of SpoIIIJQ140K in tolerating the yhdL null mutation and also 
suggesting the presence of other minor factor(s). Similarly, the small colony size, as well as the 
filamentous cell morphology of the 168 yhdK mutant can be largely rescued by SpoIIIJQ140K 
substitution (Figure 4.6G). A SpoIIIJK140Q mutation in PY79 converts the edged round big colony 
morphology of PY79 yhdK mutant into the small round morphology of 168 yhdK, and cells exhibit 
increased filamentation (Figure 4.6H). Deletion of spoIIIJ in a PY79 yhdK mutant mimics a 
SpoIIIJK140Q mutation, likely because the cells now rely on the other YidC homolog YidC2, which 
contains a Q140 in the equivalent position (Saller et al., 2009). Overall, our results show that 
SpoIIIJQ140K mutation is necessary and sufficient for B. subtilis to tolerate high SigM activity 
caused by deletion of the anti-sigma factor yhdL or yhdK. 
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Figure 4.7. SpoIIIJQ140K has increased positive charge in the substrate binding groove. 
(A). Crystal structure of SpoIIIJ from B. halodurans (3WO6). (B). Spot dilution assay of yidC2 
depletion strains with SpoIIIJR73A or SpoIIIJR73AQ140K. (C). Spot dilution assay of yhdL depletion 
strains with WT SpoIIIJ (Q140), SpoIIIJQ140K or SpoIIIJR73AQ140K. 
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4.3.8 SpoIIIJQ140K mutation causes increased positive charge inside the substrate binding 
groove 
 We then try to understand why the SpoIIIJQ140K substitution can help cells tolerate high 
SigM activity. The structure of SpoIIIJ from Bacillus halodurans reveals a positively charged 
hydrophilic groove formed by five transmembrane segments (Kumazaki et al., 2014). The positive 
charge provided by R72 (R73 in Bacillus subtilis) is essential for the function of SpoIIIJ and is 
thought to be important for binding of protein substrates for the membrane insertion step, since an 
R73A substitution in B. subtilis SpoIIIJ completely abolished the essential function of SpoIIIJ in 
vivo, while an R73K substitution retained the function (Kumazaki et al., 2014). Because Q140 is 
in close spatial proximity to R73 (Figure 4.7A), we hypothesized that the SpoIIIJQ140K mutation 
may cause a double positive charge inside the hydrophilic groove. If this hypothesis is correct, we 
speculated that the essential R73 should no longer be essential in the presence of the Q140K 
mutation. To test this hypothesis, we constructed a depletion strain of the other YidC homologue 
YidC2, and mutated the essential R73 into an alanine in the presence of the inducer for YidC2. In 
the presence of xylose inducer for YidC2, both strains containing SpoIIIJR73A and SpoIIIJR73AQ140K 
mutant are viable (Figure 4.7B). In the absence of the inducer, the mutant expressing only 
SpoIIIJR73A failed to grow (Figure 4.7B), consistent with the reported essential function of the 
positive charge from R73 (Kumazaki et al., 2014). However, the SpoIIIJR73AQ140K double 
substitution strain is viable with a similar colony morphology comparing to the strain growing in 
presence of the inducer (Figure 4.7B), demonstrating that the positive charge resulting from the 
Q140K substitution is sufficient to replace the essential positive charge from R73. Moreover, yhdL 
is still essential in a strain containing the SpoIIIJR73AQ140K double mutation (Figure 4.7C), 
suggesting it is the double positive charge, rather than the Q140K substitution per se, that rescues 
 173 
 
cells from high SigM toxicity. Overall these results support the idea that the SpoIIIJQ140K 
substitution increases the positive charge inside the hydrophilic groove and rescues cells from high 
SigM toxicity. We hypothesize that the increased positive charge may affect the initial binding of 
protein substrate into the hydrophilic groove and thus affect the insertase activity of SpoIIIJ. 
 
4.3.9 High SigM activity causes membrane secretion stress 
Because the SpoIIIJQ140K substitution acts downstream of SigM regulon expression and 
suppresses the lethality of yhdL mutant, this suggests that toxicity of high SigM is not only from 
competition with SigA, but also likely results from overexpression of membrane proteins. SpoIIIJ 
is involved in insertion of membrane proteins into the membrane, and it is possible that the 
SpoIIIJQ140K mutation affects its activity and alleviates the membrane secretion stress. In B. subtilis, 
membrane secretion stress is sensed by the CssRS (control of secretion stress regulator/sensor) 
two component system. In presence of membrane secretion stress, caused either by overproduction 
of secreted proteins or high temperature, CssR upregulates expression of membrane proteases 
HtrA (high temperature requirement) and HtrB to facilitate the re-folding or degradation of 
misfolded proteins. To test whether high SigM activity causes secretion stress, we constructed a 
PhtrA-lux reporter to monitor the CssR-dependent induction of htrA. We found that deletion of yhdK, 
which causes high SigM activity, increases PhtrA activity by over four-fold (Figure 4.8A), and this 
increase can be reduced by the SpoIIIJQ140K mutation by about 50% (Figure 4.8B). Overall these 
results support the idea that high SigM causes membrane secretion stress which can be partially 
alleviated by a mutation in membrane insertase SpoIIIJ. 
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Figure 4.8. SpoIIIJQ140K substitution relieves secretion stresses caused by high SigM 
activity.  
(A). Quantification of secretion stress measured using a HtrA promoter-luciferase reporter in WT 
and the yhdK mutant. (B). PhtrA-lux activity in yhdK mutants with different spoIIIJ alleles. 
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4.4 Discussion 
The use of sigma/anti-sigma factor pairs is common in bacteria to regulate gene expression 
under different growth conditions, and absence of the anti-sigma factor usually leads to 
constitutive activity (and often expression) of the corresponding sigma factor (Asai, 2018). In this 
work, we first found that among the two anti-sigma factors for SigM, the loss of YhdK causes 
growth defect due to toxicity from high level of SigM, while loss of YhdL is lethal, consistent with 
previous report (Horsburgh & Moir, 1999). We then moved on to show that reduction of SigM 
activity at transcriptional level, by overexpression of SigA, abolishing the positive feedback loop 
for SigM expression, or mutations in RNAP can alleviate SigM toxicity and rescue cell growth in 
absence of yhdL or yhdK. During the course of characterizing the mutations in RNAP, we found 
that the RpoCR335H mutant has greatly increased activity of SigW and mildly increased activity of 
SigH. This is, to the best of our knowledge, the first work describing an RNAP mutant that exhibits 
decreased activity to some, but increased activity to multiple other sigma factors. 
The serendipitous discovery that yhdL is not essential in PY79 led to the identification of 
SpoIIIJQ140K allele, which is a unique point mutation among closely related SpoIIIJ/YidC 
membrane protein insertases and is dominant over the SpoIIIJQ140 allele in rescuing cells from high 
SigM toxicity. Based on available structural information of SpoIIIJ from B. halodurans, we 
propose that this substitution increases the positive charge inside the substrate binding groove. 
Indeed, in a SpoIIIJR73AQ140K double mutant which still contains the Q140K mutation but not the 
increased positive charge, cells are vulnerable to high SigM activity and yhdL remains essential. 
 How does the increased positive charge rescue cells from high SigM activity? Because the 
sigM regulon includes many membrane proteins, high SigM activity leads to overexpression of 
these proteins and causes membrane secretion stress. Since many essential membrane proteins 
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need to be correctly inserted into the membrane by YidC and/or the Sec machinery for their 
function, overexpression of membrane/secreted proteins may lead to abnormal/insufficient 
insertion of some essential membrane proteins. Indeed, using a PhtrA-lux reporter, we found that 
cells undergo strong secretion stress in absence of yhdK, and this stress can be significantly 
relieved by the SpoIIIJQ140K allele (Figure 4.8). Because the positive charge in the substrate binding 
groove was previously shown to be essential for the essential function of SpoIIIJ, we speculate 
that the change in this charge may lead to changes in substrate binding and/or the membrane 
insertion step. The identification of the affected membrane proteins will be the subject of future 
investigation.  
While a changed substrate specificity of SpoIIIJQ140K is one plausible explanation for the 
cells’ tolerance of high SigM, another possibility relies on the fact that SpoIIIJ/YidC interacts with 
Sec machinery for membrane protein folding after secretion (Beck et al., 2001), as well as 
membrane proteases if the protein cannot be folded correctly (van Bloois et al., 2008). It is thus 
possible that the SpoIIIJQ140K mutant protein may have altered interaction with one or more 
membrane proteases. Preliminary data suggest that increased production of membrane protease 
HtrB is detrimental for the fitness of the yhdK mutant. How does SpoIIIJQ140K allele affect HtrB 
activity and whether there are other proteases involved will be the focus of future work. 
One important finding of this work is that it reveals a connection between high SigM 
activity and membrane secretion stress. Because cells use a positive feedback loop to turn on SigM 
to a very high level when they face cell wall stresses, it is very likely that by overexpressing 
proteins important to fight cell wall stress, bacteria impose themselves to a secondary secretion 
stress. Indeed, preliminary data suggest that many cell wall targeting antibiotics also induce the 
CssRS two-component system for secretion stress. More work is needed in this aspect to 
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potentially guide the use of multiple antibiotics to fight infectious diseases, with one traditional 
antibiotic targeting an essential bacterial pathway and the other one targeting the new Achilles’ 
heel that bacteria imposed upon themselves when dealing with the first antibiotic. 
 
4.5 Material and Methods 
4.5.1 Strains, plasmids and growth condition 
Bacteria were grown in liquid lysogeny broth (LB) medium with shaking, or on LB plates 
(1.5% agar; Difco) at 37 ˚C unless otherwise stated. Plasmids were constructed using standard 
methods (Luo et al., 2010), and amplified in E. coli DH5α before transforming into B. subtilis. For 
selection of transformants, 100 μg/ml ampicillin was used for E. coli.  Antibiotics used for 
selection of B. subtilis transformants include: kanamycin 15 μg/ml, spectinomycin 100 μg/ml, 
macrolide-lincosamide-streptogramin B (MLS, contains 1 μg/ml erythromycin and 25 μg/ml 
lincomycin), neomycin 10 μg/ml, chloramphenicol 10 μg/ml. 
 
4.5.2 Genetic techniques 
Chromosomal and plasmid DNA transformation was performed as previously stated (Luo 
& Helmann, 2012). Markerless in-frame deletion mutants were constructed from BKE strains as 
described (Meeske et al., 2015). Briefly, BKE strains were acquired from the Bacillus Genetics 
Stock Center, chromosomal DNA was extracted, and the mutation containing an erm cassette was 
transformed into our WT 168 or PY79 strain. The erm cassette was subsequently removed by 
introduction of plasmid pDR244, which was later cured by growing at the non-permissive 
temperature of 42 ˚C. Gene deletions were confirmed by PCR screening using flanking primers. 
Transduction was performed to move SPβ derivatives into the 168 strain as previously described 
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(Harwood & Cutting, 1990). Unless otherwise described, all PCR products were generated using 
B. subtilis 168 strain chromosomal DNA as template. DNA fragments used for gene over-
expression were sequence verified. Null mutant construction was PCR screen verified to have the 
right size band. 
 
4.5.3 Whole genome sequencing and sequence analysis 
Chromosomal DNA of suppressor strains was extracted using Qiagen DNeasy Blood & 
Tissue Kit.  DNA was then sent for sequencing using Illumina HiSeq2500 High Output Mode with 
Single-end 100 bp reads. Sequencing results were analyzed using CLC workbench version 8.5.1. 
Single nucleotide variants (SNVs) were detected using default settings. 
 
4.5.4 Disk diffusion assays 
Disk diffusion assays were performed as previously described (Kingston et al., 2014). 
Overnight cultures of test strains were re-inoculated into fresh LB liquid medium and grown to 
early log phase (OD600 ~0.4), and a 100 μl aliquot of the culture was mixed briefly with 4 ml LB 
soft agar (containing 0.75% agar, kept at 50 ˚C) before being poured onto LB plates (containing 
15 ml LB with 1.5% agar). Plates were then cooled and dried in a laminar airflow hood for 5 
minutes. Filter paper disks were placed on the surface of the plate, and chemicals were added to 
the paper disks. Plates were then incubated at 37˚C for 16 h before the diameter of the zone of 
inhibition was measured. Numbers reported are diameter minus the 6.5 mm diameter of the filter 
paper disk. The chemicals added to the disks include: ampicillin 1 mg, vancomycin 100 μg, 
fosfomycin 1 mg, lysozyme 100 μg, EDTA 10 μl of 0.5 M (pH 8.0) solution. 
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4.5.5 WebLogo for conserved region of RpoB and RpoC 
Conserved region near the suppressor mutations of RpoB and RpoC were generated using 
WebLogo (Crooks et al., 2004). The list of bacterial species of RpoB includes Bacillus subtilis, 
Escherichia coli, Thermus aquaticus, Mycobacterium tuberculosis, Staphylococcus aureus, 
Streptococcus pneumoniae, Salmonella typhimurium, Legionella pneumophila, Chlamydia 
trachomatis, Lactobacillus delbrueckii, Enterococcus faecium, Pseudomonas aeruginosa, Vibrio 
cholerae, Cronobacter sakazakii, Paenibacillus polymyxa and Acetobacter malorum. The list of 
bacterial species of RpoC includes Bacillus subtilis, Escherichia coli, Thermus aquaticus, 
Salmonella typhimurium, Photobacterium profundum, Rhodobacter sphaeroides, Legionella 
pneumophila, Shigella flexneri, Chlamydia muridarum, Lactococcus lactis, Listeria innocua 
serovar, Mycobacterium tuberculosis, Acinetobacter baylyi, Clostridium tetani, Staphylococcus 
aureus, Enterococcus faecium, and Streptococcus pneumoniae.  
 
4.5.6 Colony size measurement 
Colony size was measured using Fiji Image J (Schindelin et al., 2012). Briefly, bacterial cells were 
grown to mid-exponential phase (OD600~0.3-0.4), then serial diluted to desired concentrations. 
Diluted cells were plated onto fresh LB plates (15 ml medium per plate, diameter of the plate is 9 
cm), and multiple dilution rates were used. Plates were incubated at 37 °C for 24 hours. Plates 
containing 10-50 separate single colonies were used for size measurement, because this number of 
colonies per plate ensures sufficient sample size and does not cause reduced colony size due to 
crowdedness and nutrient limitation. Pictures of plates were taken with a ruler as a length reference, 
and colony size was measured using Fiji Image J per software’s instruction. For each strain, at 
least 100 colonies were measured, and box and whisker plots were used. 
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4.7 Supplemental Tables 
Table S4.1. Strains used in this study 
Strain Number Genotype 
HB17474 sigM null markerless 
HB17494 sigM null markerless PM-luxABCDE 
HB20830 yhdK::erm 
HB20833 yhdK::erm, PM-luxABCDE 
HB20928 rpoB "3301G to A" CRISPR 
HB20930 rpoC "1004 C to A" CRISPR 
HB20934 HB20928 with yhdL::kan 
HB20937 HB20930 with yhdL::kan 
HB20940 PY79 BAM1077 ΔPM-rodA yhdL::kan 
HB21075 HB20928 with PM-lacZ 
HB21077 HB20930 with PM-lacZ 
HB21079 HB20928 with PM-lux 
HB21081 HB20930 with PM-lux 
HB21083 HB20928 with PM-lacZ yhdL::kan  
HB21086 HB20930 with PM-lacZ yhdL::kan  
HB21089 HB20928 with PM-lux yhdL::kan  
HB21092 HB20930 with PM-lux yhdL::kan  
HB21105 ganA::Pxyl-sigA 
HB21107 ganA::Pxyl-yhdL-cat 
HB21108 Pxyl-yhdL-cat yhdLK::kan 
HB21166 HB20928 with PM-lux yhdK::erm 
HB21168 HB20930 with PM-lux yhdK::erm 
HB21174 PY79 PM-lux 
HB21175 PY79 PM-lacZ 
HB21228 168 PM-lacZ AntiSigA* 
HB21248 PY79 PM-lacZ yhdL::kan 
HB21281 HB20930 with sigW::erm 
HB21285 HB20928 with sigW::erm 
HB22578 PfosB-lux 
HB22580 HB20928 with PfosB-lux  
HB22582 HB20930 with PfosB-lux  
HB22745 PM-lux sigMyhdLyhdK::tet 
HB22775 ganA::Pxyl-sigA PM-lacZ 
HB22781 168 PM-lacZ  spoIIIJPY79 
HB22787 Pxyl-sigA yhdL::kan 
HB22789 168 PM-lacZ  spoIIIJPY79 yhdL::kan 
HB22799 sigE null markerless 
HB22800 sigH null markerless 
HB22801 spoIIIC null markerless 
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HB22802 spoIVCB null markerless 
HB22803 oxaAB (yidC2) null markerless 
HB22807 PspoIIM-lux 
HB22808 PspoVG42-lux 
HB22809 PspoVFA-lux 
HB22825 HB20928 with PspoIIM-lux  
HB22827 HB20930 with PspoIIM-lux  
HB22829 sigE null markerless PspoIIM-lux 
HB22830 HB20928 with PspoVG42-lux  
HB22832 HB20930 with PspoVG42-lux  
HB22834 sigH null markerless PspoVG42-lux 
HB22835 HB20928 with PspoVFA-lux  
HB22837 HB20930 with PspoVFA-lux  
HB22839 spoIIC null markerless PspoVFA-lux 
HB22840 spoIVCB null markerless PspoVFA-lux 
HB22925 PY79 PM-lacZ spoIIIJPY79 
HB22926 PY79 PM-lacZ spoIIIJ null markerless 
HB22965 168 PM-lux spoIIIJPY79 
HB22966 168  spoIIIJPY79  
HB22974 ganA::Pxyl-SpoIIIJ168 
HB22975 ganA::Pxyl-SpoIIIJPY79 
HB22983 PM-lacZ ganA::Pxyl-SpoIIIJ168 
HB22984 PM-lacZ ganA::Pxyl-SpoIIIJPY79 
HB22986 PY79 PM-lacZ ganA::Pxyl-SpoIIIJ168 
HB22987 PY79 PM-lacZ ganA::Pxyl-SpoIIIJPY79 
HB23524 168 spoIIIJ R73A 
HB23526 PY79 spoIIIJ R73A 
HB23530 yidC2 null markerless pAX01-yidC2 
HB23532 168 spoIIIJ R73A pAX01-yidC2 
HB23533 PY79 spoIIIJ R73A pAX01-yidC2 
HB23610 168 spoIIIJ R73A pAX01-yidC2 yidC2::kan 
HB23611 PY79 spoIIIJ R73A pAX01-yidC2 yidC2::kan 
HB23619 Pxyl-sigA PM-lux 
HB23650 PhtrA-lux 
HB23659 PhtrA-lux spoIIIJPY79 
HB23692 168 spoIIIJR73A Q140K 
HB23693 168 spoIIIJR73A Q140K Pxyl-yidC2 yidC2 null markerless 
HB23696 168 spoIIIJR73A Q140K Pxyl-yhdL-xylR-cat 
HB23697 168 spoIIIJR73A Q140K PM-lacZ 
HB23698 168 spoIIIJR73A Q140K Pxyl-yhdL-xylR-cat yhdL::kan 
HB23719 168 spoIIIJQ140K Pxyl-yhdL-cat yhdL::kan 
HB23720 PY79 PM-spoVG-lacZ Pxyl-yhdL-cat yhdL::kan 
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Table S4.2. Primers used in this study 
Primer 
Number Name Sequence 
6582 yhdL-cln-up-F GCCGTTTTCGTTGCGAGAAT 
6583 yhdL-cln-up-R CGCCGACATTCGCTGATTTTTCCTGGTCGCTCATTTCCC 
6584 yhdL-cln-mid-F GGGAAATGAGCGACCAGGAAAAATCAGCGAATGTCGGCG 
6585 yhdL-cln-mid-R CCTATCACCTCAAATGGTTCGCTGTCCGAAAACCGGTATAACGAAA 
6586 yhdL-cln-down-F CGAGCGCCTACGAGGAATTTGTATCGAGATACGAATTTACAGTTTGGCT 
6587 yhdL-cln-down-R ACGAATCGGGCAATCATGTG 
6588 chr-sigM-seq-F CCATTGTGCCACTCCTTCAC 
6589 chr-sigM-seq-R TGCAGTCATTTCCTGGTCGC 
6590 pAX01-check-F GGGGGAAATGACAAATGGTCC 
6591 pAX01-check-R ACGAAAGGGCCTCGTGATAC 
6599 Pxyl-yhdL-F-BamHI ATCGGGATCCTAGAGGGGAGAAAAGGCAATGATGAATGAAGAATTTAAAAAGC 
6600 Pxyl-yhdL-R-SacII  ATCGCCGCGGTCCAGCCGAATACATTGTG 
6693 pAX01-erm-cm-up-F GCCGCACTCTTCCTTTTTCAA 
6694 pAX01-erm-cm-up-R  CTTGATAATAAGGGTAACTATTGCCTTTGGTTGAGTACTTTTTCACTCG 
6695 pAX01-erm-cm-down-F GGGTAACTAGCCTCGCCGGTCCACGCTGGGGGAGGAAATAATTCTATGAGTCGC 
6696 pAX01-erm-cm-down-R TCGGCATTTTTGCATGGAGC 
6759 yhdL-check-F  ACGCTGGGAAGCTACCTCTA 
6760 yhdL-check-R  TCTGCTTTTGCGGTCGTTTG 
6808 PsigM-F-EcoRI  AGCTGAATTCGCCGTTTGCATGTAATGTG   
6809 PsigM-R-PstI AGCTCTGCAGCAGTAAGTCTTCAGCAAGATGC   
6814 pBs1ClacZ(lux)-check-F AAAGGATTTGAGCGTAGCGA 
6815 pBs1ClacZ-check-R TTGGGTAACGCCAGGGTTTT 
6816 pBs3Clux-check-R GAGAGTCCTCCTGTCGACCT 
7249 yhdL-in-check-F GAAAACACAGCACCGGCAAT 
7250 yhdL-in-check-R AATTCCACCTCGCCGACATT 
7324 rpoB-gRNA-F TACGGACTGTTAAGTCTGATGACG 
7325 rpoB-gRNA-R AAACCGTCATCAGACTTAACAGTC 
7326 rpoB-repair-up-F AAGGCCAACGAGGCCTGCGCTTCGCAATCTTGATG 
7327 rpoB-repair-up-R CTTCGTATGTTTTCACACGTCCAACAACATCATTAGACTTAACAGTCAGAATTTCTTGA 
7328 rpoB-repair-down-F TCAAGAAATTCTGACTGTTAAGTCTAATGATGTTGTTGGACGTGTGAAAACATACGAAG 
7329 rpoB-repair-down-R AAGGCCTTATTGGCCTACGGCGTTGTCCTTGTGAA 
7340 rpoC10034-gRNA-F TACGGGTAAACGTGTCGATTACTC 
7341 rpoC10034-gRNA-R AAACGAGTAATCGACACGTTTACC 
7344 rpoC1004-repair-up-R CAACAACGATTACAGAACGTCCTGAATAGTCCACATGTTTACCAAGAAGGTTTTGACGGA 
7345 rpoC1004-repair-down-F TCCGTCAAAACCTTCTTGGTAAACATGTGGACTATTCAGGACGTTCTGTAATCGTTGTTG 
7346 rpoC10034-repair-WT-up-R CGATTACAGAACGTCCTGAATAGTCCACACGTTTACCAAGAAGGTTTTGACGGAAA 
7347 rpoC10034-repair-WT-down-F TTTCCGTCAAAACCTTCTTGGTAAACGTGTGGACTATTCAGGACGTTCTGTAATCG 
7348 pJOE8999-check-F CCTTTTTGCGTGTGATGCGA 
7349 pJOE8999-check-R GTCAGCTAGGAGGTGACTGA 
7405 SigA-R-SacII  ATCGCCGCGGACAAAATTGAATAGAAACATGCCT 
7406 SigA-F-SpeI ATCGACTAGTTTGCGGAGGAGCAAATAGAT 
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7537 sigA-gRNA-F   TACGCATTATACAATAGAATAAAA 
7538 sigA-gRNA-R   AAACTTTTATTCTATTGTATAATG 
7539 sigA-repiar-up-F   AAGGCCAACGAGGCCTTCCTTCCCCGTTAATTTGT 
7540 sigA-repiar-up-R   CCATATTTTCTATTGTAAGCGTGAGATTTAGGCATGTTTCTATTCA 
7541 sigA-repiar-down-F   TGAATAGAAACATGCCTAAATCTCACGCTTACAATAGAAAATATGG 
7542 sigA-repiar-down-R   AAGGCCTTATTGGCCTCGGGTTAACCTTCTTTCTG 
7543 sigA-seq-F   CCTTTTTGATCCTTCCCCCT 
7544 sigA-seq-R   AGGTCGGCAAAGTATTTGGA 
7656 PfosB-XbaI-F CTAGACTGTATGAAACTTTCTTATGAAAAAAGTCGTATATGTGGATGATCAGCTTCTGCA 
7657 PfosB-PstI-R GAAGCTGATCATCCACATATACGACTTTTTTCATAAGAAAGTTTCATACAGT 
7815 spoIIIJ-seq-F   ACGGGAGATAACTACGGGCT 
7816 spoIIIJ-seq-R   GCTTCATCGACATTTCGCCC 
7827 sigM-int-F   CCGCTGTCTGGCACGAAATA 
7828 sigM-int-R   TTTTCAAGTGGCGCGAAACG 
7866 spoIIIJ-gRNA-F    TACGATCCAATTAAAATCGGCATC 
7867 spoIIIJ-gRNA-R    AAACGATGCCGATTTTAATTGGAT 
7868 spoIIIJ-up-F  AAGGCCAACGAGGCCTATTGCCAGAAAACCGGCGA 
7869 spoIIIJ-up-R  TCGCATGATAGAATCCAATTAAGATAGGCATCTTGATCAAAATCGGGAAACATCCC 
7870 spoIIIJ-down-F  GGGATGTTTCCCGATTTTGATCAAGATGCCTATCTTAATTGGATTCTATCATGCGA 
7871 spoIIIJ-down-R  AAGGCCTTATTGGCCATCAGACTTCCCGGCAATGG 
8110 
PspoIIM-XbaI-F   
ATCGTCTAGACATACAGCAGTTGATGATAAGG 
8111 
PspoIIM-PstI-R   
ATCGCTGCAGCGCTCTAGTGATTTGATTTAATA 
8112 
PspoVFA-XbaI-F   
ATCGTCTAGAGCGGGCTCTAAAGAAAACAT 
8113 
PspoVFA-PstI-R   
ATCGCTGCAGCTGGATCTCTAGTTGTTAAGC 
8114 
sigH-check-F   
ATTTTCGGACAGGGGGCATT 
8115 
sigH-check-R   
GGTTTCCGCATGTCTTGCAT 
8116 
sigE-check-F   
CAGGGGAGTTGGTCAGCAAA 
8117 
sigE-check-R   
ACCCCGCAGATTTCGACTTT 
8118 
spoIIIC-check-F   
TGCCTGCAACTTGGACTGAT 
8119 
spoIIIC-check-R   
AGCTTTTAGAACGTCCGGCT 
8120 
yidC2-check-F   
TCCTGCTCTAACGGCAATCG 
8121 
yidC2-check-R   
CTTTTTGCACGGGGTTGCTT 
8122 
spoIVCB-check-F   
ACAGGCCTGCCATCCATTTT 
8123 
spoIVCB-check-R   
GGCCGCAAGCGTCTTTTAAC 
8132 PspoVG42-up-F   ATCGTCTAGAATAAGAAAAGTGATTCTGGGAGA 
8133 PspoVG42-up-R   TCCTGCTCGTTTTTAAAATATTTTTTaAAAAAATAGGATATAGTTACACAATTAGGT 
8134 PspoVG42-down-F   ACTATATCCTATTTTTTtAAAAAATATTTTAAAAACGAGCAGGA 
8135 PspoVG42-down-R   ATCGCTGCAGTCCCTATATAAAAGCATTAGTGTATCA 
8246 spoIIIJ-PY79-to-168-down-F  CATTGGCGGGATGTTTCCCGATCTTGATCCAGATGCCGATTTTAATTGGA 
8247 spoIIIJ-PY79-to-168-up-R   AAAATCGGCATCTGGATCAAGATCGGGAAACATCCCGCCAATG 
8248 spoIIIJ-PY79-to-168-gRNA-F   TACGATCGGCATCTTGATCAAAAT 
8249 spoIIIJ-PY79-to-168-gRNA-R   AAACATTTTGATCAAGATGCCGAT 
8278 spoIIIJ-R73A-gRNA-F TACGAATTAATAAACGAATTAAAA 
8279 spoIIIJ-R73A-gRNA-R AAACTTTTAATTCGTTTATTAATT 
8280 SpoIIIJ-R73A-repair-up-R GCTGCTTAATCATCAGCGGTAAAATTAATAATGCAATTAAAATGGTAACTAGAATAATTGAAAGC 
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8281 SpoIIIJ-R73A-repair-down-F GCTTTCAATTATTCTAGTTACCATTTTAATTGCATTATTAATTTTACCGCTGATGATTAAGCAGC 
8282 spoIIIJ-SpeI-F ATCGACTAGTAGATTAATTATAGGAGGAAATGTTGT 
8283 spoIIIJ-BamHI-R ATCGGGATCCAGCAGTCACATTCCTCACTTTT 
8347 
spoIIIJ-XmaI-F   
ATCGCCCGGGAGATTAATTATAGGAGGAAATGTTGT 
8348 
SpoIIIJ-XbaI-R  
 ATCGTCTAGAAGCAGTCACATTCCTCACTTTT 
 
 
